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ABSTRACT 
We assembled the genome of the human fungal pathogen Candida albicans into 
eight chromosomes, and annotated each of its genes. A genome comparison with 
Saccharomyces cerevisiae revealed an increased number of C. albicans superoxide 
dismutase genes. We analyzed the expression patterns and the function of one of the se 
genes, SOD5, whose role is to prote ct the pathogen against extracellularly produced, 
neutrophil-generated superoxide radicals. Comparative genomics also showed that 
although many of the C. albicans transcription factors, such as Gal4p and Gcn4p, have 
homologues in S. cerevisiae, the sequence similarities occur only in the DNA binding 
motifs of those proteins. Deletion analysis of CaGcn4 and CaGal4 proteins show that the 
N'and C' termini respectively are needed for their transactivation ability. These two 
transactivation regions show no sequence similarity to the equivalent domains in their S. 
cerevisiae homologues, and the two C. albicans transactivating do mains themselves show 
little similarity. A comparative analysis of the transcriptional machinery between C. 
albicans and S. cerevisiae showed low sequence similarity of the mediator complex that 
bridges activation domains of transcription factors to the RNA polymerase II complex. 
We performed a comparison of intergenic DNA regions to identify the cis-regulatory 
elements from Candida and Saccharomyces species to examine the organization of the 
transcriptional regulatory networks between these two organisms. We observed that the 
C. albicans GAL genes lack Ga14p binding sites, but that such sites are found upstream of 
telomeric genes and genes involved in glycolysis, and we show that CaGal4p regulates 
the expression of those genes. We identified the regulatory DNA sequences in the 
promoters of GAL genes, inc1uding a GAL - specifie palindrome necessary for GALlO 
v 
expression. Cph 1 p, the C. albicans homolog of the Ste 12p transcription factor controlling 
pheromone-induced gene expression in yeast, acts through this GAL-specifie palindrome, 
functioning as an activator in the presence of galactose. This shows C. albicans and S. 
cerevisiae can regulate the same process by different regulatory circuits. 
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RÉSUMÉ 
Nous avons assemblé le génome du pathogène fongique humain Candida albicans 
en huit chromosomes, et avons annoté chacun de ses gènes. Une comparaison de génome 
avec Saccharomyces cerevisiae a indiqué un nombre accru de gènes superoxydes 
dismutases de C. albicans. Nous avons analysé les modèles d'expression et la fonction 
d'un de ces gènes, SOD5, dont le rôle est de protéger le pathogène contre des radicaux 
superoxydes produits extracellulairement par les neutrophiles. La génomique 
comparative a également démontré que bien que plusieurs des facteurs de transcription de 
C. albicans, tels que Gal4p et Gcn4p, aient des homologues dans le S. cerevisiae, les 
similitudes de séquence se trouvent seulement dans les motifs de liaison de ces protéines 
à l'ADN. L'analyse de suppression des protéines CaGcn4 et CaGal4 démontre que les 
termini N'et C' sont respectivement nécessaires pour leur capacité de transactivation. Ces 
deux régions de transactivation ne montrent aucune similitude de séquence avec les 
domaines équivalents dans leurs homologues de S. cerevisiae, et les deux domaines 
transactivants C. albicans eux-mêmes montrent peu de similitude. Une analyse 
comparative de la machinerie de transcription entre C. albicans et S. cerevisiae a montré 
une faible similitude de séquence du complexe médiateur qui relie les domaines 
d'activation des facteurs de transcription au complexe de la polymérase II de l'ARN. 
Nous avons effectué une comparaison des régions intergèniques de l'ADN pour identifier 
les éléments de la cis-régulation des espèces Candida et Saccharomyces afin d'examiner 
l'organisation des réseaux de régulation de transcription entre ces deux organismes. Nous 
avons observé que les gènes GAL de C. albicans manquent d'emplacements de liaison 
Gal4p, mais que de tels emplacements sont trouvés dans les promoteurs des gènes 
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télomériques et des gènes impliqués dans la glycolyse, et nous avons montré que 
CaGal4p règle l'expression de ces gènes. Nous avons identifié les séquences de l'ADN de 
régulation dans les promoteurs des gènes GAL, incluant un palindrome spécifique pour le 
GAL nécessaire pour l'expression du GALlO. Cphlp de C. albicans, l'homologue du 
facteur de transcription Ste 12p contrôlant l'expression du gène en levure induit par la 
phéromone, agit à travers ce palindrome spécifique à GAL et fonctionne comme 
activateur en présence du galactose. Ceci montre que C. albicans et S. cerevisiae peuvent 
régler le même processus par différents circuits de régulation. 
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Chapter 1: Introduction 
CHAPTER 1: INTRODUCTION 
1.1 History, Rationale, and Objectives: 
An important diploid fungal pathogen, Candida albicans, which diverged from 
the baker's yeast S. cerevisiae approximately 250 million years ago, causes the majority 
of human fungal infections (116). Genetic manipulations that are carried out easily in S. 
cerevisiae are more difficult in C. albicans due to the fact that C. albicans is diploid, 
lacks a useful sexual cycle, and does not have the abundance of molecular tools that are 
available for studies in yeast. Currently, reverse genetic approaches are commonly used 
for functional studies in C. albicans: genes are first identified by their sequence and then 
both genomic copies are sequentially mutated. Generally this approach is made efficient 
through a previous knowledge of the biological process of interest, emphasizing a 
usefulness of a model organism like S. cerevisiae. In addition, the unconventional C. 
albicans codon usage poses another significant challenge: C. albicans translates the 
universalleucine codon CUG as serine (263). Therefore, many heterologous markers do 
not fully function in C. albicans unless they are modified by codon optimization. Due to 
those difficulties in C. albicans genetics, genomic approaches are very useful in the study 
of this pathogen. 
The genome of the human fungal pathogen C. albicans had been sequenced by the 
Stanford Genome Technology Center and assembled into 412 contigs (148). We 
completed the assembly of the genome of this fungus into eight linear DNA sequences 
representing the 8 chromosomes (Van het Hoog et al, in revision). In addition we 
established a detailed annotation of the genes (33). The assembly and annotation allowed 
us to perform comparative genomics of inter- and intragenic regions of C. albicans with 
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those of other pathogenic and nonpathogenic fungi to better understand the biology of 
this organism. In particular, the comparative genomics of non-coding DNA sequences of 
two organisms with similar gene contents may explain species-specific characteristics 
that distinguish, for example, C. albicans from S. cerevisiae and humans from 
chimpanzees. Our studies show that a genome sequence assembled into chromosomes, 
coupled with the annotation of its genes: 
1) helps to direct understanding of the biology of the organism; 
2) helps to underline the differences in the human fungal pathogen C. albicans 
from the model yeast such as its virulence factors (SOD5) and the 
differences in the structure of its transcriptional machinery (GaI4p, Gcn4p, 
and mediator complex); 
3) helps to define the role of transcriptional regulators and show that C. 
albicans and S. cerevisiae can regulate the same process (galactolysis) by 
different regulatory circuits. 
1.2 Introduction to yeasts and their genomes. 
The increasing number of fungal genomes who se sequences have been completed 
allows their comparison at the nucleotide and protein levels and improves our knowledge 
of evolutionary relationships among fungi. Yeasts include important industrial organisms 
that have been used for many centuries, pathogens, and popular laboratory organisms that 
serve as general models to understand the eukaryotic cell. For decades, Saccharomyces 
cerevisiae, baker's yeast, has been one of the best-characterized organisms from the 
genetics and physiological point of view. Sequencing of yeast genomes tells us directly 
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about the coding potential and regulatory sequences that are necessary for yeasts as weIl 
as eukaryotic ceIls, but also about genes that are specific for a certain species. However, 
yeasts could also be used as a general model in comparative genomics because of the 
small genome size(s) and the well-defined evolutionary relationship among different 
lineages. 
Overall, the information on the full sequence of more than 20 fungal genomes is 
accessible. They include members of the Archiascomycetae, Hemiascomycetae and 
Basidiomycetae classes, and therefore they coyer an evolutionary range that could extend 
more than 1 billion years (117). This amount of information allows the comparison of 
fungal genomes covering short phylogenetic distances, for instance, within 
Hemiascomycetes, or larger distances that include the other two classes. Comparative 
genomics has emerged as a new discipline; in the case of fungi it allows a better 
understanding of species evolution and helps to explain the different life styles that can 
be found among the se organisms, and it introduces new information useful from a 
medical and technological point of view. Comparison of the genomes of two species such 
as S. cerevisiae and Cryptococcus neoformans demonstrates that they share at least 65% 
of their genetic information, which is noteworthy for two species that diverged in the 
evolutionary tree about 1 billion years ago (117, 191). Obviously, sorne genetic traits 
such as those coding for capsule synthesis and other possible virulence factors, such as 
melanin formation, are specific to C. neoformans. 
Analysis of the sequence of the 16 chromosomes of the S. cerevisiae genome 
revealed the existence of numerous pairs of homologous regions. On this basis it was 
postulated that whole-genome duplication had occurred in an ancestor of S. cerevisiae 
3 
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(307). This duplication event was followed by extensive gene loss, which in general 
would have affected only one of the two members of the generated gene pairs, and was 
followed subsequently, among other events, by gene inversions and transpositions 
affecting individual genes. As a result, S. cerevisiae individual genes that lack 
homologues coexist with families formed by two paralogous genes located in sister 
chromosomal regions (large blocks of homologous genes) on two different chromosomes 
(e.g. RCR1 and RCR2) (308). A consequence of gene duplication is the possibility for 
functional redundancy, with its implications on phenotypic stability. Enzymes involved in 
the defense against oxidative stress in S. cerevisiae offer a number of examples of this 
situation (276, 289). Thus, S. cerevisiae contains two cytosolic thioredoxins Trxl, Trx2, 
and one mitochondrial Trx3; and aIl three proteins show significant similarity in their 
amino acid sequences (236, 294, 295). S. cerevisiae also possesses two dithiol 
glutaredoxins: Grxl is exclusively cytosolic while its homologue Grx2 shares a cytosolic 
and a mitochondrial location (196, 198). Interestingly, S. cerevisiae has a peroxisomal 
omega class glutathione transferase Gto 1 that is induced under oxidative stress 
conditions, and two homologues, Gt02 and Gt03, located in the cytosol (11, 95). Among 
the fungal genomes sequenced up to now, only the S. cerevisiae-closely related species 
Saccharomyces paradoxus has a predicted peroxisomal Gto 1 orthologue; other fungal 
species contain a single Gto homologue, probably located in the cytosol. In contrast to 
other fungi therefore, the genome duplication in the Saccharomyces evolutionary line has 
apparently led to a new enzyme activity in an organelle such as the peroxisome as a 
distinctive trait of S. cerevisiae and close relatives. A parallel loss of peroxisomal 
glutathione transferases in different evolutionary lines from a fungal ancestor that 
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contained such enzymes could also have led to the present situation, but this seems a less 
plausible hypothesis, as it would require a larger number of independent genetic changes. 
The presence of a glutathione transferase protecting against reactive oxygen species 
generated at the peroxisome could explain the acquisition of sorne metabolic traits, such 
as the participation in lysine metabolism by S. cerevisiae peroxisomes compared to other 
fungal species (34). 
The above considerations concern evolution within fungi over a long-time scale, 
that is, a period of about 1 billion years (lI 7). How is evolution operating over a shorter 
time scale, for instance within the genus Saccharomyces? Two recent studies (62, 153) 
address this question within the Saccharomyces sensu stricto group that has accumulated 
an estimated 5-20 million years ofseparate evolution (63,161). The partial sequencing of 
the genomes of the S. paradoxus, S. mikatae, S. kudriavzevii and S. bayanus species and 
the comparison with the S. cerevisiae genome sequence (62, 153) permitted the 
observation that synteny, namely gene position and orientation relative to neighbor genes, 
is conserved for most of the observed Saccharomyces genomes. Nucleotide changes are 
about twice as frequent in intergenic regions than in si de genes, as expected from the fact 
that these intergenic regions have fewer restrictions for maintaining sequences than 
coding regions where many nucleotide changes would lead to non-functional amino acid 
substitutions. Even in intergenic regions, nucleotide changes have not occurred 
homogeneously. This has allowed the characterization of conserved intergenic sequences 
that may correspond to promoter regulatory motifs less prone to evolutionary changes 
than other sequences, for instance those downstream of the 3' ends of genes. This 
observation demonstrates the existence of a selective pressure that acts conservatively at 
5 
Chapter 1: Introduction 
gene promoters. With respect to coding sequences, there is a high level of conservation 
among the sensu stricto yeast species and most changes at the nucleotide level have 
occurred at the third position among synonymous codons, that is, they are conservative 
(153). 
In spite of the high level of genome conservation among the sensu stricto species, 
there exists a small number of genes that are species-specific (63, 153). These may have 
resulted from recombination events involving more distant species. A large proportion of 
the se species-specific genes have a metabolic function, particularly in sugar metabolism. 
Although sorne of the above genome changes are still difficult to explain on a molecular 
basis, they shed new light on the mechanisms of genome evolution that may be 
applicable to other closely related organisms, such as humans and chimpanzees. Again, 
genomic studies on S. cerevisiae and related species may open the way for analysis of the 
evolution of biological systems. 
1.3 Candida albicans 
1.3.1 A human funga) pathogen. 
Aimost aIl of us carry C. albicans in our gastrointestinal and genitourinary tracts, 
and on our skin. C. albicans can colonize and invade the host tissues when the immune 
systems are weakened either as a result of cancer chemotherapy or HIV infections, or as a 
result of elimination of competing flora after antibiotic treatment. These infections can 
range from thrush in immunocompetent colonized hosts, to life-threatening systemic 
infections in immunocompromised individuals such as patients with cancer (64). C. 
albicans is the fourth most common hospital acquired infection in the United States, and 
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its treatment costs more than US $1 billion each year (14, 216). Because this fungal 
pathogen is a eukaryote and shares much of its biological processes with humans, many 
antifungal drugs cause deleterious side effects. It is therefore important for Candida 
research to identify targets of antifungal technologies. 
1.3.2 Yeast to Hyphal transition of C. albicans. 
Because the biological processes of C albicans are similar to those of S. 
cerevisiae, rapid advances have been made in understanding Candida molecular and 
cellular biology. S. cerevisiae diverged from C albicans 250 million yearS ago (116), and 
is an important guide for studying aspects of signal transduction, mating, cell-cyc1e 
progression, cell-wall biosynthesis, and metabolism in C albicans. Despite the fact that 
many processes are conserved between the two organisms, there are also significant 
differences between the two cousins. For example, while S. cerevisiae grows exc1usively 
as budding yeast, C albicans can grow in several morphological forms: it can proliferate 
as budding yeast, and it can also form filaments, such as true hyphae and pseudohyphae. 
Hyphal formation of this fungus can be induced by high temperature, basic pH, and by 
the presence of serum, and this morphological transition is implicated in the pathogenesis 
of C albicans (35). 
Because the virulence of C albicans has been associated with its ability to switch 
between yeast and hyphal forms, morphogenesis has been the focus of the research of this 
fungus. C. albicans cells in a hyphal state are often found at sites of tissue invasion, and 
cells that do not form hyphae are often less virulent (105). In addition, other Candida 
species that do not form true hyphae are less frequently isolated from the human host, 
7 
Chapter 1: Introduction 
which suggests that they are less virulent. At the same time, strains that are unable to 
grow in the yeast form are also less virulent (30, 105, 170, 190). It is currently thought 
that the hyphal cells express cell wall proteins that both facilitate adhesion to human 
tissues, and are important for tissue invasion, as weIl for escape from the white blood 
cell-mediated phagocytosis. In contrast, it is believed that the yeast form of C. albicans 
disseminates through the blood stream (105) 
Much effort has been made by the scientific community to understand the 
environmental factors that induce hyphal formation through signaling pathways. 
Different hyphal inducing factors probably reflect the variety of microenvironments in 
which the pathogen survives in vivo (105, 187). Just as in S. cerevisiae, cAMP and MAP 
kinase pathways target transcription factors (in C. albicans the Efg 1 p and Cph 1 p factors 
respectively) that promote morphogenesis. The deletion of efgl blocks filamentation in 
most conditions, while the deletion of cphl blocks the filament formation only in 
response to a limited set of conditions (157, 173, 188). This shows that the cAMP 
pathway plays a more important role in C. albicans morphogenesis than in S. cerevisiae. 
A cphl efgl double mutant fails to form filaments in most in vitro conditions, and is 
avirulent in a systemic mouse model of candidiasis (190). This observation is often 
viewed as showing that the ability to form hyphae or pseudohyphae is an essential 
virulence factor. However, these mutations block the expression ofhyphal-specific genes, 
many ofwhich are also required for virulence. In addition, cphl efgl mutants were found 
to produce filaments under sorne in vivo and in vitro conditions (251), possibly due to the 
action of other hyphal inducing pathways, such as the Rim101p pathway, which is 
activated by alkaline pH (69, 79) and the Czf1p pathway, which is activated by growth in 
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a solid matrix (36). Hyphal induction is repressed by transcriptional inhibitors such as 
Tuplp (31), which associates with its DNA-binding partners Nrglp (32, 220) and Rfglp 
(149). 
1.3.3 C. albicans genome. 
An important tool for the scientific community working with C. albicans is the 
whole genome sequence of this fungal pathogen; this sequence is needed for the 
application of knowledge acquired from the biology of other model organisms such as S. 
cerevisiae, for the proper interpretation of functional genomic studies, and ultimately for 
the identification of novel antifungal targets that may be unique to the pathogen and 
whose inhibition won't have deleterious effects on the host. 
The Candida Genome Sequencing Project started in 1996, and in 2004 it produced a 
diploid assembly constructed from 10.9X coverage, called Assembly 19. It provided 
single contigs where heterozygosity was not obvious and allelic contigs where there was 
significant heterozygosity (148). Several important steps along the way to this release are 
detailed in a review by Nantel (223). The first was the construction of a physical map of 
chromosome 7 (54). Chibana et al. (56) completed the sequence of chromosome 7, 
identified 404 genes, and compared the synteny to the S. cerevisiae genome. The authors 
sequenced the Major Repeat Sequences and the gaps left in Assembly 19. They then 
aligned the sequence on the chromosome as determined by the physical map (54). Then 
there were the two early releases of the emerging genome sequence data, called 
Assembly 4 and Assembly 6, which were the lower density assemblies that facilitated a 
great deal of gene analysis. These assemblies provided the framework for the 
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construction of seve rai microarrays (168, 224), an analysis of genes haploinsufficient for 
filamentation (300), and the elucidation of several gene families, including a number 
important in pathogenesis, such as the secreted aspartyl proteinases (SAPs) (131), the 
agglutinin-like substances (ALSs) (127), and the phospholipases (PLB and PLC) (160, 
259). Two relatively comprehensive C. albicans disruption libraries have been described. 
One library was constructed systematically by targeted disruption of one aIlele followed 
by insertion of a regulated promoter at the other allele (254). The other disruption library 
was constructed randomly by transposon mutagenesis, inserting a UAU cassette into one 
allele, which facilitates disruption of the second aIlele via two spontaneously occurring 
steps of mitotic recombination (39). One of the very important achievements was 
Assembly 19, the diploid assembly of the genome of C. albicans strain SC5314. The 
genome sequence provided a great deal of insight into many aspects of genomic 
organization, such as the large amounts of heterozygosity (148). 
1.4 Introduction to transcription 
1.4.1. General overview of eukaryotic initiation of transcription. 
ln general, a genome consists of genes, which are transcribed into mRNA and 
then translated into proteins. Expression of a typical eukaryotic gene is a complicated 
process, which involves transcription, RNA splicing, capping, and transport out of the 
nucleus into the cytoplasm where the processed message can be translated into protein. In 
this work 1 will mostly concentrate on the initiation of transcription of genes. 
Much of what we know about the regulation of gene expression cornes from 
studies of the yeast Saccharomyces cerevisiae. Yeasts, like aIl eukaryotes, have three 
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RNA polymerases (253). PolI transcribes genes encoding RNA that functions as a part of 
ribosomes (rRNA) (246). PolII transcribes genes that code for proteins (mRNA) (113), 
while the tRNA genes are transcribed by PolIII (98). 
The transcriptional machinery of yeast is very complex: in addition to the core 
polymerase, it can contain at least 100 proteins (178) (Table 1.4.1). The function of many 
of these proteins is not known, but we can nevertheless make the following general 
points: 
• Sorne of the protein complexes, such as TBP, TFIIB, T AF 17, and TFIIA bind 
DNA directly to form a platform for RNA polymerase II (41, 106, 177,233,277). 
• Sorne of the protein complexes contain enzymes, such as TFIIH, which contains a 
kinase and two helicases (280). These activities help the polymerase initiate 
transcription and then exit the promoter. Other factors like histone acetyl 
transferases (HATs), hidtone deacetylates (HDACs), and histone kinases regulate 
transcription by chemically modifying histones in nucleosomes (19,37). 
• Sorne of these proteins are required globaIly for transcription - when any one of 
the proteins like TBP, TFIIB and the helicases in TFIIH is depleted from ceIls -
transcription of aIl genes by PolII stops. In contrast, other prote in s, like sorne 
members of the nucleosome modifying enzymes and sorne members of the 
mediator complex, are needed for the expression of only certain genes under 
certain conditions (see below) (106, 113, 177,277,280). 
• Most proteins of the transcriptional machinery can be isolated from ceIls as parts 
of complexes. The mediator complex, which consists of more than 20 proteins, 
can associate with polymerase to form a "holoenzyme" (27, 206, 221). In 
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addition, proteins found in one complex are sometimes found in another complex 
as weIl. For exampIe, certain TBP-associated factors aiso associate with the HAT 
Gcn5 in the SAGA (Spt, Ada, Gcn5 Acetyltransferase) complex (175). 
The modei of gene activation in eukaryotes is consistent with predictions of the 
"regulated recruitment" mechanism (10, 152, 177,201,202,210,245,303): 
• The transcriptional machinery is not bound to the promoter of a given gene prior 
to activation. 
• Activators are modular pro teins with separable activating and DNA-binding 
domains. 
• The activating domain must be attached to the DNA promoter to activate 
transcription of the downstream gene. 
• A given activating region will transactivate when attached to a heterologous DNA 
binding domain, even one taken from bacteria. 
• Any number of genes can be controlled by a given activator if their promoters 
contain the appropriate activator binding sequence. 
Table 1.4.1. Transcriptional machinery: S. cerevisiae vs C. albicans. 
S. cerevisiae and C. albicans transcriptional machinery are compared by calculating the 
average e values of its individual components.A pair-wise sequence comparison was 
do ne on the fuIllength amino acid sequences using a standard pair-wise blastp setting on 
http://www.ncbi.nlm.nih.gov/blast/b12seq/wblast2.cgi. P (-LOG lO(e-values)) is a 
statistical measure of the similarity between the two proteins: the higher the value of P -
the more homologous the two proteins are. 
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Galactose is utilized by almost all organisms through its conversion to glucose-6-
phosphate in a reaction catalyzed by the enzymes of the Leloir pathway (179). In 
Saccharomyces cerevisiae these enzymes are eneoded by GALl (galaetokinase), GAL7 
(galactose-l-phosphate uridyl transferase), GALlO (UDP-glucose-4-epimerase), and 
GAL5 (phosphoglueomutase) (75-77). Galactose enters S. cerevisiae cells through a 
specifie permease, encoded by GAL2 (297). Beeause eukaryotic genes are not organized 
14 
Chapter 1: Introduction 
in operons, it is intriguing that the GALl, GAL7, and GALlO genes are clustered near the 
centromere of chromosome II, and the expression of those genes is induced by galactose 
(192). The level of induction of GAL genes is unusually high for yeast genes. When cells 
grow in the absence of galactose the level of expression of GAL genes is very low. The 
addition of galactose induces GAL genes more than 1000-fold, which makes them among 
the most highly expressed genes in the cell. This high level of expression is attributed to 
the action of a single transactivator, Gal4p, which binds specifie DNA sites upstream of 
GAL genes (147). In addition, Gal4p will activate a wide array of genes in yeast and 
many other higher eukaryotes if Gal4p binding sites are introduced nearby (12). There is 
also one additional regulator of GAL genes: the repressor Mig 1 p, which only works in the 
presence of glucose (43). This ensures that if both galactose and glucose are present, 
glucose will be utilized first. A Mig 1 P site is also found upstream of GAL4 gene, so that 
glucose reduces the level of Gal4p in addition to repressing GAL genes directly (227). 
Mig 1 P binding sites are also found upstream of many other glucose-repressed yeast genes 
(107,192). 
The four sites on the GALl promoter to which Gal4p binds comprise the galactose 
upstream activating sequence (UASG), and lie about 275 base pairs upstream of the GALl 
transcriptional start site. A binding site for the Mig 1 P is found between the UASG and the 
GALl transcriptional start site. Each GAL gene, like other typical eukaryotic genes, 
contains a TATA element, which binds TBP along with many other proteins including 
polymerase. The GAL genes can exist in one of the three states (147, 192): 
• In the absence of galactose and glucose Gal4p is bound to UASG but does not 
activate transcription because it is complexed with an inhibitor Ga180p. 
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• In the presence of galactose Gal4p is freed from Ga180p, and the specific GAL 
gene is transcribed. 
• In the presence of both glucose and galactose the gene is kept off by the repressor 
Mig 1 p. This protein recruits the repressing complex, a key component of which is 
Tuplp. 
The specificity of any transcription factor cornes from its DNA binding domain 
(DBD). Gal4p homodimerizes and recognizes each of the 17 base pair sites 
(CGGN11 CCG) using a zinc cluster type do main (176,303). This motifinserts an a-helix 
into the major groove of DNA. Mig 1 P binds CCCCRNNWWWWW DNA using a related 
motif called a zinc finger (199). 
The prote in Ga13p senses galactose in the environment, binds it along with ATP, 
and interacts strongly with Gal80p (240). This interaction frees Gal4p's activation 
domain (AD) (272). In the absence of glucose, Miglp is held in the cytoplasm in a 
phosphorylated form (274). A kinase, Snflp, which is responsible for this 
phosphorylation, is inhibited by glucose: this inhibition allows Mig 1 p to enter into and 
remain in the nucleus (87). 
Gal4p has distinct DNA-binding and activating functions, which are located on 
separate domains of the protein, and the specific mode of DNA binding is not critical for 
activation (217, 271). The Gal4p DBD is found within the first 100 amino acids of the 
protein, and this region also contains a nuclear localization signal and the Gal4p 
dimerization sequences. Gal4p DBD is able to bind the DNA but does not activate 
transcription. The residues 100-881 of Gal4p can be attached to a different DBD, for 
example the DBD of the bacteriallexA, and the resulting hybrid protein can activate the 
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transcription of a gene that bears binding sites recognized by the new DBD (152, 20 1, 
202, 210). This experiment shows three important features of Gal4p: 
• The DBD does not suffice for transactivation - an AD is also required. 
• The AD must be tethered to DNA to work. 
• The same AD will function when attached to any type of DBD, ev en one from 
bacteria. 
In fact, the link between the AD and the DBD does not have to be covalent. This 
was shown by attaching the AD to Gal80p in a strain where Gal4p bears a weakened AD, 
but nevertheless binds Gal80p (200). Interestingly, the GaI80-AD hybrid activates the 
transcription of the DNA bound Gal4p. The Gal4p DBD, in fact, tethers the GaI80-AD to 
DNA so that it activates the transcription of the downstream gene. This implies that any 
protein-protein interaction that brings the AD in close proximity to the DBD will elicit 
transcription; this is the basis of the "two-hybrid" system, which detects pairs of 
interacting proteins. 
S. cerevisiae Gal4p contains two "acidic" ADs (ADI and ADII): they bear an 
excess of negatively charged glutamic and aspartic acids (201). Each of the ADs is about 
100 amino acids long, and fusing either one to a DBD creates an activator. The activation 
strength of Gal4p is proportional to the length of ADs: the sequential deletion of the ADII 
proportionally reduces the transactivation strength of this protein. In addition, mutants in 
which Gal4p ADI bears more acidic and less basic residues show an increased Gal4p 
activation ability. Finally, ADII, one of the two Gal4p activating regions, also binds 
Ga180p. These two functions can be distinguished by mutation: sorne single ami no acid 
substitutions in ADII decrease or even abolish Gal80p interaction, while having little or 
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no effect on ADII activation ability. This suggests that the same stretch of peptides can 
form two alternative structures: one somewhat defined structure needed to bind Ga180p, 
and another less-defined structure required for activation. 
When attached to a DBD many different peptides work as ADs (202). Most of 
those new ADs resemble natural ADs in that they are acidic and include hydrophobie 
amino acids. For these new ADs, as for the natural ones, scrambling the order of amino 
acids destroys the function: the arrangement of acidic and hydrophobic residues in the 
sequence is important. These properties of ADs suggest that they contain reiterated 
motifs that are difficult to recognize at the primary ami no acid sequence level. 
Activators that work by recruitment cannot activate without binding to DNA 
(200-202). If not bound to DNA, a transactivator would not be able to direct the 
transcriptional machinery to the promoter of a gene. In fact, if an unbound transactivator 
had any effect, it would be predicted to be negative: at high concentrations unbound "AD 
A" would titrate components of the transcriptional machinery and make them unavailable 
for fruitful interaction with a DNA-bound activator "B". The observation is that the 
stronger the AD and the more highly it is expressed - the tighter it is bound to its 
transcriptional machinery target. Overexpression of a Gal4p fragment lacking the DBD 
does not activate transcription, and if GAL genes are being activated by a DNA-bound 
activator, their expression is inhibited. Similar results have been observed with other 
activators. In general, the stronger the AD and the more highly it is expressed, the greater 
the degree of inhibition, a phenomenon called "squelching". It is believed that it is for 
those reasons that one can rarely find activators free of inhibitors in the nucleus, except 
when they are working appropriately. 
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A protein-protein interaction, created by mutation, between a DNA-bound prote in 
and the transcriptional machinery can suffice for activation (120). As mentioned before, 
the Gal4p (1-100) fragment dimerizes and binds DNA efficiently, but does not 
transactivate because it lacks an AD. A mutant yeast strain was isolated in which this 
Gal4p fragment activated transcription as well as the intact Gal4p. The mutant strain 
bears a single amino acid change in the Galll protein, which is a component of the 
transcription mediator. The mutation in Gall 1 p created an adhesive protein-protein 
interaction between Gall 1 p and Gal4p (1-100). The direct tethering of the transcriptional 
machinery, as in the case of lexA-Galllp or GaI4(DBD)-Galllp, leads to the expression 
of the GALl gene, provided the lexA binding site has been inserted nearby. 
In bacteria, polymerase is the only relevant complex needed for the activator to 
recruit to start transcription. Yeast, as all other eukaryotes, has several additional 
complexities. The transcriptional machinery cornes in parts: the DNA is wrapped around 
histones to form nucleosomes, and various complexes chemically modify nucleosomes or 
change their disposition on DNA (234, 285). Each nucleosome contains 146 base pairs of 
DNA wrapped around the histones. Each nucleosome is separated by linker DNA, which 
contains 15 - 20 base pairs. The nucleosomal DNA is less accessible than naked and 
linker DNA. The nucleosomes of the actively transcribed genes are often modified. The 
tail of histones H3 and H4 are typically acetylated and deacetylated at specific lysine 
residues (16, 19, 37, 108, 175). Histone acetyltransferases or HATs, enzymes that 
acetylate histones, have been shown to be required for the full induction of the 
transcription of certain genes. HDACs, enzymes that deacetylate histones, have been seen 
to repress certain genes. 
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These facts could be interpreted as follows. Nucleosomes present a barrier to the 
transcriptional machinery; acetylation of the histones weakens that barrier, while 
deacetylation strengthens it. It is possible that the acetylation of lysines in the histone 
tails eliminates positive charge and therefore weakens interaction of those tails with the 
negatively charged DNA. The expression of the genes can also be affected by enzymes, 
such as the Swi/Snf complex (65, 279), that alter the mobility or configuration of histones 
on DNA. In light of these observations it is possible to consider sorne scenarios of how 
activators might work. On the one hand, direct recruitment of transcriptional machinery 
by an activator would suffice for the initiation of transcription. On the other hand, 
recruitment of nucleosome modifiers might serve to initiate the event, with the 
transcribing complex then forming without additional help. Yet another possibility would 
be that both kinds of complexes are directly recruited. 
The induction of the GALl gene results in the appearance of various components 
of the transcriptional machinery at the promoter, such as polymerase, TFIIH, TFIIE, 
TBP, mediator components, and SAGA (178, 180, 241). Components like TFIIE and 
mediator are only found at the promoter, while others are found both at the promoter and 
downstream in the gene itself along with polymerase. In total, SAGA and mediator 
complexes contribute to activation of GALl by Gal4p; both of those complexes appear at 
the promoter along with polymerase upon activation, and may be recruited directly, or 
sorne might bind cooperatively along with those recruited directly. The following 
experiment showed that to activate efficiently, Gal4p had to touch both SAGA and the 
mediator. When a fusion protein comprising either a component of SAGA or a 
component of mediator complexes is attached to the DBD it elicits very weak activation. 
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But when binding sites for both of these fusions are placed on a promoter, strong 
activation is seen (40). 
If Gal4p binds its sites sufficiently tightly, interacts with the transcriptional 
machinery sufficiently strongly, and that machinery binds the GALl promoter sufficiently 
avidly, the help from nucleosomal modifiers is unnecessary. On the other hand, 
weakening one or another of the interactions can impose a requirement for the 
nucleosomal modifiers. But there is a cell cycle-dependent state in which the induction of 
GAL genes depends on nuc1eosomal modifiers, su ch as Gcn5p and Swi/Snf, even in the 
wild-type configuration (178). The state of DNA differs at different stages of the cell 
cycle: chromosomes are condensed during mitosis, for example. It was observed that 
during mitosis the induction of GALl would proceed normally only if both Gcn5p and 
Swi/Snf are present, which suggests that at this stage the chromatin is in such a 
configuration that those nuc1eosome-modifying enzymes are required (158). 
1.4.3 Another model case: Gcn4p. 
In S. cerevisiae GCN4 encodes a transcriptional activator of ammo acid 
biosynthetic genes that responds to amino acid starvation (123, 124). ScGcn4p is tightly 
regulated at both the transcriptional and translational levels. The 5' leader region of 
GCN4, which codes for a transcriptional activator of amino acid biosynthetic genes in 
response to amino acid starvation, contains four small upstream ORFs (uORFI-4). These 
uORFs act as negative regulators of translation: the ribosome initiates translation at 
uORF 1 and becomes re-activated for translation at subsequent uORFs. Under 
environmental stresses, such as amino acid starvation, the translation of GCN4 is 
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induced: Gcn2p kinase phosphorylates eIF2a, the a subunit of the translation initiation 
factor, and the scanning ribosome is not re-activated until it bypasses the uORFs and 
initiates translation at the GCN4 open reading frame (122). 
Gcn4p binds the 5'-TGACTC-3' DNA binding site, located upstream of many 
genes induced during amino acid starvation, as a homodimer with its basic leucine-zipper 
(bZIP) found within its carboxy terminus (7, 126). In S cerevisiae Gcn4p there are two 
transcription activation domains: one resides in an acidic segment in the center of the 
protein between residues 107 and 144 (125), the second Gcn4p activation do main is 
located in the N-terminal 100 amino acids. The two activation domains are functionaUy 
redundant and can work independently to produce high-Ievel activation (78, 141). 
1.4.4 Types of activation domains. 
The transcriptional activation domains are classified according to their amino acid 
composition: rich in acidic (e.g. S cerevisiae Gal4p and Gcn4p) or basic residues 
(tobacco BBC1), or rich in glutamine (S cerevisiae Mcm1p), threonine-serine (human 
OCT2), or isoleucine (NTF1) (8, 38, 61, 83, 125, 146, 201, 202). The DNA binding 
modules also faU into several classes, such as zinc-finger, leucine-zipper, and helix-Ioop-
helix motifs (81, 84, 306). Although the activation do main is critical for function, and can 
provide a level of regulation, the gene specificity of such transcriptional activators is 
ultimately determined by the DNA-binding address of the protein. 
The role of the transcription activator is to recruit the RNA Polymerase II 
machinery to the promoter to which it is bound. Thus, the transcriptional activation 
domains of both Gcn4p and Gal4p interact with Galll p, which is a component of the 
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mediator complex that binds the RNA Polymerase II machinery (10, 114, 142,235,248). 
Three general models have been proposed to characterize the structure of the 
transactivation domain. In the first hypothesis, it was proposed that activation domains 
are unstructured "acidic blobs" that interact with their targets via ionic interactions. This 
model is supported by the observation that the removal of the residues of activation 
domains decreases the activity gradually, rather than abruptly (271). A second model 
proposes that acidic activation domains form amphipathic a helices, in which acidic 
residues are aligned on one face of the helix. This model is supported by the observation 
that an artificial 15 residue peptide, designed to fold into an amphipathic a helix, shows 
transactivating abilities when fused to the Gal4p DNA binding do main (202). The authors 
of the third model argue that the most likely secondary structure is an antiparallel ~ sheet 
(301). 
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CHAPTER 2. THE COMPLETION OF C. ALBICANS GENOME 
The previously discussed achievements have greatly advanced the pace of 
molecular analysis of the pathogenesis and life style of C. albicans, but Assembly 19 was 
not a fini shed sequence, since it contained a total of 412 contigs, of which 266 were 
allelic. In order to provide a fini shed sequence, called Assembly 21, we used a synteny 
analysis with preliminary versions of the Candida dubliniensis genome assembly, 
bioinformatics, a Sequence Tagged Site (STS) map of overlapping fosmid clones, and an 
optical map to determine the sequence of each of the eight chromosomes. This assembly 
has eight linear DNA sequences including 9 MRSs (3 completely sequenced), 14 MRS 
subrepeats RB2 sequences, 2 MRS subrepeats HOK sequences, and the rDNA. In 
addition to its usefulness for gene mapping, Assembly 21 reveals sorne interesting 
biological features, including a putative transcription factor gene family with members 
proximal to at least 14 of the 16 telomeres, a telomere-like sequence in the middle of 
chromosome 1, information on the relationships of chromosome location to similarity of 
gene families, and a revised ORF list. Assembly 21 stimulates experiments in such areas 
as evolution and genome dynamics. 
Section 2.1 is the second version of the manuscript that has been resubmitted to 
Genome Biology, and it describes the assembly of the C. albicans genome. Section 2.2 is 
an article that describes the annotation of the C. albicans genome. 
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Section 2.1: Assembly of the Candida albicans Genome into 8 Chromosomes. 
Assembly of the Candida albicans Genome into 16 Supercontigs Aligned on the 8 
Chromosomes. 
Marco van het Hoog * l, Timothy 1. Rast *2, Mikhail Martchenko l, Suzanne Grindle2, 
Daniel Dignard l, Hervé Hogues l, Christine Cuomo 3, Matthew Berriman 4, Stewart 
Scherer\ B. B. Magee2, Malcolm Whitewayl, Hiroji Chibanat6 , André NantelI, and P.T. 
Magee$2 
IBiotechnology Research Institute, National Research Council of Canada, Montreal, 
Quebec, Canada; 2University of Minnesota, Minneapolis, MN; 3Broad Institute of MIT 
and Harvard, Cambridge, MA; 4Wellcome Trust Sanger Institute, Hinxton, United 
Kingdom; 53938 Paseo Grande, Moraga, CA 94556; 6Chiba University, Chiba, Japan. 
* These authors contributed equally to this manuscript. 
2.1.1 ABSTRACT 
The 1O.9x genomic sequence of Candida albicans, the most important human fungal 
pathogen, was published in 2004. Assembly19 consisted of 412 supercontigs, of which 
266 were a haploid set, since this fungus is diploid and contains an extensive degree of 
heterozygosity but lacks a complete sexual cycle. However, sequences of specifie 
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chromosomes were not determined. Supercontigs from Assembly 19 (183, representing 
98.4% of the sequence) were assigned to individu al chromosomes purified by pulse-field 
gel electrophoresis and hybridized to DNA microarrays. Nine supercontigs contained 
markers from 2 different chromosomes. For Assembly 21, using a synteny analysis with 
preliminary versions of the Candida dubliniensis genome assembly, bioinformatics, a 
Sequence Tagged Site (STS) map of overlapping fosmid clones, and an optical map we 
determined the sequence of each of the eight chromosomes. The orientation and order of 
the contigs on each chromosome, repeat regions too large to be covered by a sequence 
run, such as the ribosomal DNA cluster and the MRSs; and telomere placement were 
determined using the STS map. The overall assembly was compared to an optical map; 
this identified sorne misassembled contigs and gave a size estimate for each chromosome. 
Assembly 21 reveals a chromosome fusion, a number of small internaI duplications 
followed by inversions, and a subtelomeric arrangement including a new gene family, the 
TLO genes. Correlations of position with relatedness of gene families imply a novel 
method of dispersion. The sequence of the individual chromosomes of C. albicans raises 
interesting biological questions about gene family creation and dispersion, subtelomere 
organization, and chromosome evolution. 
2.1.2 INTRODUCTION 
In the last 25 years, the opportunistic human pathogen Candida albicans has 
become a serious medical problem. This fungus is now fourth on the list of hospital-
acquired infections, ahead of Gram-negative bacteria, and despite the recent introduction 
of a new class of antifungals, drug resistance continues to be a problem (159). In the last 
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15 years molecular techniques have been applied to understand the pathogenesis of this 
organism as weIl as to se arch for novel drug targets. However, C. albicans presents 
several difficulties for molecular biologists. It is diploid; only a part of a sexual cycle has 
been demonstrated; it has a very plastic genome; and it is highly heterozygous. Each of 
these properties is best investigated through a genomic approach. Hence, knowledge of 
the genome sequence has been an important goal for the last 10 years. More recently, 
genome structure and dynamics have become increasingly important in this organism as 
wide-spread aneuploidy (49, 268), the role of repeated DNA in chromosome loss (183), 
and chromosome rearrangement leading to drug resistance (269) have been reported. 
The steps taken to create C. albicans genome Assembly 19 are described in 
section 1.4.3, but Assembly 19 was not a fini shed sequence, since it contained a total of 
412 contigs, of which 266 were the haploid set. In order to provide a fini shed sequence, 
we used hybridization of chromosomes partially purified by pulse-field elecrophoresis as 
well as an STS map based on a fosmid library to identify the chromosomal location of 
various contigs. We then utilized bioinformatics to analyze both the emerging sequence 
of the sister species Candida dubliniensis and the primary traces used to generate 
Assembly 4, and coupled this with the STS map and a who le-chromosome optical map to 
construct Assembly 21. This assembly has eight linear DNA sequences including 9 
copies of the intermediate repeat called the Major Repeat Sequence (MRS), of which 3 
have been completely sequenced. The MRS is made up of three subrepeats, called RB2, 
RPS, and HOK (59). In addition to the intact MRS sequences, there are 14 RB2 
sequences and 2 HOK sequences. The ribosomal DNA constitutes another repeat, which 
is not included in the assembly. In addition to its usefulness for gene mapping, Assembly 
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21 reveals sorne interesting biological features, including a putative transcription factor 
gene family with members proximal to 14 of the 16 telomeres, a telomere-like sequence 
in the middle of Chromosome 1, information on the relationships of chromosome 
location to similarity of gene families, and a revised ORF list. 
28 
Chapter 2: C. albicans genome 
2.1.3 MATE RIALS AND METHODS 
Assembly 21. The first step in Assembly 21 was to assign contigs from Assembly 19 to 
the appropriate chromosomes. One hundred contigs were anchored by probes on the 
physical map. To assign the rest, chromosomes were separated by pulse-field gel 
electrophoresis. Chromosomal bands were eluted from the gel, labeled with either Cy3 of 
CyS dyes, and hybridized to a microarray (224) based on ORFs identified from Assembly 
4. As a control, total genomic DNA was also labelled with the reciprocal dye and co-
incubated along with the partially purified chromosomes. At least two individual 
hybridizations (including dye swap controls) were conducted for each of the 8 
chromosomes. Results and details from these experiments can be seen on our web page at 
http://candida.bri.nrc.ca/index.cfm ?page=CaChrom. Fluorescence ratios were interpreted 
visually and it was very easy for us to assign chromosomal localization for 183 Assembly 
19 contigs representing 98.4% of DNA sequences and 97.3% of known genes. This 
analysis also identified nine misassembled contigs by the fact that genes assigned to them 
hybridized to different chromosomes. The emerging sequence from the closely related 
species Candida dubliniensis was then aligned, using megablast, to the Assembly 19 
contigs. This alignment is shown at http://candida.bri.nrc.ca/dubliniensis/. After the 
release of the Assembly 19 traces, Phrap was used to conne ct pairs of contigs which were 
assigned to the same chromosome, and were found to be adjacent based on the C. 
dubliniensis overlap. Phrap and the traces were also used to locate misassemblies and to 
correct them. 
The emerging alignments were compared with the physical map and areas of 
disparity mapped with more probes. Attempts to assemble the contigs into whole 
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chromosomes with Phrap failed because of the large number of repeated elements in the 
C. albicans genome. A custom-made stitcher script (which utilized a 100 nucleotide pure 
text string starting from the previous alignment) was used to assemble the contig-
alignments into chromosomes. The resulting assembly was checked for the presence of 
aIl the ORFs from the community annotation (33), and very few ORFs were missing. The 
penultimate assembly was compared with the optical genome map and the physical map 
and disparities resolved. 
One major discrepancy was the orientation of the sequence between the MRS 
regions on Chromosome 4. The optical map and the physical map showed it in one 
conformation, while the assembly showed it in the other. The final orientation, consistent 
with the physical and optical maps, was confirmed by PCR of the border fragments of 
one MRS and by restriction digestion of genomic DNA and hybridization of a Southern 
blot with probes from the regions which flank the two MRSs on both sides. 
The remaining gaps were filled by PCR followed by sequencing of the products. 
One gap proved to be the result of a misassembly in a contig. The insertion of a partially 
overlapping contig closed it. Two gaps were filled by using the draft sequence of Broad 
Institute's WO-I assembly 
(http://www.broad.mit.edulannotationlgenome/candida _ albicans/Info.html). One gap was 
filled by a sequence from Selmecki, et al (269). The result is an assembly of eight 
chromosomes with one unresolved (not connected) contig pair. Two gaps were 
introduced due to the flip of the area between two MRSs on Chromosome 4. Two gaps 
are located around the rDNA region. In addition, most of the MRS regions have not been 
resolved and can be considered gaps, with the exception of the two MRSs in 
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Chromosome 7 and the one MRS in Chromosome 6, which were cloned and sequenced at 
Chiba University. 
The physical map. A fosmid library was constructed from strain 1161 (104) by 
M. Strathman. Sau3AI-digested genomic DNA was inserted into the fosmid vector 
pFOS 1 (156). The library consists of 3840 clones with an average insert size of 40 kb 
(10x genome coverage). For probing, the library was arrayed in 10 384-well plates. Two 
plates each were printed on a 12x16 cm nylon membrane (Hybond-N+, Amersham 
Biosciences), giving a complete library set on 5 membranes. For printing, freshly thawed 
fosmid clones were transferred, using a 384-point replicator, to the membrane overlaid on 
Luria agar containing 20 Ilg chloramphenicol. The plates were grown overnight at 37°C 
and the membranes were processed according to the manufacturer's instructions for 
colony lifts. 
Probes were variously clones of genomic DNA, T- and S-end probes from 
fosmids (52), and PCR products generated from SC5314 DNA using primers based on 
the public genomic sequences. Probes were randomly labeled with 32p. The mapping was 
carried out as described in Chibana, et al (55). Briefly, membranes containing the library 
were hybridized with probes and fosmids hybridizing with the same probe were 
considered to overlap. Probes were also hybridized to Southern blots of pulse-field 
separations of chromosomes and genomic SjiI digests. The overlapping fosmids were 
arranged in a linear fashion with chromosome markers like the MRS used to orient the 
array. The complete set of overlapping fosmids was trimmed to make a minimum tiling 
set. The physical map is available at http://albicansmap.ahc.umn.edu/index.html. 
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The optical map. The optical map was prepared by OpGen (Madison, WI), using 
a proprietary technique. The technique involves preparation of large (> 500 kb) 
molecules of genomic DNA, and spreading them on a microfluidic device, which causes 
them to elongate and adhere to the substratum. They are then treated with a restriction 
enzyme (in this case, .Thol). Since the molecules are under slight tension, restriction sites 
appear as breaks in the molecules. The molecules are then stained with a fluorescent dye, 
scanned, and the positions of the restriction sites determined, using the amount of 
fluorescence to calculate the mass of the fragments. The results are averaged over 500 
molecules, allowing the preparation of a macro-restriction map. This can be compared 
with the restriction map derived from the assembly. A more complete description of the 
technique and more information can be found at http://www.opgen.com/. Since the 
optical map software searches the image database for matches and then constructs the 
map based on the consensus pattern, the optical map of a chromosome describes only one 
of the two homologues, and no data on heterozygosity are included. 
Although in most cases the three methods were in agreement on the sequence 
assembly, in cases where disagreements could not be resolved, concurrence oftwo of the 
three approaches was deemed sufficient. 
The complete Assembly 21 has been submitted to the Candida Genome Database 
(http://www.candidagenorne.orgD, which will be in charge of its maintenance and 
curation. 
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2.1.4 RESULTS 
Assembly 21. The completed Assembly 21 contains 15.845 Mb of DNA, organized into 
the 8 Candida albicans chromosomes. The assembly does not include the complete 
telomeric sequences for every chromosome, and includes only one copy of the normaIly 
repeated rDNA on Chromosome R. AlI but two chromosomes end with the subtelomeric 
repeat CARE-2 (Rel-2) (171, 286) at each telomere. This repeat was originaIly shown to 
be telomere-associated on chromosome 7 (55). Macro-restriction maps locate Major 
Repeat Sequences on aIl chromosomes but Chromosome 3, but since the MRSs are 
highly repeated and more than 16 kb in size, they are represented but not included in the 
assembly. On Chromosomes 7 and 6, where the MRSs have been sequenced, they are 
inserted into the sequence. The fini shed sequence of Chromosome 7 has been pub li shed 
elsewhere (57); this assembly includes a slightly revised version. In addition to the 
missing MRS regions there is one gap, on Chromosome 3. Assembly 21 is a haploid 
assembly; in cases where Assembly 19 detected heterozygosity, aIlelic contigs 19-
1 XXXX and 19.2XXXX were assembled. In regions where there were aIlelic contigs in 
Assembly 19, only the 19-1 XXXX contigs were used to construct Assembly 21, so it 
provides no information about heterozygosity. 
Chromosome size and structure. Figure 2.1.1 and Table 2.1.1 show structures and the 
sizes of the individual chromosomes in Assembly 21 and compares the size of the 
sequence with the size of each chromosome as determined by the optical map. The 
Assembly 21 size in Table 2.1.1 does not include the MRS if one or more are present, and 
for Chromosome R, only one copy of the rDNA repeat is included. The chromosomes 
range in size from 3,190,598 bases for Chromosome 1 to 943,480 bases for Chromosome 
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7. For Chromosome R, the rDNA repeat adds 350 kb to one homologue and 800 kb to the 
other. Where chromosome homologues are of different sizes, as with Chromosome R, the 
optical map software will choose one homologue. The optical map thus gives the size, 
including the rDNA, of the smaUer homologue of Chromosome R. The larger homologue 
is very close to Chromosome 1 in size, about 3.1 Mb. The fact that the subtelomeric 
repeat CARE-2 is missing from one telomere may indicate that the sequence does not 
extend to the end of the chromosome. On Chromosomes 2 and 7 both the TLO gene and 
the CARE-2 sequences are missing. We were able to map 233,091 out of250,884 (93%) 
of the original sequence traces on Assembly 21. The remaining 17,793 sequences 
probably represent sorne of the se missing sequences as weU as aUelic variants but it was 
impossible to map them to the CUITent assembly. 
Assembly 21 demonstrates that the sub-telomeric repeats found on Chromosome 
7 (57) are characteristic of aU the chromosomes. The common factor is aU or part of the 
repeat CARE-2 (171), which includes the LTR kappa (AF041469) and shares sorne 
sequence with Rel-2 (286). There are several other LTRs at the telomeres, and on 
Chromosome IR there is an intact transposon pCal (AF007776). Although one telomere 
on each of Chromosomes 2 and 7 in Assembly 21 is missing CARE-2 (and the TLO gene, 
see below), the fosmid map shows these repeats on every telomere. Sequence near the 
telomere is hard to clone, and the most likely interpretation of this discrepancy is that the 
appropriate clones for these regions were underrepresented in the Stanford library. Since 
the repeats tend to be telomere-proximal to the TLO gene, the fact that TLO is missing on 
Chromosomes 2 and 7 also suggests that sorne sequence is missing. The detailed 
organization of the sub-telomeric repeats is complex and differs at each telomere. 
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Centromeres. Sequences which bind the Cse4p prote in (the CENP-A orthologue) from 
C. albicans have been identified on each chromosome by Sanyal and Carbon, who 
suggested that they are at least part of the centromere (264). This interpretation is 
supported by the observation that the sequence identified on Chromosome 7 contributes 
to its mitotic stability. Table 2.1.1 gives the address (distance in bases from the left-hand 
end of the chromosome) of each centromere and shows that the chromosomes are 
generally metacentric, with the centromere sequences located near the center of the 
chromosomes. However, Chromosomes 2 and 6 are acrocentric. On Chromosome 2 the 
centromere is about 85% of the way toward the right telomere, and on 6 it is more than 
95%. 
ORF analysis. The ORF analysis of Assembly 21 differs slightly from that of Assembly 
19. The human-curated annotation of Assembly 19 identified 6354 genes. The Candida 
Genome Database contains 12015 genes, including allelic variants. Assembly 21 contains 
6075 genes. Of these, the identity and sequence of 6065 has not changed significantly 
from Assembly 19 (>98% sequence identity). Fourteen new ORFs have been added to 
Assembly 21. Thus 290 genes from the annotation of Assembly 19 are not in Assembly 
21. Of these, 192 have been found to be identical to other Assembly 21 genes and have 
>90% of their sequence incorporated in the se genes, while an additional 19 have >50% of 
their sequence incorporated into another ORF. The 79 remaining Assembly 19 ORFs 
have no strong BIast hits and include 55 hypotheticals, 15 gene family members, 7 that 
were truncated, 1 that was overlapping, and 2 putative sequencing errors. The Candida 
Genome Database provides an extensive analysis of the changes in ORF classifications 
between the two assemblies. http://www.candidagenome.org/). Sorne discrepancies 
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between their numbers and ours arise from the fact that they started from a greater 
number of orf19 genes. 
Repeated DNA. Candida albicans was shown to have 8 chromosomes by pulse-field 
electrophoresis. Early studies demonstrated not only that the organism was diploid but 
that it contained several large blocks of repeated DNA, the Major Repeat Sequence 
(MRS), with a complete or partial copy on each of the 8 chromosomes (53, 58, 59, 140). 
Analysis of the emerging sequence demonstrated the existence of a large number 
of L TRs and other repeated sequences related to transposons (103). Gene families also 
constitute a significant source of repeated DNA. Sorne of these repeated sequences, 
especially the MRSs, are too large to be crossed in a single sequencing run, so that 
assembly-using bioinformatics is blocked. The sequences of the MRSs on chromosomes 
should be considered unreliable due to the repeated nature of MRSs, which attract traces 
from many different other MRSs in the genome. The smaller repeated DNA regions are 
subject to the same potential problem and led to erroneous assembly in sorne of the 
Assembly 19 contigs. The fosmid map and the optical map were very helpful in 
identifying these errors and correcting them. 
The TLO gene family. The putative transcription factor gene CTA2 was identified by 
Kaiser, et al in a one-hybrid screen in S. cerevisiae (150). This sequence has homology to 
members of a gene family found at 14 of the 16 telomeres. Since CTA2 is a gene name, 
we renamed the family TLO for TeLOmere-associated genes. On this assembly, they are 
numbered so that the left arm of the chromosome has an odd-numbered TLO gene and the 
right TLO gene has an even number, ascending from Chromosome R through 
Chromosome 7. Thus, Chromosome R has TLOI on the left and TL02 on the right. 
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Although the original member of this gene family was isolated because it has 
transactivating activity in S. cerevisiae, the function of the se genes in C. albicans has not 
been determined. There are 15 members of this gene family in Assembly 21. Fourteen 
are located within 14 kb of an end of a chromosome contig, and aU are oriented in a 5' -3' 
direction toward the centromere and away from the telomere (Figure 2.1.1). In addition, 
aU but one (Chromosome IR) have the LTR kappa 5' to the ORF, usuaUy immediately 
adjacent but sometimes a few kb away. One member of the TLO gene family 
(ORF19.2661) is found in the interior of Chromosome 1, 1.29 Mb from the left end of 
this 3.19 Mb chromosome. Like the other family members, this ORF points toward the 
centromere and away from the telomere and has a kappa sequence from the subtelomeric 
repeat CARE-2 in its 5' region. In this case, the kappa sequence is the only part of the 
CARE-2 sequence present. Thus, this particular copy resembles a telomere but is located 
in the middle of Chromosome 1, and we have numbered it TL034, since it is located 
between TL03 and TL 04. In order to keep the numbering system consistent, we have 
saved the names TL06 and TLO 15 for the genes on 2R and 7L that we expect will 
eventuaUy be identified. The alignment of the TLO genes shows that TL013 (orfI9.6337, 
Chromosome 6) has an intron while TL 03, TL 04, and TL015 are truncated at the 5' end 
(orf19.2661 and orf19.7276, both on Chromosome 1, and 19.7127, Chromosome 7). Each 
of the se truncations contains 5' sequences with homology to the ORF19.6337 intron, 
which suggests the presence of unidentified exons. This gene family can be clearly 
separated into two sub-groups based on their carboxy-terminal sequences. The existence 
of TLO 14, on the right arm of Chromosome 6, has been confirmed by peR but this gene 
has yet to be sequenced. 
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Other gene families. As noted by Braun and coworkers (33), C. albicans has a number 
of gene families. These range in size from 2 members to as many as 26 (the ABC 
transporter superfamily) (97). Several are clustered on one or two chromosomes. For 
example, Chromosome 6 contains members of 6 families, with 5 represented by more 
than one member, and one, ALS, with 5 members. Most of the families with more than 
two members have representatives on more than one chromosome. In addition, sorne two-
member families are on different chromosomes. Examination of the genes surrounding 
family members on different chromosomes for the most part gives no hint as to the 
mechanism by which homologous sequences arrived at different locations. 
The arrangement of the se families on the chromosomes is not random. Figure 
2.1.2A shows the ORFs from Assembly 21 aligned along the eight chromosomes. ORFs 
with 80% or more similarity are connected by lines. There are sorne areas that appear to 
be tandem duplications. An example from Chromosome 3 is shown in Figure 2.1.2B. 
The sequence containing the gene DTD2 and those for two hypothetical proteins seems to 
have undergone a duplication accompanied by an inversion. A similar event seems to 
have occurred 40 kb away involving the genes DAL5, ECM18, and FUR4. There are no 
sequences such as L TRs near these duplications. Although the most plausible mechanism 
for the generation of gene families whose members are close together on one 
chromosome is tandem duplication, in many cases of gene families that contain tandemly 
repeated genes, the most closely related members are dispersed. For the SAP gene family, 
only SAP 5 and SAP6, 84 kb apart on Chromosome 6, are both nearest neighbors and most 
closely related in sequence. SAP 1 and SAP4 are adjacent and each is most closely related 
to another member. For the UP gene family, LIP5 is most similar to LIP9, and they are 
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12 kb apart on Chromosome 7. Family members LIP1, 6, and 10 are adjacent on 
Chromosome 1 and each is most homologous to a distal gene (LIP 3 for LIP 1 and LIP 2 
for LIP6 and LIP 10). It is interesting to note from Figure 2.1.2A that the number of 
highly similar ORFs outside the TLO and MRS sequences (represented by the blue 
connecting lines) is relatively small compared to the number of gene families. 
2.1.5 DISCUSSION 
Assembly 19, the diploid assembly of the genome of Candida albicans strain 
SC5314 was a very important achievement. It provided a great deal of insight into many 
aspects of genomic organization, especially the large amount of heterozygosity (148). 
The subsequent annotation of the assembly by the community demonstrated a number of 
important properties of the genome, including the number of genes (6,354), the number 
with introns (224), the frequency and characteristics of short tandem repeats, and the 
characteristics of several multigene families. Braun, et al. also identified putative 
spurious genes and genes either on overlapping contigs or truncated by the end of 
contigs. However, they did not address chromosome location nor try to join the 266 
haploid contigs of Assembly 19 into chromosome-sized assemblies. Thus, although these 
two projects brought the C. albicans genome to a very useful state, they still left it 
incomplete, lacking chromosome-size contigs and with sorne genes in an ambiguous 
state. Subsequently, Chibana et al (57) completed the sequence of Chromosome 7, 
identified 404 genes, and compared the synteny to the S cerevisiae genome. They 
sequenced the Major Repeat Sequences and the gaps left in Assembly 19. They then 
aligned the sequence on the chromosome as determined by the physical map (55). Our 
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ultimate objective is to increase our understanding of the evolutionary mechanisms that 
affect the genome of this fungal pathogen. 
There are chromosome size discrepancies between Assembly 21 and the optical 
map; these are attributable to several causes. Where the Assembly 21 size is smaller than 
the optical map size, the explanation may be the missing MRS, missing telomere-
associated sequences, or size heterozygosity between the homologues. For example, we 
know that on Chromosome 5 the MRS is 50 kb in size (183), very close to the difference 
between the two estimates. Where the size determined by the optical map is smaller 
(Chromosomes 2, 3, and 4), the difference seems most likely to be heterozygosity for 
insertions of retrotransposon-related sequences. In these cases, the optical map of this 
chromosome is probably derived from the smaller homologue. For Chromosome 2, the 
discrepancy is rather large, given that this chromosome in Assembly 21 lacks the MRS 
and probably sorne telomere sequences. Interestingly, the size estimates in Jones et al, 
for the various chromosomes are remarkably close to the sizes determined by the optical 
map in Table 2.1.1 (148). 
The amount of repeated DNA in C. albicans is significant. The MRSs were a 
major problem and their placement on the chromosomes required the physical and optical 
maps. Chromosomes 4 and 7 each have two MRSs forming an inverted repeat, and in 
principle the internaI DNA fragment could invert via mitotic recombination. In strain 
SC5314 and its derivative, CAI-4, this inversion seems to occur very rarely, at least in the 
laboratory. In spite of the fact that most of the known translocations in C. albicans occur 
at the MRS, suggesting that this is a hot spot for recombination, there is no evidence on 
either chromosome for a flip of the bracketed sequence. 
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The specific sequences of 6 of the 9 MRSs are unavailable. This is only a problem 
if sequence variation in the MRS plays a biological role, and there is no evidence that it 
does. In addition to the MRSs and the subtelomeric repeats, there are more than 350 LTR 
sequences belonging to 34 different families scartered throughout the genome (103), and 
several of the se are found clustered at telomeres. The subtelomeric repeat CARE-2 
contains an L TR called kappa (102), which is found at the 5' end of each member of the 
TLO gene family. Whether this is related to the expansion of this family to the telomeres 
is not clear. The repeated DNA led to misassembly of sorne contigs in Assembly 19, 
including chimeras, artifactual duplications, and omirted sequence. The two physical 
maps and the C. dubliniensis sequence were essential in sorting out these artifacts. 
The numerous gene families in C. albicans distinguish it from S. cerevisiae. A 
very common feature of these families is a clustering of members on a particular 
chromosome, which might retlect an ontology wherein a single copy undergoes tandem 
duplication and then sequences diverge as function diverges. There are several instances 
where similar but oppositely oriented gene clusters suggest that an inverted duplication of 
a region larger than a gene has occurred (Figure 2.1.2A). 
The model for gene family ontology of duplication followed by dispersion would 
pre di ct that, in general, similarity should be related to proximity. The arrangements of the 
two families we examined in detail, the SAP family and the LIP family, raise sorne 
questions about this model. In only two cases are the most similar family members the 
closest neighbors (SAP6 and SAP5; LIP9 and LIP5). However, the members clustered on 
one chromosome tend to be most closely related. For the LIP gene family, Hube and 
coworkers showed that LIP5, 8, and 9, on Chromosome 7 form a group and LIPl,2,3,6, 
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and 10, on Chromosome 1 are a related but distinct group (132). LIP7, on Chromosome R 
is an outlier, only distantly related, while LIP4, on Chromosome 6, fits with the 
Chromosome 7 group. For the SAP gene family, SAP4, 5, and 6 (Chromosome 6) form a 
highly related cluster, while the rest of the group, on Chromosomes R, 3, 4, and 6 form a 
loose association, with the highest similarity being between SAP 2 on Chromosome R and 
SAP 1 on Chromosome 6. These relationships suggest that the families originate on one 
chromosome and expand there, and when one member is duplicated on another 
chromosome, the pattern may or may not be repeated. The large number of gene families 
whose members are dispersed but not randomly would suggest that C. albicans is 
efficient at gene duplication at a distance. However, there are no hints of a specific 
mechanism in the sequence, such as homology between flanking sequences on different 
chromosomes or traces of mobile genetic elements. The relatively small number of highly 
similar ORFs suggests that the gene family members either diverged sorne time ago or 
are under strong selection to perform specific functions. 
The TLO gene family is unique in C. albicans because it is found on every 
chromosome, and there are no closely adjacent members. This suggests that it arose by a 
mechanism different from, for example, the LIP family. One clue is that in aIl cases it is 
flanked on its 5' side by the L TR kappa. It seems possible that it has moved via genomic 
rearrangements caused by the transposon for which kappa is the L TR. On Chromosome 
l, there is an interior TLO gene, as weIl as one near each telomere. A plausible 
explanation for this arrangement is that a chromosome translocation has occurred, with 
DNA being added to the end of a smaller precursor of Chromosome l, followed by 
reconstitution of the telomere at the new end generated. There are only three genes in the 
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emerging C. dubliniensis sequence with similarity to the TLO family, and they are not 
located at the telomeres. On chromosomes 1 and R in C. dubliniensis, the genes adjacent 
to the TLO family member are present and are several kilobases from the end of the 
assembled sequence, suggesting that their absence is not due to missing telomere-
proximal sequence. Since there are significant differences in virulence between C. 
albicans and C. dublin iensis, there may be a role for the TLO gene family in sorne aspect 
of pathogenesis. The function of the TLO genes is unknown. Although a member of this 
gene family was isolated as a potential trans-activating protein (and named CTA2), based 
on a one-hybrid screen in S. cerevisiae, there is no evidence beyond those experiments as 
to function (150). 
Table 2.1.1. Chromosome Size and Features 
Chromosome Size (bp) 
Assembly Optical 
21 Map* 
R 2,294,279 2,709,974 
1 3,190,598 3,218,448 
2 2,233,511 2,228,646 
3 1,798,342 1,794,194 
4 1,622,838 1,619,262 
5 1,191,532 1,246,010 
6 1,030,364 1,057,155 
7 943,480 961,199 
Centromere MRS 
location 
1,748,965 1 
1,561,879 1 
1,924,678 1 
816,770 
° 1,000,800 2 
465,800 1 
975,879 1 
423,765 2 
Features 
Ribosomal DNA cluster 
is ~800 kb on one 
homologue, ~350 kb on 
the other. Lacks CARE-2 
on the right telomere. 
The left-hand telomere 
lacks TLO and CARE-2 
One gap 
The right-hand telomere 
lacks TLO and CARE-2 
* The MRS is included in aIl the optical map sizes 
43 
Chapter 2: C. albicans genome 
Chromosome 
CARE-Z 71.01 NItS ŒN RDNA 71.02 R • • =$ lw) i.J il'il!! P 
71.OB 'Tl.OB4 TL04 
1 •• • • :::) ... fi! \ 
71.05 
Z • • 0 ... 1 
71.07 TUJB 
3 •• 0 P. 
4 7L09 71.010 •• ...l ,::) .... P • "'i' 'F 
5 71.071 71.012 •• 0 .... P • 'F 
6 71.018 71.014 •• ...!.. cJ!!.II ; 
71.016 
7 ..... ::) .... P • "'i' 'F 
Figure 2.1.1. Schematic representation of the chromosomes in Assembly 20. 
The major structural features, including the centromeres, the MRS sequences, the CARE-
2 sequences, and the TLO genes are represented. The positions are approximately to 
scale. The smaller homologue of Chromosome R (containing a 350 kb rDNA repeat) is 
shown. 
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Figure 2.1.2. Highly related ORFs in the C. albicans genome. 
A. The eight chromosomes are shown with the ORFs indicated by the small black lines. 
The red lines conne ct the TLO genes, while the green lines connect the ORFs in the MRS 
sequence. The blue lines connect ORFs with relatedness greater than 80%. 
B. Close-up of Chromosome 3 from base 622,329 to base 785,321 showing two areas 
which appear to have undergone duplication followed by inversion. 
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Section 2.2: The Annotation of the Candida albicans Genome. 
From Assembly 19 we identified 11,615 putative open reading frames (ORF), 
which encode proteins grater than 150 amino acids, as weIl as smaller genes with good 
possibility to encode functional polypeptides (33). We used a special pro gram (Artemis 
annotation software (258)) and a custom database to "walk" along the individual contigs. 
We validated and corrected the coordinates and descriptions of each putative ORF while 
removing small and overlapping ORFs with no sequence similarity in other organisms to 
yield 6,354 C. albicans genes. 
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2.2.1 ABSTRACT 
Recent sequencing and assembly of the genome for the fungal pathogen Candida 
albicans used simple automated procedures for the identification of putative genes. We 
have reviewed the entire assembly, both by hand and with additional bioinformatic 
resources, to accurately map and de scribe 6,354 genes and to identify 246 genes whose 
original database entries contained sequencing errors (or possibly mutations) that affect 
their reading frame. Comparison with other fungal genomes permitted the identification 
of numerous fungus-specific genes that might be targeted for antifungal therapy. We also 
observed that, compared to other fungi, the protein-coding sequences in the C. albicans 
genome are especially rich in short sequence repeats. FinaIly, our improved annotation 
permitted a detailed analysis of several multigene families while comparative genomic 
studies show that C. albicans has a far greater catabolic range, encoding respiratory 
Complex 1, several novel oxidoreductases and ketone body degrading enzymes, malonyl-
CoA and enoyl-CoA carriers, several novel amino acid degrading enzymes, a variety of 
secreted catabolic lipases and proteases, as weIl as numerous transporters to assimilate 
the resulting nutrients. The results of these efforts will thus ensure that the Candida 
research community has uniform and comprehensive genomic information for medical 
research as weIl as for future diagnostic and therapeutic applications. 
48 
Chapter 2: C. albicans genome 
2.2.2 INTRODUCTION 
Candida albicans is a commonly encountered fungal pathogen responsible for 
infections generally classed as either superficial (thrush and vaginitis) or systemic (such 
as life-threatening blood-borne candidiasis) (91, 231). Its life cycle has fascinating 
aspects that have generated great excitement over the last decade, with an influx of 
workers and new molecular techniques brought to bear on long-standing problems (18). 
Topics of particular interest are the organism's capacity to shift into several different 
phenotypic states, each with distinct roles in infection, and its recently discovered 
capacity to mate, providing at least part of a sexual cycle to what was previously believed 
to be a strictly clonaI diploid population. Other special adaptations for infection include a 
battery of externally displayed proteins and secreted digestive enzymes, and complex 
interactions with the host immune system that normally keep C. albicans at bayas a 
minor part of the mucosal flora. 
Here, we report a detailed annotation of the genome sequence of this organism, 
bringing the previously available raw sequence to a new level of stability and usability. 
The genome of C. albicans has previously been shotgun sequenced to a level of 10.9-fold 
coverage (148). However the assembly ofthis sequence faced special difficulties because 
the organism is a diploid with little or no gene exchange in the wild. Thus homologous 
chromosomes show substantial divergence, and many genes are present as two distinctive 
alleles. This required that the assembly process be aware of the diploid status and be 
prepared to segregate reads into two alleles for any section of the genome. At the same 
time, the genome is ri ch in recently diverged gene families that are easily confused with 
alleles. This task was further complicated by the absence of a complete physical map of 
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the C. albicans genome. Nevertheless, this arduous assembly process resulted in a data 
set (assembly 19, with 266 primary contigs over 8 chromosomes) that has aIready yielded 
a number of significant advances including the production of DNA microarrays (224), 
libraries of systematic gene knockouts (254), large scale transposon mutagenesis (300) 
and the ability of many individual researchers to identify novel genes using bioinformatic 
tools (299). Unfortunately, due to the mostly computational methods used in its 
development, the current genome assembly still contains a significant number of 
predicted genes that are fragmented, overlapping, or otherwise erroneous. As a 
consequence, different groups have been using different methods for the identification 
and classification of C. albicans genes, which has hindered communication and 
complicated comparisons between large-scale data sets. 
Following the publication of the se early functional genomlcs studies, it was 
realized that the needs of the C. albicans research community would be better served by a 
unified gene nomenclature. The results of this community-based effort were initially 
based on the version 19 computational assembly and preliminary annotation produced 
independently by various research groups. We used visual inspection of 11,615 putative 
coding sequences and various bioinformatic tools to refine the quality and description of 
each open reading frame (ORF). 
In the end, we provide unique identifiers, coordinates, names and descriptions for 
6,354 genes. With the exception of certain large gene families, we have not annotated the 
portion of the Assembly 19 DNA that was set-aside as secondary alleles, instead 
concentrating on the primary sequence that forms one haploid genome equivalent. 
Investigation of the identity and relative divergence of aIl alle1es will be an important 
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further project for the C. albicans genome, as will finishing and linking the small number 
of gaps that remain in the primary sequence. In addition, we de scribe a variety of gene 
families and we discuss insights into virulence. Finally, we used comparative genomics to 
point out a variety of additional insights that are illuminated by the high-quality 
annotation provided here. This project serves as a model for community-based annotation 
that could be applied by other research communities that wish to improve on automated 
sequencing pipeline output that may be available for their organisms of interest. 
2.2.3 MATERIALS AND METHODS 
Identification of C. albicans ORFs and merging of preliminary annotations 
Nucleotide sequence data for Assembly 19 were retrieved from the Stanford Genome 
Technology Center (SGTC) web site (http://www-
sequence. stanford. edul /group/candidal). Assembly 19 lS composed of a haploid 
supercontig set (contigs 19-831 to 19-10262), here referred to as the haploid set, and a 
allelic supercontig set (contigs 19-20001 to 19-20161), here referred to as the allelic set 
(148). 
The 11615 orf19 ORFs identified in the haploid set were compared by reciprocal 
BLASTP to the 9168 ORFs identified by the SGTC using Assembly 6 of the C. albicans 
genome sequence (designated orf6.n). A similar reciprocal comparison was run using the 
set of 6165 C. albicans proteins available in the CandidaDB database that have been 
defined by applying a procedure similar to that outlined above on Assembly 6 and 
through a manual curation aiming to reach a non-redundant prote in set 
(http://genolist.pasteur.fr/CandidaDB; (66)). Furthermore, orf19 ORFs were reciprocally 
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compared to the S. cerevisiae prote orne usmg data available at the Saccharomyces 
Genome Database (60). AlI data were parsed using readblast (284) and a matrix was 
generated that correlated ORFs from each data set. 
We used the genome annotation tool Artemis (258), which provides very detailed 
annotation capability, visually mapping desired features onto the target sequence. AH 
ORFs were assigned a col or code in order to facilitate annotation using Artemis. AlI 
orf19 corresponding to an Integrated Processing Facility (lPF) classified as F ALSORF 
and orf19 identified at the SGTC and not found among IPFs were color-coded in grey. 
orf19 with an unambiguous allele (90% identical amino acids over the whole length of 
the longest ORF) were color-coded in red (> 150 codons) or pink « 150 codons). orf19 
with a questionable allele (90% identical amino acids over the whole length of the 
shortest ORF) were color-coded in green (> 150 codons) or pale green « 150 codons). 
orf19 without a clear allele (less than 90% identical amino acids over the whole length of 
the shortest ORF or no reciprocal match) were color-coded in blue (> 150 codons) or 
light blue « 150 codons). 
From this "master" file of sequences and their corresponding preliminary 
annotation, groups of contigs were selected and saved as partially annotated 
subsequences that were reserved and retrieved by members of the annotation consortium, 
and once fully annotated, were returned to a central web site. A version of Artemis was 
distributed to the consortium that included a modified "options" file (20) allowing 
project-specific qualifiers to be used, and also featuring the C. albicans-specific 
translation table. 
52 
Chapter 2: C. albicans genome 
Whole genome BLAST searches and visualization of sequence homologies 
ORF sequences were translated to proteins using the translation table for C. 
albicans (232), and compared, using the BLASTP algorithm (5) with the NR database, 
the C. albicans proteome itself, the putative proteomes of five fungi; Saccharomyces 
cerevisiae, Schizosaccharomyces pombe, Neurospora crassa, Aspergillus nidulans, 
Magnaporthe grisea and the proteomes of five other eukaryotes; Arabidopsis thaliana, 
Drosophila melanogaster, Caenorhadbitis elegans, Mus musculus and Homo sapiens. 
Sequence data was obtained from the EMBL-EBI Integr8 Browser 
[http://www.ebi.ac.uk/integr8IEBI-Integr8-HomePage.do] and the Broad Institute for 
Genome Research [http://www.broad.mit.edu/annotationl]. For the most similar proteins 
by BLAST, negative exponents of the expect (E) values were parsed from the output 
files, collected in a relational database and visualized as a color range associated with 
each reference prote in (Figure 2.2.1). For this purpose, a web-accessible visualization 
tool was constructed using Macromedia Co Id Fusion and an Apache2 web server. These 
results can be consulted at [http://candida.bri.nrc.calcandidalindex.cfm?page=blast]. 
2.2.4 RESUL TS AND DISCUSSION 
The annotation process 
Compilation of Candida annotation data 
As detailed in the Methods section, we used assembly version 19 of the C. 
albicans genome (148) to identify 11,615 putative ORFs. These inc1ude genes encoding 
proteins greater than 150 amino acids (a. a.) as weIl as smaller genes of between 150-447 
b.p. that have a coding function > 0.5 as determined with a GeneMark matrix (197). 
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These ORFs were then compared to the set of 7680 C. albicans ORFs defined by the 
Stanford Genome Technology Center (SGTC), thus permitting their classification using 
the same systematic identifiers of the format orf19.n (148). The 3936 novel ORFs 
without an orf19.n counterpart were assigned a new reference number of the format 
orf19.n.i where orf19.n is the 5-prime closest (contig-wise) ORF defined by the SGTC 
and i is an integer that varies between 1 and the number of novel ORFs found in the 
orf19.n - orf19.n+ 1 interval. To simplify correlation with previously published data that 
use the orf6.# or earlier nomenclatures, we have produced a web-accessible translation 
tool [http://candida.bri.nrc.ca]. 
Positional information for each ORF was merged with data from a variety of 
different sources, including the SGTC (http://www-
sequence.stanford.edulgroup/candida/index.html), CandidaDB 
(http://genolist.pasteur.fr/CandidaDB; (66)), the Agabian lab annotation 
(http://agabian.ucsf.edu/canoDB/anno.php) and annotation data from the Johnson/Fink 
laboratories (15) that had been updated with a Magpie annotation (224). This large 
dataset was then reformatted into EMBL-style files thus allowing for input in the Artemis 
annotation software (258). Volunteer annotators accessed a custom-made database to 
reserve and download EMBL files containing sequence and annotation data for each of 
the 266 DNA sequence contigs. To help in validating various and sometimes conflicting 
sources of information, translated prote in sequences from putative C. albicans ORFs 
were compared to putative protein sequences extracted from five fungal genomes; 
Saccharomyces cerevisiae (99, 153), Schizosaccharomyces pombe (309), Neurospora 
crassa (94), Aspergillus nidulans (The Aspergillus database, http://www-
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genome.wi.mit.edulannotation/fungi/aspergillusl) and Magnaporthe grisea (The 
Magnaporthe database, http://www-genome.wi.mit.edulannotationlfungi/magnaporthel) 
as well as to the genomes of five other eukaryotes; Arabidopsis thaliana (The 
Arabidopsis Sequencing Consortium, 2000), Drosophila melanogaster (2), 
Caenorhadbitis elegans (The C. elegans Sequencing Consortium, 1998), Mus musculus 
(302), Homo sapiens (167), and the GenBank non-redundant (NR) prote in database. 
Comparisons against the translated C. albicans genome were also performed to help 
identify overlapping genes and putative gene families. To help interpret such a large 
number of sequence comparisons, we organized sequence similarity data in a web-
accessible database using a novel visualization concept whereby we used a colorimetrie 
display to indicate BLAST similarity, which was easy and rapid to scan visually (Figure 
2.2.1). The annotators could thus rapidly determine which genes are potentially unique to 
C. albicans (e.g., orf19.4741 and orf19.4786), those that are members of gene families 
(e.g., orf19,4736 and orf19.4779), genes that only have homologs in fungal genomes 
(e.g., orf19.4756 and orf19,4778) or those with homologs in aIl eukaryotic genomes (e.g., 
orf19.4732 and orf19.4784). FinaIly, a strong hit against the complete NR database, but 
not in the other genomes (orf19,4772 and orf19,4800), aIlowed us to identify C. albicans 
genes that had already been described and submitted to the sequence databases prior to 
the publication of assembly orf19. Clicking on the relevant boxes opened an additional 
window containing the precompiled sequence alignments, thus permitting the validation 
of interesting observations. These visualization tools and the results of sequence 
comparisons are available at [http://candida.bri.nrc.ca/candida/index.cfm?page=blast]. 
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The coordinates and annotations for all II,615 putative ORFs were thus verified, 
corrected and (if necessary) rewritten by the annotators. We removed ORFs smaller than 
300 b.p. with no significant sequence similarity to other genes, either within the C. 
albicans genome or in the sequence databases. In cases where two ORFs overlapped by 
more than 50%, the smallest gene was removed unless it showed even a slight sequence 
similarity to another gene in the sequence databases. In other cases, we encountered two, 
or more, contiguous ORFs that obviously were part of the same gene. These interruptions 
were usually due to unidentified introns or presumed sequencing errors. In these cases, 
we decided to merge the relevant gene fragments into a single entry. A total of 5262 ORF 
entries were thus removed from the database, or merged with neighboring ORFs, leaving 
6354 confirmed genes. 
A nomenclature for C. albicans genes 
Following consultations with the C. albicans research community during the 5th 
and 6th ASM Conferences on Candida and Candidasis, it was agreed that C. albicans 
gene names should follow the format established for S. cerevisiae (51). Gene names 
consist of three letters (the gene symbol) followed by an integer (e.g., ADE12); the gene 
symbol should be an acronym for, or relate to, the gene function, gene product, or mutant 
phenotype. It is preferable that a given gene symbol have only one meaning, so that all 
genes using that symbol are related in sorne way, for instance by sharing a function, 
participating in a pathway, or belonging to a gene family. In addition, gene symbols that 
are used in S. cerevisiae gene names should retain the same meaning when used for C. 
albicans genes. The prefix 'Ca' has sometimes been used on gene names to denote that a 
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gene is derived from C. albicans; however, while the use of prefixes adds clarity to 
discussions of genes from different species that share a name (e.g., comparing CaVRA3 
to ScVRA3), the prefix is not considered part of the gene name proper. For more details 
on genetic nomenclature, see the Candida Genome Database (CGD; (6» website 
[http://www . candidagenome. org/N omenclature.html]. 
Wherever possible, genes that are orthologous between C. albicans and S. 
cerevisiae should share the same name. We have provided 3409 suggested names (in the 
/SuggGene field of the EMBL files) for many C. albicans open reading frames based on 
their orthology to S. cerevisiae genes; these are not yet considered the standard C. 
albicans gene names, but rather provide guidance for investigators wishing to name the se 
genes. CGD assigns standard names to C. albicans genes for which there are published 
data (the /PubGene field). The annotation contains 355 such entries. Generally CGD 
considers the first published name in the correct format to be the standard name; common 
usage and uniqueness are also considered. AIl names that have been used for a gene are 
collected in CGD, regardless of their format, so that information from the literature can 
be traced to the correct gene. In the current annotation, additional published gene names 
have been placed in the /Synonym field. The complete annotation dataset, results of 
BLAST sequence similarity searches and the identification of conserved prote in do mains 
can be obtained from our web page at 
[http://candida. bri.nrc.calcandidalindex.cfm?page=CaGeneSearch]. Furthermore, the 
Candida Genome Database (CGD; www.candidagenome.org), funded by the National 
Institute for Dental and Craniofacial Research (NIDCR) at the NIH, will curate the 
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scientific literature and provide tools for accessing and analyzing the C. albicans genome 
sequence. 
Content and general statistics 
We identified 6,354 genes in version 19 of the C. albicans genome assembly. This 
number is certain to change slightly with time as more data come to light. For instance, 
80 of the se genes are probably duplicates, having almost identical counterparts near the 
extremities of sequence contigs. Novel genes may also lie in unsequencedlunassembled 
gaps between the DNA sequence contigs. We identified 246 genes containing mutations 
or sequencing errors that result in a frameshift, or the insertion of a stop codon, that will 
have to be confirmed through resequencing. In the meantime, these elements have been 
joined as a single ORF entry and tagged with the entry "sequencing error?" inside their 
/Note field. We have also identified 190 genes truncated at the ends of contigs, only 35 of 
which have an identical counterpart on a potentially overlapping contig. New information 
will be continuously integrated into the community data as it is submitted. 
The mean prote in coding length of 1439 b.p. (480 a.a.) is almost identical to what 
has been observed in S. cerevisiae and S. pombe while the gene density stands at one 
gene per 2342 b.p. Short descriptions for aIl gene products were provided by annotators, 
usually based on sequence similarity. 1218 (19.2%) genes encode unique proteins with no 
significant homologs in the sequence databases, an almost identical percentage with that 
observed in the current version of the S. cerevisiae annotation (153). An additional 819 
(12.9%) gene products exhibited significant similarities to other proteins of unknown 
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function. Furthermore, we have provided Enzyme Commission numbers and GO terms to 
1334 and 3586 gene products respectively. 
Analysis of protein domains 
Compared to the S. pombe and S. cerevisiae proteomes, the C. albicans prote orne 
shows a slight increase in the abundance of leucine-rich repeats (IPR001611), sorne zinc 
finger transcription factors (lPROOI138), esterasesllipases (lPR000379) and trans-
membrane transporters for polyamines (lPR002293) and ami no acids (lPR004841). If the 
analysis is expanded to the other fungal proteomes, only the increased abundance in 
leucine-rich repeats appears to be unique to C. albicans. 
Genome-based identification of antifungal targets 
One of the main arguments supporting large-scale sequencing projects for fungal 
pathogens is the hope of finding novel antifungal targets, particularly those that are 
absent from the genome of their host. 228 C. albicans genes have a very strong sequence 
homolog (Based of a top hit BLASTP E-value < le-45) in aIl of 5 fungal genomes but no 
significant sequence similarity (best BLASTP E-value > le-lO) to genes in the genomes 
of either humans or mice. For example, these include FKSJ which encodes a 1,3-beta-
glucan synthase that is the target for the cell wall-agents echinocandins (28). The list 
includes 46 gene products that are assumed to be located on the plasma membrane, 71 
that are predicted to be involved in the transport of small molecules and 21 that appear to 
be involved, directly or indirectly, with cell wall synthesis. Furthermore, 41 gene 
products have been associated with an E.C. number, indicating an enzymatic activity, 
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with phospholipases being the most abundant. The roles and sites of action of these gene 
products suggest that they would be both more accessible, and theoretically amenable to 
inhibition by small molecules. 
Multigene families 
Many putative and demonstrated virulence factors of C. albicans are members of 
large multigene families. Well-known examples of such families encode secreted aspartyl 
proteinases (SAPs; (203), (304)), agglutinins (ALSs; (129)), secreted lipases (LIPs; 
(132)), high-affinity iron transporters (FETs; (243)), and ferric reductases (FREs/CFLs; 
(166)). Members of each ofthese families are differentially expressed as a function of the 
yeast-hyphae transition, phenotypic switching, or timing during experimental infection. 
AIso, each of these families is large relative to the corresponding homolog or family of 
homologs in S. cerevisiae, leading to the concept that expansion of many C. albicans 
gene families may be an adaptation to a commensal lifestyle and may be, in part, 
responsible for C. albicans' unusual ability to occupy a variety of host niches. 
A striking difference between C. albicans and S. cerevisiae is the manner in 
which they acquire nutrients from the environment. In addition to the well-described 
SAPs, LIPs, and FETs, C. albicans possesses expanded families of acid 
sphingomyelinases (with 4 genes per haploid genome), phospholipases B (6 genes), 
oligopeptide transporters (7 genes), and amino-acid permeases (23-24 genes). Another 
striking difference is the emphasis by C. albicans on respiratory catabolism, as reflected 
in expanded families of peroxisomal enzymes. These include families of acyl-CoA 
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oxidases (3 genes), 3-ketoacyl-CoA thiolases (4 genes), acyl-CoA thioesterases (3-4 
genes), fatty acid-CoA synthases (5 genes), and glutathione peroxidases (4 genes). 
Additional families that may pertain to colonization or pathogenesis include those 
encoding the estrogen-binding protein OYEl (7 genes), the fluconazole-resistance 
transporter FLUl (13 genes), and the vacuolar protein PEP3IVPSl6 (4 genes), whose 
Aspergillus homolog is required for nuclear migration and polarized growth. 
Zinc c1uster transcription factors 
Proteins of the zinc finger superfamily represent one of the largest classes of 
DNA-binding proteins in eukaryotes. Several different classes of zinc finger domains 
exist which differ in the arrangement of their zinc-binding residues (213). One of these 
domains, which appears to be restricted to fungi, consists of the Zn(II)2Cys6 binuclear 
cluster motif in which six cysteines coordinate two zinc atoms (265, 288). S. cerevisiae 
possesses fifty-four zinc cluster factors defined by the presence of the zinc cluster 
signature motif CX2CX6CX5-16CX2CX6_SC which is generally located at the N-terminus 
of the protein. These proteins function as transcriptional regulators involved in various 
cellular processes including primary and secondary metabolism (e.g. Ga14p, Pprl p, 
Haplp, Cha4p, Leu3p, Lys14p, Cat8p), pleiotropic drug resistance (e.g. Pdrlp, Pdr3p, 
Yrrlp) and meiosis (Ume6p) (3, 288). Quite often, they bind as homo- or heterodimers to 
two CGG triplets organized as direct, indirect or inverted repeats and separated by 
sequences of variable length (118, 288). A large proportion of the se factors (50%) also 
contain a middle homology region (MHR; Fungal_trans in PF AM) located in the central 
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portion of the protein that has been proposed to participate in DNA-binding and to assist 
in DNA target discrimination (265). 
Analysis of the C. albicans proteome using a combination of sequence analyses 
tools (SMART, PFAM, PHI-BLAST) allowed us to identify 77 binuclear cluster proteins. 
These factors are characterized by the presence of the zinc cluster signature motif 
CX2CX6CXS-24CX2CX6-9C generally located at the N-terminus of the prote in (72 out of 
77) and with spacing between cysteines 3 to 4 and 5 to 6 slightly different from the S. 
cerevisiae motif. To our knowledge, only six of the C. albicans zinc cluster genes have 
been characterized in detail, including SUCl involved in sucrose utilization (154), FCRl 
implicated in pleiotropic drug resistance (281), CWT 1 required for cell wall integrity 
(218) and CZFl, FGRl7 and FGR27 involved in filamentous growth (35, 300). The 
functions of many uncharacterized C. albicans zinc cluster factors (approximately 20%) 
can be inferred from the fact that they display high levels of sequence similarity (Top 
BLASTP Evalue :s 1 e-20) with the products of S. cerevisiae genes with a known 
function. In the case of GAL4, however, the C. albicans homologous ORF identified 
(orf19.5338) encodes a significantly smaller protein (261 a. a.) than S. cerevisiae Gal4p 
(881 a. a.), lacking the C-terminal two thirds of the prote in that contains one of two 
transcriptional activating domains, and must therefore have somewhat different functions. 
Finally, it is noteworthy that many of the zinc cluster factors known to be involved in 
pleiotropic drug resistance in S. cerevisiae, such as Pdrlp, Pdr3p, Yrrlp, Yrmlp, Rdslp, 
and Rdrlp, do not appear to possess close structural homologs in C. albicans. Since 
pleiotropic drug resistance is frequently observed in C. albicans, it is likely that this 
62 
Chapter 2: C. albicans genome 
organism possesses functional homologs of the se genes or other novel processes which 
remain to be identified. 
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Figure 2.2.1. Visualization of proteins sequence similarities 
Sample from a web page used by annotators of the C. albicans genome to visualize the 
significance of the best hit from whole proteome BLASTP searches. Each putative ORF 
was compared to the non redundant database (NR), the Candida ORF list itself (Ca19: 
showing results from the 4 top hits) and amino acid sequences from the proteomes of 
Saccharomyces cerevisiae (Sac), Schizosaccharomyces pombe (S.p), Magnaporthe grisea 
(Mag), Neurospora crassa (Neu), Homo sapiens (H.S), Mus musculus (M.m), Drosophila 
melanogaster (Dro), Caenorhadbitis elegans (C.e) and Arabidopsis thaliana (A.t). The 
BLASTP E-value from the top hit was converted to a col or scale as indicated. Examples 
of C albicans genes with interesting similarity patterns are indicated. 
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CHAPTER 3. POSTGENOMIC STUDIES OF CANDIDA ALBICANS: 
INTRAGENIC COMPARATIVE GENOMIC STUDIES OF C. ALBICANS. 
We compared the translated amino acid sequences to the proteomes of five fungi 
(s. cerevisiae, Schizosaccharomyces pombe, Neurospora crassa, Aspegilus nidulans, and 
Magnaporthe grisea) and five higher eukaryotes (Caenorhabditis elegans, Drosophila 
melanogaster, Arabidopsis thaliana, Mus musculus, and Homo sapiens) (33). 
Comparative genomic studies have provided a better understanding of the C. albicans -
specific biological processes: we observed that close to 20% of C. albicans genes are 
specific to that organism. In addition, 228 genes showed very high sequence similarity 
among six fungal genomes but are completely absent from mammalian genomes. The 
products of those genes present attractive antifungal drug targets who se inhibition would 
unlikely provoke secondary effects in the host. These include trans-membrane 
transporters and enzymes. The C. albicans genome is also rich in gene families that 
encode products with a role in pathogenesis. These include secreted lipases (132) and 
aspartyl proteases (222), the ALS family of ceIl surface agglutinins (129), high affinity 
iron transporters and ferric reductases (243), ABC transporters that can pump out drugs 
(261, 262), and superoxide dismutases (134, 162, 211, 249). 
We have characterized the function and the transcriptional regulation of one 
member of the copper-zinc superoxide dismutase, SOD5, which is needed for the 
pathogenicity of this fungus. The expression of this gene was induced during the yeast to 
hyphal transition of C. albicans, and when the fungus was chaIlenged with osmotic and 
oxidative stresses. SOD5 transcription was also induced when C. albicans ceIls were 
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grown on nonfennentable carbon sources. Transcription factors RimlOlp and Efglp were 
found to regulate the transcription of the SOD5 gene. To characterize the function of 
SOD5 we created a SOD5 deletion strain, which showed sensitivity to hydrogen peroxide, 
and established that the SOD5 product was necessary for the virulence of C. albicans in a 
mouse model of infection. While we observed that a sod5 mutant strain is resistant to 
macrophage attack, Fradin et al. showed a reduced survival of a sod5 strain when mixed 
with neutrophils (90). Finally, the Sod5 protein was shown to localize on the cell surface 
of C. albicans through glycosylphosphatidylinositol (GPI) anchorage (73), which 
suggests that its role is to neutralize neutrophil-generated superoxide radicals at the 
surface of the fungal cells, while the roles of CuZnSod 1 p and MnSod2p are to inactivate 
cytosolic and mitochondrial superoxide radicals (134, 249). We propose that C. albicans 
has its duplicated CuZnSODs downstream of different promoters to allow response to 
different conditions that demand antioxidant enzymes. Our results show that under 
certain hyphal-inducing conditions SOD5 is the major player among CuZnSODs; a recent 
study shows SOD4 to be regulated in White-Opaque phenotype switching, which is 
involved in the mating processes of C. albicans (165). 
Section 3.1 is an article that describes the characterization of SOD5, and section 
3.2 is an article that describes activation domains of C. albicans transcription factors. 
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Section 3.1: Superoxide dismutases in C. albicans. 
CuZn superoxide dismutases in Candida albicans: Transcriptional regulation and 
functional characterization of the hyphal induced SOD5 gene. 
Mikhail Martchenko l, Anne-Marie Alarc02, Doreen Harcus2, and Malcolm Whitewayl,2*. 
IDepartment of Biology, McGill University, Stewart Biology Building, 1205 Avenue 
Docteur Penfield, Montreal, Quebec, Canada H3A 1 BI; 
2Genetics Group, Biotechnology Research Institute, National Research Council, 
Montreal, Quebec, Canada H4P 2R2 
Molecular Biology of the Ce1l2004 Feb;15(2):456-67 © 2004 The American Society for 
Cell Biology. 
3.1.1 ABSTRACT 
Superoxide dismutases (SOD) convert superoxide radicals into less damaging hydrogen 
peroxide. The opportunistic human pathogen, Candida albicans, is known to express 
CuZnSOD (SODi) and MnSOD (SOD3) in the cytosol and MnSOD (SOD2) in the 
mitochondria. We identified three additional CuZn containing superoxide dismutases, 
SOD4, SOD5 and SOD6 within the sequence of the C. albicans genome. The 
transcription of SOD5 was upregulated during the yeast to hyphal transition of C. 
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albicans, and SOD5 was induced when C. albicans cells were challenged with osmotic or 
with oxidative stresses. SOD5 transcription was also increased when cells were grown on 
non-fermentable substrates as the only carbon source. The Rim 10 1 P transcription factor 
was required for aIl inductions observed, while the Efglp transcription factor was 
specifically needed for serum-modulated expression. Deletion of SOD5 produced a viable 
mutant strain that showed sensitivity to hydrogen peroxide when cells were grown in 
nutrient limited conditions. Sod5p was found to be necessary for the virulence of C. 
albicans in a mouse model of infection. However, the sod5 mutant strain showed the 
same resistance to macrophage attack as its parental strain, suggesting that the loss of 
virulence in not due to an increased sensitivity to macrophage attack. 
3.1.2 INTRODUCTION 
Aerobic eukaryotic pathogens can encounter superoxide radicals (02-) generated 
from several sources. These sources can be internaI or external. An important internaI 
source is the mitochondrial respiratory chain (29, 46, 181), and thus the rate of respiration 
can have a significant impact on reactive oxygen species (ROS) production. A key 
external source of ROS encountered by pathogens is from phagocytes. The superoxide 
radical is the first intermediate in the oxidative burst generated in the phagosome, and 
this burst is thought to be involved in pathogen killing (247). The superoxide radicals are 
known to inactivate [4Fe-4S] c1uster-containing enzymes by oxidizing one iron and 
releasing it from the c1uster (93, 186). Free iron can react with hydrogen pero xi de to 
generate toxic hydroxyl radicals (OH-) by Fenton chemistry (92, 215). The hydroxyl and 
superoxide radicals react with cellular components resulting in oxidation of proteins and 
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nucleic acids as weIl as lipid peroxidation. These effects can lead to inactivation of 
enzymes, to disruption of membranes, to mutations, and to cell death (111, 112). 
In order to reduce the harmful effects of superoxide radicals, cells express 
detoxifying enzymes. Superoxide dismutase (SOD) is an antioxidant enzyme involved in 
elimination of superoxide anions; it catalyzes the reaction: O2- + O2- + 2H+ - H20 2 + 
O2• Normally, hydrogen peroxide (H20 2) is still toxic to the ce Il , therefore another 
enzyme, catalase, converts it to water. Superoxide dismutases can be classified according 
to metal cofactor(s) bound to them: there are iron (FeSOD), manganese (MnSOD), 
copper and zinc (CuZnSOD) and nickel (NiSOD) versions of the enzymes. The 
CuZnSOD family is thought to have evolved separately, and thus the se enzymes share no 
sequence similarity with other SOD families (151, 275). 
An important aerobic eukaryotic pathogen, Candida albicans, causes the majority 
of human fungal infections. These infections range from thrush in immunocompetent 
colonized hosts, to life-threatening systemic infections in immunocompromised 
individuals such as patients with cancer (64). C. albicans can grow in several 
morphological forms: it can proliferate as a budding yeast and it can also form filaments, 
such as true hyphae and pseudohyphae. Hyphal formation of this fungus can be induced 
by high temperature, basic pH, and by the presence of serum, and this morphological 
transition is implicated in pathogenesis of C. albicans (35). 
Typically, eukaryotes express cytosolic CuZnSOD and mitochondrial MnSOD 
(93). C. albicans possesses both cytosolic CuZnSOD and mitochondrial MnSOD encoded 
by the SODI and SOD2 genes respectively (134,249). In addition to these proteins, a C. 
albicans cytoplasmic MnSOD (the SOD3 gene product) was recently identified (162). 
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SODI was shown to form homodimers (162); while SOD2 and SOD3 were shown to 
form homotetramers (162, 249). C. albicans Sod 1 p was shown to prote ct cells against 
superoxide radicals produced by macrophages, and it was shown to be important for the 
virulence of C. albicans in a mouse model (135). C. albicans catalase was also shown to 
be involved in virulence of this pathogen. C. albicans Sod2p was shown to have no effect 
on the virulence aspect of this fungus, but rather protects the cell against intracellularly-
produced superoxides (133). C. albicans appears to coordinate the production of 
CuZnSOD and MnSOD in a reciprocal manner: CuZnSOD shows the highest activity in 
the mid-exponential phase, while MnSOD has the highest activity upon the entry to 
stationary phase (162, 249). The morphology of C. albicans is coupled to CuZnSOD 
production since cells generate increased amounts of CuZnSOD during the switch from 
yeast to hyphal forms (109). In particular, conditions of elevated production of CuZnSOD 
coincide with increased levels of ROS produced by C. albicans as cells produce the 
highest levels of ROS, including superoxide, during hyphal growth and in exponential 
phase (266). In addition, C. albicans generates higher amounts of ROS when grown in 
the presence of salt (260, 266). 
We have identified three new potential C. albicans superoxide dismutase genes. 
We studied the expression, regulation and function of one of these genes, SOD5, and 
show that this gene is under a complex regulation of expression. Functional tests show no 
involvement of SOD5 in defense against macrophage-induced killing. However, the 
effects of the deletion of SOD5 on virulence may suggest the involvement of Sod5p in 
removal of superoxides produced by the host. 
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3.1.3 MATERIALS AND METHODS 
C. albicans and Bacterial Strains. The C. albicans strains are listed in Table 1; plasmids 
and oligonucleotides used in this study are listed in Tables 2 and 3. The C. albicans 
strains SC5314 (88), HLC52 (190), JKC19 (188), DAY25 and DAY185 (69), BWP17 
(305), and GK06 (71) were used for transcription analysis; RMlOOO (226) was used as a 
parental strain to generate the RMlOOO-HU, HI0, UHI6, UHI6-1, UHI6-2, and UH16-3 
strains. The Escherichia coli strain DH5a was used for aIl plasmid constructions and 
maintenance. The plasmid pVEC (205) was used for the generation of plasmids p37, 
p37H, p37U, and pSOD5-110; plasmids p5921 (88) and pRMI00 (239) were used for the 
amplification of hisG-CaURA3-hisG and CaHISl markers respectively. 
Media and Culture Growth Conditions. C. albicans strains were routinely cultured on 
YPD (1 % yeast extract, 2% peptone, 2% dextrose, pH6) medium at 30°C. CelIs with 
integrated selection markers or disrupted genes were cultured in synthetic glucose 
medium containing 0.67% yeast nitrogen base, 0.15% amino acids, 2% dextrose and 
appropriate supplements. AlI media were supplemented with uridine (25 f!g/ml) for the 
growth of C. albicans Ura auxotrophic strains. 
Since under certain conditions C. albicans celIs form hyphae at 37°C, it is 
difficult to accurately measure the growth of cells in the culture media. We therefore 
prepared standard growth-curves in YPD media at 3 rc. We observed that it takes 300 
minutes for SC5314 strain to reach an OD600 of 1.0 at 30°C, and it takes 225 minutes for 
SC5314 strain to reach an OD600 of 1.0 at 3rc. It takes 325 minutes for RMI000-HU 
and UH16-2 strains to reach an OD600 of 1.0 at 30°C, and it takes 250 minutes for 
71 
Chapter 3: C. albicans intragenic comparison 
RM1000-HU and UH16-2 strains to reach an OD6oo of 1.0 at 3rc. These standard 
curves were used to approximate the time when the conditions should have changed. 
For the Northern analyses performed with the yeast and mycelial forms of C. 
albicans, blastospores were first grown overnight at 30°C in the following media: 
mammalian cell culture media IMDM (pH6.5) (Gibco-Invitrogen), YPD, YP, or YP 
supplemented with either 2% galactose (YPGal), 3% glycerol (YPGlyc) or 1.5% 
methanol (YPMeth). The precultures were then diluted to an OD600 of 0.1 and incubated 
in the same media at either 30°C until the OD600 reached 1.0, or at 37°C until the OD600 
reached 2.5. In other cases, the pre culture grown in YPD medium was diluted to an OD600 
of 0.1 and then incubated until the OD600 reached 1.0 at either 30°C or 37°C in the 
following media: YPD, YPD supplemented with 10% serum, YPD adjusted to pH8, YPD 
with 0.3M NaCI, and YPD with 0.3M NaCI at pH8. 
For sorne samples, the preculture grown in YPD medium was diluted to an OD600 
of 0.1 and then incubated at either 30 or 3rC in YPD. In those cultures the pH, the NaCI 
concentration or both of those factors were increased 10, 30, or 60 minutes before the 
OD600 reached 1.0. In those conditions the pH of the media was increased to 8.0 with ION 
NaOH; the salt concentration was increased to 0.3M by adding an appropriate amount of 
5M NaCI solution into the media. 
In other cases, the preculture grown in YPD medium was diluted to an OD600 of 
0.1. The culture was then supplemented with reactive oxygen species-generators one hour 
before the OD600 reached 1.0 at 30°C, or one hour before the OD600 reached 2.5 at 3rC. 
In this case cells were grown in YPD with O.4mM H202, YPD with 0.5mM Menadione 
(Sigma), or YPD with 0.5mM Riboflavin (Sigma) (illuminated with 100W table-Iamp). 
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AlI liquid cultures were rotated at 250 rotations per minute. Spot-assays were done on 
media solidified with 2% agar. 5'-Fluoroorotic acid (5-FOA) (Diagnostic Chemicals 
Limited) containing medium was prepared as described before (25), except that uridine 
was substituted for uracil. C. albicans cells were transformed by the previously described 
method (48). 
RNA Preparation and Northern Blot Analyses. Total RNA was extracted by the hot 
phenol extraction method (44). The Northern blot analyses were performed by the 
previously described method (4) with the following modifications. RNA samples (80!-tg) 
were electrophoresed on a 7.5% formaldehyde, 1% agarose gel and transferred by 
capillarity to a Zeta-Probe nylon membrane (Bio-Rad, Mississauga, Ontario). Detection 
of specific RNAs was performed by hybridization at 65°C in 0.5 M NaP04, pH7.2, 1 
mM EDT A, 7% SDS, 1 % bovine serum albumin with SOng of 32P-Iabeled DNA probes 
(ssDNA was omitted from this solution). Probes were generated by using the random 
prime labeling system (Amersham Pharmacia Biotech) with the following modifications: 
50ng (rather than 25ng) of DNA was added to the reaction, the reaction was incubated at 
37°C for 45 minutes (rather than for 10 minutes), and all of the labeled probe (rather than 
1.25ng) was used for hybridization. The unincorporated labeled nucleotides were 
removed by G-50 micro columns (Amersham Pharrmacia Biotech). Membranes were 
washed once at 65°C with a solution containing 40 mM NaP04, pH 7.2, 5% SDS, 1 mM 
EDTA, 0.5% bovine serum albumin for 10 minutes (rather than twice for 20 minutes), 
and once with a solution containing 40 mM NaP04 pH 7.2, 1% SDS, and 1 mM EDTA 
for 20 minutes (rather than four times for 20 minutes) and were visualized using a 
Phosphorlmager (Molecular Dynamics, Model # 4255). 
73 
Chapter 3: C. albicans intragenic comparison 
AlI Northern probes were made by PCR: the 0.24kb long SOD5 probe used 
primers OMM8 and OMM9, the 0.24kb long SOD4 probe used primers OMMI0 and 
OMMll, the 0.21kb long SODI probe used primers OMM14 and OMMI5, and the 0.5kb 
long SOD6 probe used primers OMMl6 and OMMI7. A CaACTI probe was generated 
with UO 1 06 and UO 1 07 oligos and was used as an internaI control to monitor RNA 
loading and transfer (a gift from Dr. Ursula Oberholzer). The Dot-Blot was performed the 
same way as the Northern, with the difference that 80""g of SODI, SOD4, SOD5, and 
SOD6 unlabeled probes (rather than 80""g of RNA) were spotted on the membranes. 
Deletion and Reversion of SOD5.In order to delete the SOD5 gene, the SOD5 ORF and 
its lkb flanking regions were PCR-amplified from genomic DNA of the CAI4 strain with 
oligos OOH157 and ODH158 that contained EcoRI sites. The PCR product (2.6kb) and 
plasmid pVEC were digested with EcoRI, and a 4.7kb EcoRI fragment ofpVEC was gel-
purified and ligated with the EcoRI digested 2.6kb SOD5 PCR product. Clone p37 
contained an insert with the SOD5 ORF running in the opposite orientation with respect 
to that of the Amp marker. The SOD5 ORF was deleted from p37 by the use of inverse 
PCR using either oligonuc1eotides OMMI and OMM2 or OMMI and OMM3. The hisG-
URA3-hisG marker was cut from p5921 with BgnI and BarnHI; OMMI and OMM2 
create Barn HI restriction sites in p37 into which the hisG-URA3-hisG marker was 
inserted to yield p37U. The HISI marker was PCR amplified from pRMlOO with OMM4 
(containing an XbaI site) and CB20R (containing a BarnHI site, a gift from Dr. Catherine 
Bachewich); OMMI and OMM3 created BarnHI and XbaI restriction sites respectively in 
p37 into which the HISI marker was ligated to yield p37H. The HISI and SOD5-1kb-
flanking regions were PCR amplified from p37H with oligos ODH157 and ODHI58, and 
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this PCR product was transformed into RMI000 to yield the HI0 strain, in which the 
sod5::HISl fragment replaces the chromosomal SOD5 ORF. The hisG-URA3-hisG and 
SOD5-1kb-flanking regions were eut out ofp37U withXmnl and Spel, and this fragment 
was transformed into HI0 to yield the UH16 strain, in which the sod5::hisG-URA3-hisG 
fragment replaces the second chromosomal SOD5 ORF. Strain UH16 was plated on 5-
FOA-containing plates to select for Ura-auxotrophs. As a result, the UH16-1 strain was 
created in which one SOD5 ORF was replaced with HISl marker, and the second SOD5 
ORF was replaced with hisG. In order to create the prototrophic strain UHI6-2, UH16-1 
was transformed with the p37U construct, which was targeted to the chromosomal SOD5-
promo ter region by cutting the construct in the SOD5-promoter region with NsiJ. The 
HISl URA3 - auxotrophic wild type stain was transformed with the p37U and p37H 
constructs in a sequential manner; the se were targeted to the chromosomal SOD5-
promoter region by cutting the constructs in the SOD5-promoter region with NsiJ, 
creating strain RMI000-HU. For SOD5 reversion studies, the SOD5 ORF and its lkb 
flanking regions were PCR-amplified from CAI4 genomic DNA with the OMM18 and 
OMM19 oligos that contained BamHI and Xbal sites respectively. The resulting PCR 
product (2.6kb) and plasmid pVEC were double-digested with BamHI and Xbal 
restriction enzymes and ligated together to yield pSOD5-110. pSOD5-110 was 
transformed into UH 16-1 to yield revertant strain UH 16-3. 
Genomic DNA was prepared from aIl of the obtained strains, digested with Nhel 
and Xhol, and analyzed for the correct integration events by Southern blotting with a 
digoxigenin (DIG) system (Boehringer Mannheim). The DIG probe was generated by 
PCR with ODH157 and OMMl oligos that amplified the lkb SOD5 promoter sequence 
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from p37. To confirm the absence of the SOD5 ORF, genomic DNA from UHI6, UHI6-
l, and UH16-2 strains were cut with Dral, and analyzed by Southern blotting with a 
probe that binds in si de the SOD5 ORF. This probe was also used for Northern analysis to 
confirm the absence of SOD5 mRNA in the SOD5 inducing conditions (see 
"experimental" section for results). 
Protein preparation and In-gel SOD activity assay. Prote in preparation was done as 
previously described (139). The prote in concentration was determined by the Bradford 
method using an assay kit (BIO-RAD), as described by the pro vider. SOD activity in 
polyacrylamide gels was detected using nitroblue tetrazolium (NBT) (13), with the 
modification that 5mg of cell extracts were electrophoresed on 10% non-denaturing 
polyacrylamide gels in triplicates. After electrophoresis, one gel was used for Coomassie 
blue staining (207). The other two gels were used for determining SOD activity with or 
without 4mM KCN (139). 
Spot Assay and Growth Assay. Overnight cultures of C. albicans cells were 
concentrated to OD6oo of 20.0. SeriaI twofold dilutions were made and 5ul of cells were 
spotted onto a plate and incubated for 48 hours at either 30°C or 37°C. Spot assays were 
prepared on the types of media described in the results section. The growth assay of cells 
in liquid media was made by diluting overnight cells in those media to OD600 of 0.1. The 
growth rate was monitored at OD600 for 24 hours at 30 and 37°C. 
Macrophage and Virulence assays and fungal burden. The end point dilution survival 
assay was performed as described previously (208). Dilutions of C. albicans without 
macrophages where colonies could be distinctively visualized were counted toward the 
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lower limit and compared to the same dilutions with macrophages. Colonies from a total 
of at least 72 wells per condition were used to provide data. 
For virulence assays, C. albicans strains were passaged overnight at 30°C in YPD 
prior to infection. Cells were harvested, washed in co Id phosphate-buffered saline (PBS) 
(Wisent inc., St.-Bruno, Canada), and counted using a hemacytometer. Cells were then 
resuspended at a density of 5.75 x 106 cells / ml. B6 mice (8 weeks old, females) (Charles 
River Laboratories, Wilmington, MA, USA) were infected through the lateral tail vein 
with 200 !-lI (1.15 x 106 organisms). Mouse survival was monitored at least three times 
daily, and moribund mi ce were euthanized by CO2 gas. We used C. albicans strain 
RMI000-HU to infect 13 mice, UH16-2 and UH16-3 to infect 12 mice. C. albicans 
colony forming units (cfu) in kidney were counted from live animaIs sacrificed at day 
five after the infection. The kidneys were removed aseptically from four mi ce per strain; 
the organs were weighed, homogenized, diluted in sterile saline and plated on YPD 
plates. Colonies were counted after incubation of the plates at 30°C for 48 hours and the 
results were expressed as cfu per gram of infected organ. 
3.1.4 RESULTS 
Identification of SOD4, SOD5, and SOD6 
The mammalian pathogen, Candida albicans, is known to possess both a copper-
ZInC dependent superoxide dismutase (CuZnSOD encoded by SaDI) (134) and a 
manganese dependent superoxide dismutase (MnSOD, encoded by SaD3) (162) in the 
cytosol, and to encode a second MnSOD (SaD2) that is localized to mitochondria (249). 
The C. albicans genome sequence revealed three additional open reading frames with 
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high sequence homology to the copper-zinc family of superoxide dismutases: orf 
19.2062, orf 19.2060 and orf 19.2108 in version 19 of Stanford's Candida albicans 
genome sequence assembly (Stanford Genome Technology Center, http://www-
sequence.stanford.edu/group/candidal ). We have designated these new genes as SOD4, 
SOD5 and SOD6 respectively. AU three of the se genes share sequence homology to the 
previously described SODi and to each other, but share no homology to the manganese-
containing superoxide dismutases (Figure 3.1.1A). AU three predicted proteins (Sod4p, 
Sod5p and Sod6p) contain characteristic residues involved in copper and zinc binding, 
and amino acids involved in dimer contact (86) (Figure 3.1.1B). Northern analysis 
(described below) showed that the mRNAs for each of the three genes were 
approximately 700 nucleotides in length. However, the predicted length of Sod6p of 316 
amino acids was too large to be easily accommodated within this size of message. This 
discrepancy could be resolved if SOD6 contained an intron. Nucleotide sequence analysis 
shows that SOD6 contains a weU-characterized 3' splicing site "CT AGG" motif starting 
at nucleotide 752, a signal for lariat formation "AACTGAC" starting at nucleotide 723, 
and a possible 5' splicing site "GTCGGT" starting at nucleotide 462, which closely 
resembles the previously reported "GTANGT" motif (9). Splicing of this potential intron 
would generate a predicted ORF of 218 amino acids, close in size to the predicted 232 
amino acids and 228 amino acids of Sod4p and Sod5p. AU these proteins are likely to be 
cytosolic, since they lack mitochondria-targeting sequences. Intriguingly, SOD4 and 
SOD5 are close together in the genome, with SOD410cated 2kb upstream of SOD5 (224). 
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SOD5 is transcriptionally induced during yeast to hyphal transitions 
Hyphal formation in C. albicans can be induced by incubation of the cells in the 
presence of serum and high temperature. Recent transcriptional profiling experiments 
established that the SOD5 gene was induced during the yeast to hyphal switch (224). In 
order to study the expression pattern of the copper-zinc SOD genes, we generated probes 
to unique sequences within each gene (Figure 3.1.1B). Dot-blot analysis confirmed the 
specificity of each probe; there was an insignificant cross-hybridization between the 
SOD4 and SOD5 probes, and no cross-hybridization for any of the other combinations 
(our unpublished results). These probes were used to investigate transcriptional 
regulation of the SOD5 gene under a variety of conditions. Northern blot analysis of the 
Actin (ACTl) mRNA in C. albicans strains was used as an internalloading control, since 
the transcription of this gene was shown to be unaffected under most of the growth 
conditions tested in our study (224). In agreement with microarray data, Northern 
analysis demonstrated that the SOD5 transcription increases at 37°C in the presence of 
serum, compared to the control condition of no serum and 30°C (Figure 3.1.2A, lanes 1 
and 4). We investigated whether serum, temperature or both ofthese factors regulated the 
expression of SOD5. In the absence of serum, a temperature increase from 30°C to 37°C 
reduced the expression of SOD5 from a relative intensity of 1.0 to 0.3 (Figure 3.1.2A, 
lanes 1 and 2). In contrast, the presence of serum caused high levels of SOD5 expression 
(Figure 3 .1.2A, compare lane 1 with lanes 3 and 4). This suggests that serum, rather than 
temperature, controls the induction of SOD5 expression. 
The mammalian cell culture medium IMDM lacks serum, but allows C. albicans 
to grow exclusively in a hyphal form at both 30°C and 37°C. SOD5 was highly expressed 
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in this medium at both temperatures (Figure 3.1.2B). As in (162), we observed the 
accumulation of a new, 3.4kb mRNA species hybridizing to the SOD5 probe (lane 3), 
which does not correspond to the specific SODi, SOD4 or SOD6 mRNAs (our 
unpublished results). The nature of this mRNA is unc1ear, but since the distance between 
the start codon of SOD5 and the stop codon of SOD4 on the chromosome is 3.3kb it is 
possible that the SOD5 probe hybridized to a mRNA species that contains both SOD4 and 
SOD5. This idea is supported by the detection of the same message by a SOD4 probe (our 
unpublished results). 
Another way to induce the yeast-to-hyphal transition is to increase the pH and the 
temperature of the medium. At both temperatures, 30°C and 37°C, an increase of pH from 
6.0 to 8.0 increases the expression of SOD5 (Figure 3.1.3a, lanes 6-9 and 18-21). At both 
temperatures the rise in SOD5 mRNA expression persists up to 300 minutes for 30°C or 
225 minutes for 37°C of growth in the media with an increased pH. The induction peaks 
at 30 minutes for cells grown at 30°C, and at 10 minutes for cells grown at 37°C. 
Osmotic and oxidative stresses affect SOD5 transcription 
C. albicans cells grown in the presence of salt were shown to generate higher 
amounts of ROS (260, 266). Intriguingly, previous transcription profiling established that 
osmotic stress also induced the expression of SOD5 (82). We confirmed the se results by 
Northern analysis, as cells grown in the presence of high salt concentrations showed an 
increased transcription of SOD5 at 30°C (Figure 3.1.3a). The levels of SOD5 mRNA 
increase as early as 10 and 30 minutes after the addition of salt to the media at both 30°C 
80 
Chapter 3: C. albicans intragenic comparison 
and 37°C, but stay up after 60 and 300 minutes only at 30°C (Figure 3.1.3a, lanes 1-5 and 
13-17). 
When pathogens are engulfed by neutrophils there is an increase in both pH and 
salt concentration inside the phagosome (247). Intriguingly, high salt and high pH have a 
cumulative effect on SOD5 transcription at 30°C; at 37°C high salt and high pH yield to a 
higher SOD5 response compared to the levels of SOD5 transcripts induced separately by 
high pH and high salt (Figure 3.1.3a, lanes 10-13 and 22-23). The fact that high salt and 
high pH together lead to increased SOD5 expression was expected for a model that the 
expression increase permits the mobilization of superoxide dismutase activity to de fend 
against phagosome mediated killing. 
ln sorne organisms su ch as S. cerevisiae, the transcription of the gene encoding 
the cytoplasmic superoxide dismutase is induced by treatment with various oxidative 
agents like hydrogen peroxide and menadione (162, 174, 311). We investigated the 
transcription profile of the C. albicans CuZn superoxide dismutases in cells treated either 
with hydrogen peroxide or superoxide radicals. We used two types of superoxide 
generators: riboflavin, which generates superoxides outside of the cell (139), and 
menadione, which creates superoxides inside the cell (174). The presence of hydrogen 
peroxide caused increased levels of SODI expression (Figure 3.1.3b, compare lane 1 with 
lanes 3 and 4) and moderate increases in transcription of SOD5. Menadione leads to 
moderate increases in transcription of SODI at both temperatures and that of SOD5 
(Figure 3.1.3b, lanes 5 and 6). Riboflavin treatment results in elevated levels of SODI at 
37°C and that of SOD5 at both temperatures (Figure 3.1.3b, lanes 7 and 8). The SODI 
induction was weak, as previously described (162). The fact that the transcription of 
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SOD5 was increased upon the induction of oxidative stress is also expected if the gene is 
involved in defense against a phagosome-generated oxidative burst. Since SOD5 
transcription was induced by both intracellular and extracellular superoxide generators, it 
provides us with the first evidence that Sod5p is needed for elimination of superoxides 
who se source is from within the cell. 
Non-fermentable carbon sources affect SOD5 expression 
Since we saw that the intracellular superoxide generator, menadione, induced 
SOD5 levels, we further investigated the effect of intracellularly-generated superoxide on 
SOD5 transcription. Studies of isolated mitochondria showed that up to 80% of the 
superoxide in eukaryotic cells was produced in the mitochondria by electron leakage at 
the QH2:cytochrome c segment (complex III) during respiration (47). Therefore, the 
effect of respiration on SOD5 transcription was investigated. One of the ways to increase 
respiration is to grow the cells in media with a non-fermentable carbon source, such as 
glycerol or methanol, while providing glucose or galactose as the sole carbon source 
allows cells to grow by fermentation (72, 193). 
At 30°C we grew cells until they reached an OD600 of 1.0. We observed that the 
growth on glucose or galactose as the only carbon source leads to relatively low levels of 
SOD5 transcription (Figure 3.1.4, lanes 1 and 3). When cells were grown in the presence 
of glycerol or methanol as the only carbon source at 30°C SOD5 expression was 
moderately increased (Figure 3.1.4, lanes 5 and 7), compared to fermentable carbon 
sources at the same temperature (compare with lanes 1 and 3). At 30°C, the highest 
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SOD5 transcript levels were detected in ceUs grown in the absence of any carbon source 
(YP) (Figure 3.1.4, lane 9). 
At 3rC we grew cells until they reached an OD6oo of 2.5. We observed that the 
growth on glucose or galactose as the only carbon source leads to very low levels of 
SOD5 transcription (Figure 3.1.4, lanes 2 and 4). When ceUs were grown in the presence 
of glycerol or methanol as the only carbon source at 3rC SOD5 expression was highly 
increased (Figure 3.1.4, lanes 6 and 8), compared to fermentable carbon sources at the 
same temperature (compare with lanes 2 and 4). At 3rC, the highest SOD5 transcript 
levels were detected in ceUs grown in the absence of any carbon source (YP) (Figure 
3.1.4, lane 10). These results show that growth on non-fermentable carbon sources 
increase SOD5 transcription, which might suggest that one of the roI es of Sod5p is to 
eliminate intraceUularly generated superoxide radicals. SODi and SOD4 were also up-
regulated by increased temperature when grown on non-fermentable carbon sources, and 
SODi, SOD4, and SOD6 were also up-regulated in the absence of carbon sources (YP) 
(our unpublished results). 
Transcription Factors involved in the regulation of SOD5 expression 
Previous transcription profiling established that the non-hyphal efgi cphi double 
mutant failed to induce SOD5 expression under hyphal inducing conditions (224). We 
used Northern analysis to determine the relative impact of each transcription factor on the 
expression of the SOD5 gene. For each of the individual null mutants we attempted to 
induce SOD5 transcription by one of the following conditions: serum and high 
temperature, osmotic stress (0.3 mM NaCI) and basic pH (pH8). In aU ofthese conditions 
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the cphl mutant showed the same pattern of SOD5 expression as the wild type strain: 
SOD5 was induced in aIl three conditions as compared to the non-induced condition 
(YPD 30°C) (Figure 3.1.5, lanes 1-8). On the other hand, the efgl mutant failed to 
increase the transcription of SOD5 specifically under serum inducing conditions (Figure 
3.1.5, lanes 9-12, compare lanes 2 and 10). In addition, under non-inducing conditions 
the efgl mutant showed generally elevated levels of SOD5 message (Figure 3.1.5, 
compare lanes 1 and 9). Interestingly, the addition of salt to the media does not increase 
the SOD5 mRNA levels, compared to SOD5 levels during the growth of efgl mutant 
strain under non-inducing conditions (Figure 3.1.5, lanes 9 and Il). The SOD5 mRNA 
levels were increased in the efgl mutant in alkaline-inducing conditions, although not to 
the same extent as the corresponding increase in the wild type strain (Figure 3.1.5, lane 
12). To investigate the factors responsible for the pH-mediated induction of SOD5 
expression we looked at cells defective in either the Rim101p transcription factor or in 
Mds3p; these factors represent independent branches of the pH response (71). In contrast 
to both the efgl and cphl mutants, the rimlOI mutant blocked SOD5 induction under aIl 
of the conditions tested compared to SOD5 expression in its parental strain (Figure 3.1.5, 
lanes 13-20). Just as in the wild type and the cphl mutant, the mds3 mutant showed that 
SOD5 was induced in aIl three conditions (YPD 30°C) (Figure 3.1.5, lanes 21-28). 
Therefore, the Cphl p transcription factor and Mds3p have essentially no effect on SOD5 
transcription under the conditions tested, Efglp is required for SOD5 transcription in the 
presence of serum and perhaps for suppressing the SOD5 expression under the non-
inducing condition, and Rim 101 P is important for the normal SOD5 transcription under 
aIl of the conditions tested. 
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SOD5 is not essential for viability in C. albicans 
To study the function of Sod5p in C. albicans, we created a strain in which both 
copies of SOD5 were deleted. We generated a strain UH16 with the sod5::HISI 
sod5::hisG-URA3-hisG constructs replacing both copies of the SOD5 gene (see 
"Materials and Methods" for details). The correct position of insertions during the se steps 
was analyzed by Southern blotting (Figure 3.1.6a). The absence of the SOD5 gene was 
also confirmed with a Southern blot probed with a SOD5 internaI fragment probe. This 
probe binds in si de the SOD5 open reading frame exclusively, and it fails to generate a 
SOD5-corresponding band in the SOD5 double-mutant (our unpublished results). When 
the DNA was restricted with Dral, the SOD5 probe hybridized to an unexpected 7kb-
DNA fragment, which could be derived from the accumulation of a 7kb DNA fragment 
se en with ethidium bromide staining. The nature of this piece of DNA is unclear, but it 
might be derived from the multiple repeat sequence whose DraI restriction digest yields a 
7kb DNA fragment that has an affinity to the SOD5 probe (our unpublished results). In 
addition, the absence of SOD5 mRNA under either SOD5 inducing conditions (the 
presence of either serum or alkaline conditions or high pH) or non-inducing conditions 
(YPD) was confirmed by Northern blotting using the same internaI probe (Figure 3.1.6b). 
No increase in SODI, SOD4, and SOD6 transcript levels was observed in the sod5 mutant 
strain (UH16-2) (our unpublished results). Finally, we performed an in-gel activity assay 
that detects the activity of both types of superoxide dismutases, CuZnSOD and MnSOD. 
RMlOOO-HU cells grown in IMDM media at 3rC express both MnSOD (Figure 3.1.6c, 
lane 1, upper band) and high amounts of CuZnSOD (Figure 3.1.6c, lane 1, lower band). 
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On the other hand, UH16-2 cells showed reduced levels of the CuZnSOD activity (Figure 
3.1.6D, lane 2, lower band is missing) under the conditions tested. The CuZnSOD 
activity is restored in the UH16-3 revertant strain (Figure 3.1.6c, lane 3, lower band). The 
rimlOl mutant strain also showed reduced levels of the CuZn superoxide dismutase 
activity band (Figure 3.1.6c, lane 4). This observation is consistent with the results in 
Figure 3.1.5, and shows that the RIMlOl mutant cells possess low levels of both SOD5 
transcripts and Sod5p enzyme activity. The activity of the CuZnSOD can be inhibited by 
cyanide (KCN), which blocked the CuZnSOD activity ofRMlOOO-HU and UH16-3 cells 
grown in IMDM medium at 3rC (Figure 3.1.6c, lanes 5 and 6, lower bands are missing). 
This shows that in IMDM media SOD5 seems to be a major contributor of overall 
CuZnSOD activity in C. albicans. The ability to generate the viable double-mutant strain 
shows that SOD5 is not an essential gene in C. albicans. 
Hydrogen Peroxide together with limited nutrients impairs growth of the SOD5 
mutant strain 
We examined the growth properties of the sod5 mutant strain under conditions 
that were shown to increase the transcription of the SOD5 gene. The spot assay showed 
that there is no growth difference between the UH16-2 strain and the wild type strain in 
medium that contained serum, NaCl, pH8, NaCl and pH8. The sod5 mutant strain showed 
no heat sensitivity at 42°C, and no growth defect on Lee and Spider medium (our 
unpublished results). In addition, the sod5 mutant strain showed no defect with respect to 
hyphal development triggered by serum, IMDM media, or high pH (pH 8.0) at 3rC as 
shown by spot assays and growth in liquid media (our unpublished results). 
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In S. cerevisiae both of the single genes encoding CuZnSOD and MnSOD were 
found to be upregulated during the metabolic transition from fermentation to respiration 
(209), and the S. cerevisiae CuZnSOD mutant possesses a reduced ability to grow by 
respiration in glycerol rich medium (72, 193). We therefore investigated the ability of the 
sod5 mutant strain UH16-2 to grow on media rich with non-fermentable carbons. We 
found that there was no growth difference in the liquid or solid medium that contained 
either glucose, galactose, glycerol or methanol as a carbon source; in the absence of any 
of above-mentioned carbon source molecules the SOD5 mutant grew as fast as its 
parental strain (our unpublished results). CuZnSOD deficient S. cerevisiae require lysine 
and methionine for aerobic growth (22), whereas superoxide dismutase defective E. coli 
require branched chain amino acids (138). However, the C. albicans SOD5 mutant 
showed neither lysine, methionine, nor branched amino acids auxotrophies (our 
unpublished results). 
The E. coli and Helicobacter pylori SOD mutants were found to be more sensitive 
to the effect of hydrogen pero xi de than its parental isogenic strain (42, 155, 270). We 
compared the growth rate of the SOD5 mutant with that ofits parental isogenic strain. We 
found no growth difference between the SOD5 mutant and the wild type strains grown on 
nutrient-rich media (YPD) supplemented with 1.0mM hydrogen peroxide (Figure 3.1.7). 
However, the SOD5 mutant (UH16-2) grew poorly on SC (synthetic complete) media 
supplemented with 1.0mM hydrogen peroxide, compared to its parental strain (Figure 
3.1. 7). The growth of UH 16-3 strain showed an intermediate growth on SC media 
supplemented with hydrogen peroxide, consistent with the reintroduction of SOD5 in one 
copy into the UH16-1 background. The SOD5-phenotype suppression is observed in 
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UH16-2 cells after incubation in SC media, which contains hydrogen peroxide and slight 
excess of fermentable glucose (2.5% glucose, rather than 2.0% of glucose) or in YPD 
media, which contains hydrogen peroxide (Figure 3.1.7). 
SOD5 is involved in virulence of C. albicans but is not involved in defense of C. 
albicans against the fungicidal activity of macrophages 
The sensitivity to hydrogen peroxide is often linked to a decrease in virulence. To 
test directly the SOD5 involvement in macrophage-defense the UH216-2 strain was 
incubated with RA W 264.7 mouse macrophage cells and the percent survival 
(28.9±5.7%) was not different from the survival of its parental RMlOOO-HU strain 
(27.6±7.0%) and from the revertant UH16-3 strain (28.9±7.0%). These results suggest 
that Sod5p is not required for C. albicans survival when cells are subjected to the 
fungicidal activity of macrophages. 
To test directly the SOD5 involvement in an organism-defense, we tested the 
virulence of the sod5 mutant strain in a mouse systemic infection model by intravenous 
tail infection. The results showed that 90% of the mice infected with the wild type 
(RMI000-HU) died within 8 days of being inoculated. However, the homozygous sod5 
mutant strain (UH16-2) had markedly diminished virulence compared to the wild type 
parental strain (RMlOOO-HU). Mice infected with UH16-3 strain showed an intermediate 
survival rate consistent with the reintroduction of one copy of SOD5 gene into the UHI6-
1 background. 
The colony forming units (cfu) in mi ce kidneys were determined on the fifth day 
after infection. One hundred percent of the kidneys recovered from mice infected with the 
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wild type parental strain (RMI OOO-HU) revealed an average of 1.0 x 106 cfu g-l kidney at 
day of sacrifice. Seventy five percent of the kidneys recovered from mice infected with 
the sod5 revertant strain (UHI6-3) revealed an average of 7.0 x 105 cfu g-l kidney at the 
day of sacrifice, and 2.0 x 104 cfu g-l kidney in the remaining twenty five percent. 
Seventy five percent of the kidneys recovered from mice infected with the sod5 strain 
(UHI6-2) revealed an average of 5.0 x 104 cfu g-l kidney on the day of sacrifice, and 5.0 
x 105 cfu g-l kidney of the remaining twenty five percent, indicating an effective 
clearance of the sod5 knock out strain. These results demonstrate that a functional Sod5p 
plays an important role in the virulence of C. albicans. 
3.1.5 DISCUSSION 
C. albicans is known to express a CuZnSOD (SODi) and a MnSOD (SOD3) in 
the cytosol and a second MnSOD (SOD2) in the mitochondria (134, 162, 249). In this 
study we report the existence of three additional candidate CuZn containing superoxide 
dismutases, the products of the SOD4, SOD5 and SOD6 genes. We have characterized the 
SOD5 gene that appears to he important factor in the virulence of this fungus. Virulence 
of C. albicans is often attrihuted to its ability to switch from yeast to hyphal forms. 
Consistent with this, SOD5 expression increases with several hyphal-inducing conditions, 
SOD5 expression is dependent on known components of hyphal inducing signaling 
pathways, and the absence of this gene leads to a defect in the virulence of this organism. 
As expected for superoxide dismutases, SOD5 has sorne roles in responding to certain 
stresses. 
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Superoxide dismutases serve to convert damaging superoxide radicals, a key form 
of reactive oxygen species (ROS), to less damaging hydrogen peroxide that can be 
converted into water by catalase action. SOD5 clearly encodes a CuZn-containing 
superoxide dismutase: it has the highest sequence similarity to the CuZn superoxide 
dismutase family, and deletion of the SOD5 gene eliminates the major source of CuZn 
dependent (cyanide sensitive) superoxide dismutase activity detected in IMDM grown 
cells. 
What is the significance of C. albicans having multiple CuZn superoxide 
dismutase genes, most of which are potentially expressed in the cytosol? For pathogens 
like C. albicans, there are both internaI and external sources of superoxides. An attractive 
model would be to have high levels of SOD activity to protect the fungal cell against the 
oxidative burst inside the phagosome. The fact that SOD5 is highly expressed in the 
hyphal state of C. albicans (this study and (224)), and hyphal cells are typically the form 
that interacts with the host phagocytic cells (reviewed in (105)), would support such a 
model. In addition, increases in pH, salt concentration, or presence of oxidative species 
lead to increases in SOD5 transcription, the same events happen inside the phagosome 
(247), further strengthening a model that SOD5 could have a defense-related function. 
Most significantly, the strongest evidence that supports this model is the fact that the 
sad5 knock out strain is defective in mouse killing. It was previously shown that the C. 
albicans sadi mutant strain is defective in virulence and in macrophage killing. Our 
results have shown that the sad5 mutant behaves similarly to sadi with respect to the 
virulence in mice, but surprisingly Sod5p does not affect macrophage killing. This would 
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suggest that there are other phagocytic mammalian cells, like neutrophils or dendritic 
cells, to which Sod5p is critical for a wild type response. 
We investigated the possibility that a further function of SOD5 is to prote ct C. 
albicans cells against intracellularly-generated superoxide radicals. C. albicans produces 
the highest levels of CuZnSOD during the mid-exponential phase (162, 249) and it 
generates increased amounts of CuZnSOD during the switch from yeast to hyphal forms 
(109). During the same conditions, hyphal growth and in exponential phase of the 
growth, C. albicans is known to produce more ROS, including superoxide radicals (266). 
These two parameters, superoxide generation and superoxide detoxification, were 
correlated to respiration of C. albicans (139). Mitochondrial respiration was shown to be 
a powerful source of superoxide radicals in yeast (47), and factors like non-fermentable 
carbon sources were linked to increased superoxide production by electron transport 
chain in C. albicans (252), S. cerevisiae (67, 193, 209), and in Schizosaccharomyces 
pombe (143). In our study, these conditions that increase ROS production also increase 
SOD5 transcription. SOD5 expression levels were increased when cells grew in the 
presence of salt or on non-fermentable carbon as the only carbon source. In addition, an 
increased amount of fermentable glucose restored the growth ability of the SOD5 mutant 
cells grown in nutrient limiting media in the presence of hydrogen peroxide. We also 
observed that SOD5 transcription was induced by both menadione and riboflavin, which 
are intracellular and extracellular superoxide generators respectively. This also provides 
us with the evidence that Sod5p is needed for elimination of superoxides found on both 
sides of the cell membrane. This might suggest that Sod5p shares the redundancy with 
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other superoxide dismutases in eliminating extracellularly and intracellularly-generated 
superoxide radicals in C. albicans. 
All the increases in SOD5 transcript levels were observed in C. albicans grown in 
exponential phase, the same phase in which C. albicans produces more ROS. AlI hyphal-
inducing conditions induced SOD5 transcription, and SOD5 transcription was found to be 
regulated by transcription factors regulating the yeast to hyphal switch of C. albicans. AlI 
these lines of evidence might suggest that hyphal growth and log-phase growth processes 
increase mitochondrial respiration in aerobically growing C. albicans, which 
subsequently increase mitochondrially generated superoxide radicals, leading to 
increased levels of detoxification enzymes. It is possible that these detoxification 
enzymes include proteins like SOD5. 
Our results also show that SOD5 possesses a complex regulation of expression. 
Intriguingly, Efgl p was found to positively regulate SOD5 transcription in the presence 
of serum as seen in Nantel et al., 2002, and negatively regulate SOD5 transcription under 
non-inducing conditions. In addition, SOD5 transcription was found to be dependent on 
the RimlOl transcription factor, which is required for alkaline-induced filamentation 
(70). This implicates the Rim 10 1 p pathway in the response of the C. albicans cell to 
oxidative stress. RimlOlp was shown to be required for SOD5 induction in response to a 
variety of external signaIs, not just pH. Interestingly enough, the growth of the S. 
cerevisiae rimlOl mutant was found to be inhibited at basic pH and in the presence of 
NaCI (163), the same conditions in which SOD5 transcription was found to be up-
regulated. The lkb sequence upstream of the SOD5 start codon revealed four potential 
92 
Chapter 3: C. albicans intragenic comparison 
Rim 101 P binding sites, which closely resemble the previously described CCAAGAAA -
RimlOlp binding site (244), and four potential Efglp binding sites (CAWWTG) (182). 
All recent evidence suggests that C. albicans possesses a complicated cytosolic 
detoxification system. During the log-phase growth of C. albicans, SODI and SOD5 
(CuZn-containing superoxide dismutases) are expressed (this study and (162)). SODI 
appears to be primarily responsible for removal of extracellular, macrophage-generated 
superoxide radicals (135). SOD5 appears to be responsible for detoxification of 
extracellularly and intracellularly, possibly mitochondrially-generated superoxide 
radicals during log-phase and hyphal growth. As C. albicans cells enter the stationary 
phase, the expression of CuZn-containing superoxide dismutases is repressed and the 
expression of Mn-containing cytosolic superoxide dismutase (SOD3) is increased (162). 
The search for sequences similar to CuZnSOD in genomes of Neurospora crassa, 
Aspergillus fumigatus, S. cerevisiae and Schizosaccharomyces pombe revealed that aU of 
these organisms have SODI homologues, but only filamentous fungi (N crassa and A. 
fumigatus) have additional sequences homologous to SOD5 (NCU03013.1(161682-
160794) and contig:69:a_fumigatus (74890-75198), respectively). Perhaps filamentous 
fungi have more sources of production of harmful superoxide radical s, which applies 
more pressure on the se fungi to possess extra isoforms of superoxide detoxificators, like 
SOD5. The role of SOD4 and SOD6 remain to be established, although SOD4 was 
recently shown to be regulated in White-Opaque phenotype switching (164). 
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SOD4 
SOD6 
SOD"1 
Figure 3.1.1. Similarity of the CuZn-containing and Mn-containing superoxide 
dismutases in C. albicans. (a) Phylogenetic tree shows the similarity between aH C. 
albicans' superoxide dismutases: Sod4p, SOD5p, and Sod6p are homologous to Sodlp, 
and the CuZnSODs share no sequence similarity with the MnSODs. The analysis was 
produced by the Multiple Sequence Alignment pro gram of Florence Corpet 
(http://prodcs.toulousc.inra.tr/multalin/multalin.html). 
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(b) Amino acid sequence alignment of CuZn Superoxide dismutases (SODi, SOD4, 
SOD5, SOD6) and Mn Superoxide dismutases (SOD2, SOD3). Deduced amine acid 
sequences were aligned with the CL UST AL W program. Identical ami no acids are boxed 
in black and conservative changes are boxed in grey. Hyphens indicate gaps that were 
introduced to maximize the alignment. "+" indicate oligos used for Northem and 
Southem analysis for Sod4p, Sod5p and Sod6p. "#" indicate oligos used for Northem and 
Southem analysis for Sodlp. The Sod4p, Sod5p, and Sod6p contain CuZn-SOD 
characteristic residues. Asterisks below Cu and Zn stand for copper and zinc metals 
binding respectively; asterisks below DC stands for amino acids involved in dimer 
contact (86). Numbers at the ends of the sequences represent the amino acid lengths of 
the proteins. 
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Figure 2B. 
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Figure 3.1.2. Hyphal-inducing conditions induce SOD5 expression. (a) Serum, rather 
than temperature, induces SOD5 transcription. Northern blot analysis of the SOD5 
transcripts in C albicans strain SC5314 grown in the log-phase in indicated media (YPD 
and YPD containing 10% serum) at indicated temperatures. (b) SOD5 transcription is up-
regulated in IMDM medium. Northern blot analysis of the SOD5 transcripts in C. 
albicans strain SC5314 grown in the log-phase in IMDM medium at 30 and 37°C. 
Northern blot analysis of the Actin (ACTl) transcripts in C. albicans strain SC5314 was 
used as an internaI loading control. Relative intensities are shown below each of the 
genes analyzed. Relative intensities of cells grown at 3rC are underlined and quantified 
independently from SOD5 intensities obtained at 30°C. Quantifications were performed 
by NIH Image software (RSB-NIMH-NIH http://rsb.info.nih.gov/nih-image/). 
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Figure 3.1.3. Alkaline conditions, Osmotic and Oxidative stresses affect SOD5 
transcription. (a) SOD5 transcription is upregulated in alkaline conditions and in the 
presence of increased amounts of salt. Northern blot analysis of the SOD5 transcripts in 
C albicans strain SC5314 diluted to an OD600 of 0.1 and then incubated at either 30 or 
3rc in YPD. In those cultures the pH, NaCI concentration or both ofthose factors were 
increased 10, 30,60 or 300/225 minutes before the OD600 reached 1.0. 
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(b) Effects of oxidative shock on SOD5 and SODI of C. albicans. Northern blot analysis 
of the SOD5 transcripts in C. albicans strain SC5314 grown in log-phase, from OD600 of 
0.1 to OD600 of 1.0 at 30°C or from OD600 of 0.1 to OD600 of 2.5 at 3rC; the hydrogen 
pero xi de / menadione / riboflavin were supplemented one hour before reaching the final 
OD600 of 1.0 or 2.5. Lanes 1 and 2: no oxidative shock was applied. Lanes 3 and 4: 
hydrogen peroxide was added 1 hour before OD600 reached 1.0. Lanes 5 and 6: 
menadione was added 1 hour before OD600 reached 1.0. Lanes 7 and 8: riboflavin and 
light were added 1 hour before OD600 reached 1.0. Northern blot analysis of the Actin 
(A CT I) transcripts in C. albicans strain SC5314 was used as an internalloading control. 
Analysis as described in Figure 3.1.2. 
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Figure 3.1.4. SOD5 transcription is affected by non-fermentable carbon source. Northern 
blot analysis of the SOD5 transcripts in C. albicans strain SC5314 grown in log-phase, 
from OD600 of 0.1 to OD600 of 1.0 at 30°C or from OD600 of 0.1 to OD600 of2.5 at 3rC in 
YPD, YPGal, YPGlyc, VPMeth, and YP. Northern blot analysis of the Actin (ACTl) 
transcripts in C. albicans strain SC5314 was used as an internalloading control. Analysis 
as described in Figure 3.1.2. 
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Figure 3.1.5. Transcription factors involved in the transcription of SOD5. Northern blot 
analysis of the SOD5 transcripts in C. albicans strains lacking indicated transcription 
factors (strains SC5314, JKC19, HLC52, DAY25, DAYI85, BWP17 and GK06 (mds3) 
(see Table 1 )). The potential transcription of SOD5 was induced by one of the three 
inducing conditions: presence of serum (10%) at 3rC, presence of salt (0.3M NaCI) for 
1 hour at 30°C, or switch to alkaline conditions (pH8) for 1 hour at 30°C. Analysis as 
described in Figure 3.1.2. The intensities of SOD5 in HLC52 were compared to SOD5 
intensities of JKC19. The intensities of SOD5 in DA Y25 were compared to SOD5 
intensities of DAYI85. The intensities of SOD5 in mds3 were compared to SOD5 
intensities of BWPI7. These Northern blot analyses were reproduced twice. The general 
drop in SOD5 levels in rimlOI was reproduced, but the difference in relative intensities 
of SO D5 in the riml 01 strain was not significant. 
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Figure 3.1.6. SOD5 gene is deleted from UH16 strain. (a) Restriction endo-nuclease map 
of SOD5, of HISl inserted in place of SOD5 ORF, and of hisG-URA3-hisG inserted in 
place of SOD5 ORF digested with Nhel and Xhol. The arrows indicate lkb of SOD5 
promoter region. Southern blot analysis with the use of a 1 kb probe generated with 
ODH157 and OMMI oligos recognizes lkb of the SOD5 promoter region. The genomic 
DNA samples, digested with Nhel and Xhol were prepared from strains RMI000 
(SOD5/S0D5; lane 1), HlO (l1sod5::HISl/SOD5, lane 2), UH16 (l1sod5::hisG-URA3-
hisG/l1sod5::HlSl, lane 3). The wild-type SOD5 band is 3.6kb, the band corresponding to 
the URA3 cassette is 4.1kb, and the band corresponding to the HISl cassette is 2.7 kb. 
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(b) Northern blot analysis of the SOD5 transcripts in the UH16-2 mutant and its parental 
strain, RMlOOO-HU. The transcription of SOD5 was induced by one of the inducing 
conditions: presence of serum (10%) at 3 rc, or switch to alkaline conditions (pH8) for 1 
hour at 30°C, or presence ofO.3M NaCl for 1 hour at 30°C for UH16-2 and RMlOOO-HU 
strains. Northern blot analysis of the Actin (ACTl) transcripts in indicated C. albicans 
strains was used as an internalloading control. Analysis as described in Figure 3.1.2. 
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(c) Superoxide dismutase activity staining revealed SOD activity by staining the 10% 
native polyacrylamide gel with nitro blue tetrazolium and riboflavin. A sample (5mg) of 
the crude extract from exponentially growing cells in IMDM 3rC ofRMI000-HU (Janes 
land 5), UH16-2 (Jane 2), UH16-3 (Jane 3 and 6) and DA Y25 (Janes 4) was loaded into 
three gels. One gel (Janes 1-4) was stained for SOD activity in the absence of 4mM KCN, 
the second gel (lanes 5-6) was stained for SOD activity in the presence of KCN, and the 
third gel was stained with Coomassie blue as an internai loading control (our unpublished 
results). Relative intensities are shown below each of the genes analyzed. Quantifications 
were performed by NIH Image software (RSB-NIMH-NIH http://rsb.info.nih.gov/nih-
image/). 
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Figure 3.1.7. Hydrogen peroxide and limited nutrients inhibit growth of UH16-2 strain. 
Spot assay of RMIOOO-HU, UHI6-2, UH16-3 strains on sc or YPD, sc supplemented 
with hydrogen peroxide, and sc supplemented with 2,5% dextrose and hydrogen 
pero xi de (SDD) media at 30°C for 48 hours. 
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Figure 3.1.8. Sod5p activity is required for virulence in animal mode!. Survival of mice 
infected with C. albicans sod5 mutant UH16-2 (squares), sod5 revertant UH16-3 
(triangles), and wild type parental RMIOOO-HU (round) strains. Mice were inoculated by 
tail vein injection and survival was measured over a 30-day period. 
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Section 3.2: Transcription factors in C. albicans. 
As shown by Davis et al, a C albicans transcription factor RimlOlp, which is 
under the control of pH response pathway, is required for host-pathogen interaction (69). 
We showed that RimlOlp regulates the expression ofC albicans virulence factor SOD5, 
which therefore makes it a virulence factor as well. This example shows that transcription 
factors, which regulate the expression of genes whose products participate in host-
pathogen interaction, can be just as important as the virulence factors themselves. Thus, 
comparative genomic studies have also provided an opportunity to understand the 
mechanisms of gene expression in C albicans. 
Proteins of the zinc finger superfamily, for example, represent one of the large st 
classes of DNA-binding proteins in eukaryotes. The functions of many uncharacterized 
C albicans zinc cluster factors could be inferred from the fact that they display high 
levels of sequence similarity with the products of S. cerevisiae genes with a known 
function. However, approximately half of the C albicans zinc cluster genes do not appear 
to have homologues in S. cerevisiae, and are therefore likely to participate in processes 
specific to C albicans. In addition, the majority of S. cerevisiae transcriptional activators 
that were found to have C albicans homologues, one half shared homology only within a 
DNA binding domain. 
The lack of homology in the activation domains of transactivators between S. 
cerevisiae and C albicans might suggest a concomitant reduced structural similarity in 
the activation-domain-interacting complexes between the two species. A pair-wise 
sequence comparison of the transcriptional machinery between C albicans and S. 
cerevisiae shows a high level of conservation in the RNA polymerase II complex. The 
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exceptions to this are TFIIA and the Mediator complex: S. cerevisiae and C. albicans 
show low levels of homology with respect to the proteins of those two complexes. 
Interestingly, of aU RNA polymerase machinery, both of those complexes were shown to 
interact with transcriptional regulators. Since C. albicans' Med-type mediator complex 
shares very little homology to that of its host, it may be an attractive target for antifungal 
drugs. 
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3.2.1 ABSTRACT 
Many putative transcription factors in the pathogenic fungus Candida albicans contain 
sequence similarity to well-defined transcriptional regulators in the budding yeast 
Saccharomyces cerevisiae, but this sequence similarity is often limited to the DNA 
binding domain of the molecules. The Gcn4p and Gal4p proteins of Saccharomyces 
cerevisiae are highly studied and well-understood eukaryotic transcription factors of the 
bZip (Gcn4p) and C6 zinc cluster (GaI4p) families; C. albicans has CaGcn4p and 
CaGal4p with DNA binding domains highly similar to their yeast counterparts. Deletion 
analysis of the CaGcn4p protein shows that the N' terminus is needed for transcriptional 
activation; an 81 amino acid region is critical for this function, and this domain can be 
coupled to a lexA DNA-binding module to provide transcription activating function in a 
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heterologous reporter system. Deletion analysis of the C. albicans Gal4p identifies a C-
terminal 73 amino acid long transcription activating do main that also can be transferred 
to a heterologous reporter construct to direct transcriptional activation. These two 
transcriptional activation regions show no sequence similarity to the respective do mains 
in their S. cerevisiae homologs, and the two C. albicans transcription activating domains 
themselves show little similarity. 
3.2.2 INTRODUCTION 
Transcriptional regulators control the expression of genes to co-ordinate the 
availability of cellular function with the physiological needs of the cell. Gene-specific 
transcriptional activation is often regulated by the binding of positively-acting proteins to 
upstream activating sequences (UAS) in the DNA where they recruit and control the 
activities of chromatin-modifying and remodeling complexes and the transcription 
apparatus (178). A typical transcriptional activator then interacts with the RNA 
Polymerase II complex through binding to an adaptor complex termed Mediator; this 
Mediator complex consists of about 20 proteins and is conserved from yeast to humans 
(27). Eukaryotic transcriptional activator proteins are generally bipartite in nature, with 
separate domains for DNA binding and transcriptional activation (217, 292). The 
transcriptional activation domains are classified according to their amino acid 
composition: ri ch in acidic (e.g. Saccharomyces cerevisiae Gal4p and Gcn4p) or basic 
residues (tobacco BBCl), or rich in glutamine (s. cerevisiae Mcmlp), threonine/serine 
(human OCT2), or isoleucine (NTFl) (8, 38, 61, 83, 125, 146, 201, 202). The DNA 
binding modules also faH into many classes, such as zinc-finger, leucine-zipper, and 
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helix-Ioop-helix motifs (81, 84, 306). Although the activation domain is critical for 
function, and can provide a level of regulation, the functional targets of such 
transcriptional activators are determined by the DNA-binding address of the protein. 
In both S. cerevisiae and C. albicans GCN4 encodes a transcriptional activator of 
amino acid biosynthetic genes that responds to ami no acid starvation (123, 293). 
ScGcn4p is tightly regulated at both transcriptional and translationallevels. The 5' leader 
region of GCN4, which codes for a transcriptional activator of amino acid biosynthetic 
genes in response to amino acid starvation, contains four small upstream ORFs (uORFl-
4). These uORFs act as negative regulators of translation: the ribosome initiates 
translation at uORFl and becomes re-activated for translation at subsequent uORFs. 
Under environmental stresses, such as amino acid starvation, the translation of ScGCN4 
is induced: ScGcn2 kinase phosphorylates eIF2, and the scanning ribosome is not re-
activated until it bypasses the uORFs and initiates translation at the GCN4 open reading 
frame (122). The unusually long S'-leader sequence on the GCN4 mRNA, which carries 
four upstream open reading frames is conserved in C. albicans (293). It was recently 
shown that the prote in kinase, Gcn2, which is involved in transcriptional and translational 
regulation of Gcn4p in S. cerevisiae, is not involved in the regulation of C. albicans 
Gcn4p (290). 
Gcn4p binds as a homodimer with its basic leucine-zipper (bZIP) found in its 
carboxy terminus to a TGACTC sequence located upstream of many genes induced 
during amino acid starvation (7, 126). In S. cerevisiae Gcn4p there are two transcription 
activation domains: one resides in an acidic segment in the center of the protein between 
residues 107 and 144 (78, 125, 141), the second Gcn4p activation do main is located in 
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the N-terminal 100 amine acids. The two activation domains are functionally redundant 
and can work independently to produce high-Ievel activation (78, 141). 
S. cerevisiae Gal4p represents a second well-studied transcription factor, and 
functions as the transcriptional activator of galactose catabolism (192, 237, 291). 
ScGal4p contains a DNA binding do main (amino acids 1-65), and two transcriptional 
activation domains, do main 1 (amino acids 149-196), and domain II (amino acids 768-
881) (76, 202). The transcriptional activation do main II of Gal4p interacts with Gal80p in 
the absence of galactose, and through this contact, Ga180p inhibits Gal4p (230), 
preventing it from activating the expression of galactose-dependent genes. During growth 
on galactose, Ga13p binds Gal80p and removes it from Gal4p at the GAL gene's promoter 
and prevents Ga180p from inhibiting Gal4p function (237). Therefore, in the presence of 
galactose, Gal4p is freed from Gal80p inhibition, and subsequently activates the 
expression of the galactose regulon (192, 237, 291). The Gal4p DNA binding domain 
interacts with a specific upstream activating sequence UASa (CGG(Nll)CCG), located in 
the promoter regions of the genes whose products participate in the galactose metabolism 
circuit, such as GALl, 2, 3, 7, 10, 80 (147). NMR analyses of various amino terminal 
Gal4p fragments and X-ray crystal structure determination of GaI4p-UASa complex 
(210) show that the C6 zinc c1uster is the DNA binding module of Gal4p. 
The primary role of a transcription activator is to recruit the RNA Polymerase II 
machinery to the promoter to which it is bound. To achieve this, the transcriptional 
activation domains of both Gcn4p and Gal4p interact with Gal11 p, which is a component 
of the mediator complex that binds the RNA Polymerase II machinery (10, 114, 142,235, 
248). 
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Three general models have been proposed to characterize the structure of the 
transcriptional activation domain. In the first hypothesis, it was proposed that activation 
domains are unstructured "acidic blobs" that interact with their targets via ionic 
interactions. This model is supported by the observation that the removal of the residues 
of activation domains decreases the activity gradually, rather than abruptly (271). A 
second model proposes that acidic activation do mains form amphipathic a helices, in 
which acidic residues are aligned on one face of the helix. This model is supported by the 
observation that an artificial 15 residue peptide, designed to fold into amphipathic a 
helix, shows transcription activating abilities when fused to the GAL4 DNA binding 
do main (202). The authors of the third model argue that the most likely secondary 
structure is an antiparallel ~ sheet (301). 
We have recently established a detailed annotation of the C albicans genes (33). 
Intriguingly, although many of the C albicans transcription factors have sequence 
similarity to transcription factors in S. cerevisiae, the similarities occur primarily in the 
DNA binding motifs of those proteins. In addition, it has been previously shown that 
although C albicans Rfglp, Raplp, Gatlp, Msn2p and Msn4p have S. cerevisiae DNA-
binding-domain homologs, these transcription factors control the regulation of different 
processes in the two organisms (23, 149, 185, 228). Here we have investigated the 
transcription activation domains of C albicans homologs of the Gcn4p and Gal4p 
transcription factors; these domains are serine-threonine rich and lack sequence similarity 
to the yeast homologs. 
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3.2.3 MA TERIALS and METHODS 
C. albicans and bacterial strains. CAI8 (88) was used to generate CRC103 and 
CRC106 (256). CRC106 carries the s. aureus lexA operator; CRC103 does not and serves 
as a negative control for lexA binding. CRC106 and BWP17 (305) were used to define 
the transcription activation domains of GCN4 and GAL4. 
Plasmid construction. Plasmids and oligonucleotides are shown in Tables 2 and 3. To 
create plexA-HISl we PCR-amplified the CaHISl open reading frame and its termination 
sequence from pFA-HISl with OMM46 and OMM47, which contain the lexA binding 
site and the CaADH2 TATA box. The PCR product, which contains the lexA binding site, 
T AT A box, HISl open reading frame and termination sequence, was cloned into pF A-
ARG4 using the SalI and SunI restriction sites. Two more lexA binding sites were added 
by annealing oligonucleotides OMM50 and OMM51 and cloning them into the SunI site 
close to the third lexA binding site to yield plexA-HISl. To create strain CMM25, the 
plexA-HISl construct was integrated into the ARG4 locus of strain BWP17 by treating 
plexA-HISl with Agel, which cuts once in the ARG4 sequence. Clp-lexA-GCN4 deletion 
constructs were created by PCR using divergent primers: oligo OMM56 annealed to 
region upstream of GCN4 while oligos OMM60 and OMM62 align inside the GCN4 
open reading frame in the CIp-lexA-GCN4 template. Oligos OMM66-67 were used for 
Clp-lexA-GAL4. To fuse GAL4 in-frame with lexA, CIp-lexA-GAL4 was cut with MluI. 
The resulting 5' overhangs were filled with T4 Polymerase, and the constructs were self-
ligated with T4 DNA ligase. Clp-lexA-GCN4 and Clp-lexA-GAL4,1l-8l were cut with 
EstEI and self-ligated to yield CIp-lexA-GCN4,1247-323 and CIp-lexA-GAL4,1l-8l,1247-
323 respectfully. Clp-lexA-GAL4 was cut with ZraI and Pst! and self-ligated to create 
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Clp-lexA-GAL4L!188-26l. OMM125 and OMM57 were used to PCR amplify GCN4AD, 
which was ligated into AatII and Pst! eut Clp-lexA-GAL4 to create Clp-lexA-GAL4-
GCN4AD. CaHISl open reading frame, its promoter, and termination sequence was eut 
out from pF A-HISl using Not! and ligated into Not! - eut pOPlacZ to create pOPlacZ-
HISl. CMM85 strain (gcn4 with pOPlacZ-HISl) was created by first converting gcn4 
(229) into URA3 auxotroph (gcn4-ura3) using 5-FOA containing media, folIowed by an 
integration of XcmI - eut pOPlacZ-HISl at HISllocus. CMM86, CMM87, CMM88 and 
CMM89 were created by transforming CMM85 (gcn4 with pOPlacZ-HISl) with Clp-
lexA, CIp-lexA-GCN4, Clp-lexA-GCN4L!l-8l, and Clp-lexA-GCN4L!l-8l L!247-323 
respectively. AlI of the constructs created in this study were integrated into the genome of 
C. albicans: aIl of the constructs, except for pOPlacZ and plexA-HISl were digested with 
StuI to integrate them at RPSllocus. pOPlacZ was digested with BamHI and plexA-HISl 
was digested with Agel to integrate them at ADE2 and ARG4 loci respectively. 
f:l-galactosidase assays. The expression level of the lacZ was assayed in two ways: by 13-
galactosidase overlay assay using independently isolated transformants grown on solid 
YPD, YPGal, or SC-aa media, or by l3-galactosidase assays performed on mid-
exponential shake-flask YPD, YPGal, or SC-aa - grown liquid cultures (255). The 13-
galactosidase assays were expressed in Miller units from three independent transformants 
using means and standard deviations. 
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3.2.4 RESUL TS 
Definition of the CaGcn4p activation domain 
We have recently performed a detailed genome annotation of C. albicans genome 
(33), which showed that frequently the transcription factors of this organism share 
homology to transcription factors of other organisms only within the DNA binding 
domain. We have defined 198 S. cerevisiae genes whose products contain a DNA binding 
domain and are classified as transcription factors by combining the list of transcriptional 
regulators from Harbison et al. (115) with the list from 
http://www.yeastract.com/tflist.php. Of these, 32 were experimentally shown to be 
transcriptional repressors in S. cerevisiae. Ninety-nine of the remaining 166 S. cerevisiae 
transcriptional activators were found to have C. albicans homologs, one half of which 
share homology only within a DNA binding domain (Figure 3.2.1). A detailed 
assessment of global and transcriptional activation domain similarities are provided 
(Table 3.2.1) Since there is no primary sequence that defines the activation domain as a 
module, the nature of the activation domain is based on the experimentally defined part 
of transcription factor. A majority of S. cerevisiae transcription factors, such as Gal4p, 
Gcn4p, Upc2p, Leu3p, and Arg81p (68,78,125,141,202,242,313) were experimentally 
shown to have acidic activation domains. When we compared the transcription factors of 
S. cerevisiae with the transcription factors of C. albicans we observed that in sorne cases 
the sequence of the experimentally defined activation domains of S. cerevisiae is very 
weIl conserved in the C. albicans transcription factors homologs, such as in Upc2, Leu3, 
and Arg81 (68, 242, 313). In other cases the sequence of experimentally defined 
activation do main of S. cerevisiae is not detectable in the C. albicans transcription factor 
115 
Chapter 3: C. albicans intragenic comparison 
homologs, such as in Ga14p and Gcn4p. The presence of homology in the DNA binding 
do main of the C albieans transcription factors like Gcn4p and Ga14p tells us that these 
might be transcriptional regulators, but the absence of homology in the activation do main 
makes it difficult for us to predict whether these could work as activators or repressors. 
We therefore directly investigated the function of the regions outside the DNA binding 
motif. 
We have investigated the role of the non-homologous regions of candidate 
transcription factors to establish if they play a role in transcriptional activation. Within 
the DNA binding domain, CaGcn4p shares strong sequence similarity (88%) with S. 
eerevisiae Gcn4p. To establish ifthis protein possesses a functional activation domain we 
made use of the s. aureus lexA one-hybrid system (256). This system contains the C. 
albieans actin promoter (pACTl) placed upstream of the S. aureus lexA open reading 
frame to create Clp-lexA, and the S. aureus lexA operator upstream of both an ADHl 
basal promoter and a laeZ open reading frame, creating pOPlaeZ (256); as weIl, we 
placed the S. aureus lexA operator upstream of the HISl open reading frame to create 
plexA-HISl. We integrated pOPlaeZ into strain CAI8 to yield reporter strain CRCI06 
(256) and integrated plexA-HISlinto strain BWP17 to yield reporter strain CMM25. 
Fusions were constructed in Clp-lexA and introduced into these two reporter strains. In 
the absence of any transcriptional activator fused to lexA, the reporter CRC 106 derivative 
yielded basal levels of ~-galactosidase and the reporter CMM25 derivative produced no 
growth in the absence of histidine; when a trans-activator is fused to lexA, the system 
yielded higher levels of ~-galactosidase and permitted growth in the absence of histidine. 
A full length CaGCN4 cloned downstream of the lexA open reading frame, creating Clp-
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lexA-GCN4, was fully capable of trans-activation in the C. albicans assays. This 
construct generated five times higher p-galactosidase activity when transformed into 
CRCI06 to generate CMM14 and permitted growth in one day in the absence of histidine 
when transformed into CMM25 to create CMM30, compared to the appropriate controls 
CMMI0 and CMM26 which contain Clp-lexA (Figure 3.2.2). This result suggests that C. 
albicans GCN4 contains a transcription activation do main (256). 
The C-terminal systematic deletions of lexA-GCN4 identified the N-terminal 81 
amino acid region serving as an activation domain; Clp-lexA-GCN4Ll247-323, Clp-lexA-
GCN4Ll1 61 -323, Clp-lexA-GCN4Ll123-323, and Clp-lexA-GCN4Ll82-323 were as active 
as full-Iength Clp-lexA-GCN4 in both the lacZ background and HIS1 background. 
Further C-terminal deletions gradually reduced both lacZ and HIS1 activities, suggesting 
that the Gcn4p activation do main is at least 81 amino acids long (see Clp-lexA-
GCN4Ll69-323, Clp-lexA-GCN4Ll56-323, and Clp-lexA-GCN4Ll42-323) (Figure 3.2.3). 
The deletion of the proposed N-terminal activation domain in the context of the full 
length GCN4 (Clp-lexA-GCN4Lll-81) showed the same activity of p-galactosidase in 
CMM21 compared to the activity of full length GCN4 in CMMI4, while Clp-lexA-
GCN4Lll-81 in CMM37 showed a slightly reduced HIS1 activity compared to CMM30. 
This observation could be explained either by a second transcription activation domain 
(as in S. cerevisiae Gcn4p) located between the N-terminal activation domain and C-
terminal DNA binding domain, or due to the Clp-lexA-GCN4Lll-81 interaction with the 
endogenous wild type Gcn4p through a dimerization domain located at the C' terminus of 
the prote in (126), generating an activating heterodimer. We directly tested the capacity of 
the region between the DNA binding domain and the N-terminal activating domain to 
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allow transcriptional activation by creating CIp-lexA-GCN4.t11-81.t1247-323, in which 
both the activation and the DNA binding domains were deleted; this construct generated 
background ~-galactosidase activity and no HIS1 activity (see CMM64 and CMM65), 
suggesting that either the activation domain at the N' terminus is the only CaGcn4p 
activation domain, and that CIp-lexA-GCN4.t11-81.t1247-323 yields an unstable protein, or 
that the Gcn4p DNA binding do main directs transcriptional activation. To distinguish 
the se hypotheses we tested lexA-GCN4.t11-81, which lacks N-terminal activation domain, 
for its ability to activate the expression of lacZ in the absence of endogenous Gcn4p 
(gcn4 strain). Although lexA-GCN4.t11-81 resulted in high expression of lacZ in the wild 
type strain (CMM21), the lacZ expression was dropped down to background levels in the 
absence of the endogenous GCN4 (CMM88). At the same time, lexA-GCN4 showed high 
lacZ expression in both wild type and gcn4 backgrounds (CMMI4 and CMM87), while 
lexA and lexA-GCN4.t11-81.t1247-323 showed low lacZ levels of expression in both GCN4 
and gcn4 backgrounds (CMM10, CMM86, CMM64, and CMM89). These results suggest 
that the activation domain at the N' terminus of C. albicans Gcn4p is the only CaGcn4p 
activation domain. At the amino acid level, this activation domain is nucleophilic (has a 
composition of 20% serine-threonine) and shares no similarity with the activation domain 
ofScGcn4p. 
Definition of the CaGal4p-homologue activation domain 
We examined the activation do main of a candidate C. albicans version of the yeast 
Gal4p protein. In S. cerevisiae Gal4p is a highly studied transcription factor, and the 
structure of its DNA-binding and transcriptional activation modules as well as the target 
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promoters have been extensively investigated (192, 237, 291). Within the DNA binding 
domain, the putative Gal4p protein, encoded by C. albicans ORF 19.5338, shares strong 
sequence similarity (86%) with S. cerevisiae Gal4p; the DNA binding do main has the six 
cysteine residues, the linker region, and the dimerization region aIl weIl conserved. A 
blast search of the ScGal4p sequence in the C. albicans genome yields Orf19.5338 as its 
closest homologue; at the same time, searching the Orf19.5338 sequence in the S. 
cerevisiae genome yields ScGal4p as its closest homologue. Since ScGal4p and 
Orf19.5338 form a "reciprocal best hit" relationship, we named Orf19.5338 CaGal4p. 
Although this C. albicans Gal4p homologue binds 5'-CGGNIICCG-3', the upstream 
activating sequence (UASG) to which Gal4p binds in S. cerevisiae (data not shown), the 
promoters of C. albicans GAL genes lack UASG. Rather, UASG are found upstream of 
C. albicans subtelomeric and glycolysis genes (data not shown). In addition, this C. 
albicans gene encodes a much smaller 261 amino acids long protein, compared to S. 
cerevisiae Gal4p of 881 amino acids. The regions outside the DNA binding domain of 
those two proteins share no similarity, and the negatively charged region that serves as 
the interaction domain for ScGal80p is missing in CaGal4p. Interestingly, although C. 
albicans can grow on galactose (89), its genome also lacks a Gal80p homologue. 
To establish if CaGal4p contains a transcriptional activation domain, full-Iength 
GAL4 was cloned downstream of the lexA open reading frame to create CIp-lexA-GAL4. 
We transformed this construct into strain CRCI06 to create CMMll; CIp-lexA-GAL4 
showed five times more trans-activating ability compared to the activity of the control 
vector CIp-lexA, which was transformed into CRCI06 to create strain CMMI0 (Figure 
3.2.2). Similarly, strain CMM25, which contains the lexA operator in front of HIS1, was 
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transformed with CIp-lexA and CIp-lexA-GAL4 to create CMM26 and CMM27 
respectively. As was found for the lacZ system, lexA -GAL4 showed high transcription 
activating ability compared to the activity of the vector alone, since only CMM27 grew in 
the absence of histidine. These results suggest that C. albicans Gal4p can act as a 
transcriptional activator. 
We examined which part of CaGal4p was essential for the trans-activating 
capacity. Deletion ofthe C-terminal 71 amino acids, creating (CIp-lexA-GAL4t1188-261), 
abolished the trans-activating ability of lexA-GAL4 when introduced into both CRC106 to 
create CMM13 and into CMM25 to create CMM29. As weIl, fusion of lexA to the C-
terminal 71 amino acids of CaGal4p showed transcription activating abilities similar to 
the full-iength GAL4 (see CMM60 and CMM61) (Figure 3.2.4). Similarly to the Gcn4p 
activation domain, the CaGal4p activation domain showed a nucleophilic nature; it has a 
30% serine-threonine composition, but shares no other similarity with the activation 
domain of ScGcn4p. 
It is currently believed that the gene specificity of the transcription factor cornes 
from its DNA binding domain: this domain binds to a nucleotide motif on the promoters 
and recruits the RNA Polymerase II machinery (178). To see whether the transcriptional 
activation domain plays a role in the transcriptional selectivity of CaGal4p, we replaced 
the 71 amino acid-Iong CaGal4p activation domain (GaI4AD) with the 81 amino acid-
long Gcn4p activation domain (Gcn4AD). We observed that in vivo the lexA-GAL4-
GCN4AD construct in CMM12 and CMM28 showed the same transcription activating 
ability as the lexA-GAL4-GAL4AD in CMMll and CMM27 respectively (Figure 3.2.4). 
3.2.5 DISCUSSION 
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Eukaryotic transcription factors are typically bipartite in nature, with a region (the 
DNA binding or DB do main) specifically designed to interact with a defined DNA 
sequence, and a region (the transcriptional activation or TA domain) required to interface 
the factor with the transcriptional machinery. There are several classes of each of these 
modules, and they are connected together in a variety of ways. Within the transcriptional 
activation modules there are domains rich in acidic or basic residues, or ri ch in glutamine, 
threonine/serine, or isoleucine residues (8, 38, 61, 83,125,146,201,202). In this study 
we defined the transcription activation domains in a pair of C. albicans transcription 
factors that share sequence similarity with their S. cerevisiae homologs only within their 
DNA binding domains. The Zn(II)2Cys6 (or C6 zinc) binuclear cluster DNA binding 
do main is one of the largest classes of fungal DNA binding proteins, the best 
characterized of which are Gal4p, Pprl p, Leu3p, Hap 1 p, and Put3p. Although the DNA 
binding sequence of ScPut3p (CGGN IOCCG) is very similar to that of ScGal4p 
(CGGNIICCG), the distinction in recognition sequences in conserved; C. albicans 
possesses homologs of all of these S. cerevisiae Gal4-like Zn(II)2Cys6 proteins, 
including Put3p. 
In S. cerevisiae it was shown that Gal4AD and Gcn4AD have an acidic amino 
acid - ri ch nature and are located in the C' and N' termini respectively (78, 125, 141, 
201, 202). We analyzed the transcription activation domains of the C. albicans Gcn4p 
(CaGCN4) and Gal4p (CaGAL4) homologs, and found that just as in S. cerevisiae they 
are positioned at the N'and C' termini of the respective proteins. However, the C. 
albicans Gcn4p and Gal4p activation domains do not share sequence similarity either to 
each other or to the activation domains of their S. cerevisiae homologs, and C. albicans 
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Gal4p and Gcn4p have nucleophilic activation domains. Nucleophilic transcriptional 
activation regions have been previously seen almost exclusively in higher eukaryotic 
transcription factors (50, 61, 110). A screen for C. albicans transcriptional activation 
domains using a genomic library fused downstream of lexA yielded an active fragment 
containing a normally non-co ding region that expressed 33% serines and threonines in 
the fusion construct (data not shown), which also suggests that nucleophilicity can be an 
important feature of C. albicans activation domains. The serine and threonine ami no 
acids could potentially be converted into an acidic form by phosphorylation. 
The S. cerevisiae Ga14p and Gcn4p proteins each contain two transcriptional 
activation do mains (78, 126, 141, 201, 202). In contrast, the C. albicans Gcn4p and 
Gal4p homologs appear to each contain only one transcriptional activation do main 
(Figures 3.2.3 and 3.2.4). Each of the two ScGcn4p activation do mains seems to be 
composed of two or more small sub-domains that have additive effects on transcription 
and that can cooperate in different combinations to promote high-Ievel expression of the 
Gcn4p-dependent genes (78, 141). These results are consistent with our observation that 
the C-to-N-terminal deletions within the CaGcn4p activation domain lead to a graduaI, 
rather than to an abrupt, reduction of the transcription activating abilities of the fusion 
prote in (Figure 3.2.3). 
To determine when the changes in the activation do mains of Gcn4p and Gal4p 
occurred during the evolution of the yeast species, we used available genomic data of the 
ascomycota (Schizosaccharomyces pombe, Neurospora crassa, Aspergillus niger, S. 
cerevisiae, S. paradoxus, S. mikatae, S. kudriavzevU, S. bayanus, C. glabrata, S. castellU, 
Kluyveromyces lactis, Ashbya gossypU, Debaryomyces hansenU, C. tropicalis, C. 
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dubliniensis, and C. albicans) (Figure 3.2.5A and 3.2.B). Archiascomycetes were 
observed to lack the activation domains of either ScGcn4p or CaGcn4p. Euascomycetes 
possessed the ScGcn4p activation do main II (ADII). We noted that the common ancestor 
of D. hansenii, C. tropicalis, C. dubliniensis, and C. albicans lost the activation domain 1 
(ADI) of ScGcn4p and acquired the activation domain of CaGcn4p. We also observed 
that the ancestor of C. tropicalis, C. dubliniensis, and C. albicans lacked ScGcn4p ADII 
(Figure 3.2.5A). In addition, the ancestor of C. tropicalis, C. dubliniensis, and C. albicans 
lacked ScGa14p ADI, while the ancestor of D. hansenii, C. tropicalis, C. dubliniensis, and 
C. albicans missed ScGa14p ADII (Figure 3.2.5B). In both cases, D. hansenii represents 
an intermediate with both S. cerevisiae and C. albicans activation domains. These 
observations show that the changes in the activation do main of Ga14p and Gcn4p of C. 
albicans occurred relatively recently on the evolutionary scale. 
The lack of homology in the activation domains of transcriptional activators 
between S. cerevisiae and C. albicans might suggest a concomitant reduced structural 
similarity in the activation-domain-interacting complexes between the two species. A 
pair-wise sequence comparison of the transcriptional machinery between C. albicans and 
S. cerevisiae shows a high level of conservation in the RNA polymerase II complex. The 
exceptions for this are TFIIA and the Mediator complex: S. cerevisiae and C. albicans 
show low levels of homology with respect to the proteins of those two complexes, that 
also interact with transcriptional regulators (Figure 3.2.6, Table 1.3.1). 
The characterization of the bipartite structure of eukaryotic transcription factors 
like yeast Ga14p was a fundamental conceptual advance (152), and has led to important 
technical developments like the yeast two-hybrid system (85). In general C. albicans 
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transcription factors foIlow the pattern of distinct DNA binding and transcriptional 
activation domains, and many show strong sequence similarity, extending to both 
domains, to specific yeast transcription factors. However, a large number of C. albicans 
proteins have strong sequence similarity that is limited only to the DNA binding module 
of a yeast transcription regulator. We have shown that although the weIl studied Gal4p 
and Gcn4p pro teins of yeast share similarity only to the DNA binding regions of the 
Gcn4p and Gal4p proteins of C. albicans, the Candida proteins still contain 
transcriptional activation capacity. Further work will be necessary to establish the 
molecular logic oflinking common DNA binding modules to distinct activation domains in 
these two fungi, in particular in cases such as Gcn4p where similar cellular processes are 
regulated by the two proteins. 
Table 3.2.1: Genome-wide comparison of transcriptional activators between C. 
albicans and S. cerevisiae. 
One hundred and sixt Y six transcriptional activators of S. cerevisiae were tested by Blast 
against the C. albicans genome to pre di ct 99 C. albicans homologues out of 216 
transcription factors. Fifty of those 99 transcription factors share homology in both their 
DNA binding do mains and potential transcriptional activation domains, while 49 share 
sequence similarity only within the DNA binding domain. A pair-wise sequence 
comparison was do ne on the fuIllength (FL), DNA binding domain (DBD), and on the 
sequence outside of the DBD (Non-DBD). Analysis was done using a standard pair-wise 
blastp setting on http://www.ncbi.nlm.nih.gov/blastlb12seq/wblast2.cgi. The values are 
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shown in "-LOGIO(e-values)", which is a statistical measure of the similarity between 
the two proteins: the higher the value of P - the more homologous the two proteins are. 
Sc TF Name FL DBD Non-DBD orfl9.#### Ca TF Name 
Sefl 2.00E-169 5.00E-25 4.00E-147 orfl9.3753 Sefl 
Put3 3.00E-163 9.00E-14 1.00E-143 orf19.6203 Put3 
Asgl 7.00E-J32 1.00E-16 1.00E-126 orf19.166 Asgl 
Dal81 2.00E-J30 0.004 4.00E-122 orfl9.3252 Dal81 
Ar080 2.00E-J30 3.00E-14 3.00E-116 orfl9.3012 Aro80 
Upe2 6.00E-116 1.00E-J3 6.00E-J03 orfl9.391 Upe2 
Rds2 3.00E-J08 1.00E-07 5.00E-102 orfl9.5849 Cwtl 
Stb5 6.00E-98 4.00E-98 orf19.3308 Stb5 
Snt2 1.00E-99 3.00E-13 1.00E-86 orf19.1259 orfl9.1259 
Arg81 5.00E-83 I.OOE- J3 4.00E-83 orfl9.4766 Arg81 
PprI 1.00E-92 4.00E-11 8.00E-80 orfl9.3986 Pprl 
YER051W 2.00E-69 2.00E-69 orf19.3281 orf19.3281 
Cat8 6.00E-94 3.00E-22 5.00E-68 orf19.5097 Cat8 
YBR239C 6.00E-76 2.00E-11 1.00E-62 orf19.2423 Zefll 
YML081W 8.00E-79 8.00E-23 2.00E-61 orfl9.5026 orfl9.5026 
Sip3 3.00E-94 7.00E-24 6.00E-58 orf19.3047 orfl9.3047 
Stb4 1.00E-57 3.00E-57 orfl9.4288 Cta7 
YPR022C 1.00E-61 8.00E-J3 2.00E-48 orfl9.7397 orfl9.7397 
Teal 8.00E-47 1.20E-02 9.00E-45 orfl9.6985 Teal 
Warl 4.00E-54 2.00E-08 2.00E-44 orfl9.1035 Warl 
Pde2 2.00E-73 6.00E-18 2.40E-44 orfl9.4863 Pde2 
Skn7 1.00E-76 5.00E-32 9.00E-42 orfl9.971 Skn7 
Uga3 3.00E-50 7.00E-12 3.00E-38 orfl9.7570 Uga3 
Pho2 4.00E-48 2.00E-10 2.00E-34 orf19.4000 orfl9.4000 
Lysl4 4.00E-46 4.00E-08 1.00E-33 orf19.4776 Lysl43 
Mbpl 3.00E-n 1.00E-38 2.00E-29 orfl9.5855 orf19.5855 
Spt23 2.00E-68 1.00E-39 3.40E-28 orfl9.1751 Spt23 
Stp2 3.00E-37 6.00E-05 1.00E-23 orf19.4961 Stp2 
Sfpl 1.00E-70 5.00E-46 5.00E-23 orfl9.5953 Sfpl 
Yapl 1.00E-23 1.00E-03 1.00E-20 orfl9.1623 Capl 
Stp4 3.00E-33 1.00E-14 3.00E-19 orfl9.909 Stp4 
MalJ3 I.OOE-33 5.00E-05 5.00E-16 orfl9.7319 Suel 
Yap3 800E-15 8.00E-15 orf19.3193 Fer3 
Msnl 2.00E-13 2.00E-J3 orfl9.3328 orf19.3328 
Rts2 2.00E-31 5.00E-12 2.00E-13 orfl9.3817 orf19.3817 
Basl 500E-60 7.00E-40 I.OOE-08 orfl9.3809 Basl 
Hal9 4.00E-11 1.40E-O 1 2.00E-07 orfl9.3188 Tael 
Stel2 2.00E-n 4.00E-47 6.00E-07 orfl9.4433 Cphl 
YDR266C 2.00E-74 300E-67 7.00E-07 orfl9.3449 orfl9.3449 
Met4 7.00E-05 2.00E-06 orf19.5312 orf19.5312 
Azfl 3.00E-67 5.00E-58 9.00E-06 orfl9.173 orfl9.173 
Gtsl 9.00E-44 5.00E-39 I.OOE-05 orfl9.6393 orfl9.6393 
Adrl 4.00E-23 9.00E-14 2.00E-05 orf19.2752 Adrl 
Meml 2.00E-26 1.00E-14 3.00E-04 orf19.7025 Mcml 
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Dot6 3.00E-18 8.00E-18 0.003 orfl9.2545 Dot6 
Aeal 2.00E-09 3.00E-07 0.011 orfl9.6102 orfl9.6102 
Aee2 1.00E-29 3.00E-21 0.03 orfl9.6124 Aee2 
Imp2' 0.35 orfl9.3136 orfl9.3136 
Hapl 5.00E-08 1.00E-09 0.41 orfl9.7372 Zef36 
Hael 5.00E-17 5.00E-17 0.999 orfl9.2432 Hacl 
Gzf3 9.00E-19 4.00E-20 2.1 orfl9.2842 Gzf3 
In04 3.00E-03 3.00E-03 NA NA 
Skol 4.00E-07 3.00E-08 orfl9.1032 Skol 
Rpn4 5.00E-15 3.00E-16 orfl 9. 1069 Rpn4 
Fl08 0.12 0.12 orfl9.1093 Fl08 
Hap2 5.00E-23 6.00E-24 orfl9.1228 orfl9.1228 
Ph04 5.00E-05 4.00E-06 orfl9.1253 orfl9.1253 
Gatl 3.00E-19 1.00E-20 orfl9.1275 Gatl 
Gcn4 4.00E-18 7.00E-II orfl9.1358 Gen4 
Gat3 1.00E-04 9.00E-06 orfl9.1577 orfl9.1577 
Met31 1.00E-15 7.00E-17 orfl9.1757 Met31 
Rapl 7.00E-17 9.00E-18 orfl9.1773 Rapl 
Hap5 2.00E-42 1.00E-42 orfl9.1973 Hap5 
Ndt80 9.00E-49 4.00E-49 orfl9.2119 Ndt80 
Fhll 6.00E-51 1.00E-52 orfl9.2236 orfl9.2236 
Rtg3 1.00E-15 9.00E-17 orfl9.23 15 orfl9.23 15 
Eem22 0.21 0.007 orfl9.2623 Ecm22 
Rgtl 1.00E-08 4.00E-1O orfl9.2747 Rgtl 
Cbfl 2.00E-28 3.00E-22 orfl9.2876 Cbfl 
Zapl 7.00E-51 5.00E-51 orfl9.3794 Csrl 
Gln3 4.00E-15 3.00E-16 orf19.3912 orfl9.3912 
Mgal 9.00E-II 5.00E-12 orf19.3969 orf19.3969 
Leu3 6.00E-130 6.00E-19 orfl9.4225 Leu3 
Ithl 2.00E-07 orfl9.4281 orfl9.4281 
Sutl 7.00E-04 3.00E-04 orfl9.4342 orfl9.4342 
Rmel 6.00E-07 4.00E-08 orfl9.4438 Rmel 
Hap3 9.00E-25 1.00E-25 orfl9.4647 Hap3 
Rlml 5.00E-25 9.00E-20 orfl9.4662 Rlml 
Rtgl 7.00E-24 1.00E-24 orfl9.4722 orfl9.4722 
Msn4 1.00E-17 4.00E-19 orfl9.4752 Msn4 
Heml 1.00E-26 7.00E-28 orfl9.4853 Heml 
Tye7 9.00E-15 2.00E-15 orfl9.4941 Tye7 
Cup2 4.00E-16 3.00E-14 orfl9.5001 Cup2 
Gal4 1.00E-18 7.00E-19 orfl9.5338 Gal4 
Fkh2 3.00E-89 2.00E-89 orfl9.5389 Fkh2 
EthllSok2 1.00E-31 5.00E-33 orfl9.5498 Ethl 
YDR026C 1.00E-44 1.00E-45 orfl9.5722 orfl9.5722 
Tecl 5.00E-15 3.00E-14 orfl9.5908 Tecl 
Stpl 2.00E-30 2.00E-31 orfl9.5917 Stp3 
Efgl/Sokl 7.00E-50 3.00E-48 orfl9.610 Efgl 
Msn2 1.00E-13 4.00E-15 orfl9.6121 Mn Il 
Cup9 8.00E-13 9.00E-14 orfl9.6514 Cup9 
Met28 2.3 2.3 orfl9.7046 Met28 
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Figure 3.2.1. Genome-wide comparison of transactivators between C. albicans and S. 
cerevisiae. 
Ninety-nine of the transcriptional activators of S. cerevisiae share sequence similarity to 
the C. albicans transcription factors. Fifty of those 99 transcription factors share 
homology in both their DNA binding domains and potential transactivation domains, 
while 49 share sequence similarity only within the DNA binding domain. 
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Figure 3.2.2. Ga14p and Gcn4p act as transcriptional activators in C. albicans. 
C. albicans GCN4 and GAL4 were fused to lexA, which binds to lexA binding DNA 
sequence upstream of HIS] and lacZ. The activities of the HIS] and lacZ reporters were 
analyzed in three independent transformants. 
A. Cells were grown for 1 day in the absence of histidine. 
B. Candida cells grew overnight on selective media; cells were permeabilized by 
chloroform, and overlaid with X-gal. The color was allowed to develop for 4 hours. 
Liquid beta-galactosidase assays are expressed in Miller units. 
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Figure 3.2.3. Identification of CaGcn4p Transcriptional Activation Domain. 
Structural and functional analysis of lexA-GCN4 derivatives. The structures of various 
lexA-GCN4 derived proteins are indicated by grey and black bars respectively, with the 
N- and C- terminal residues defined as in the wild type proteins. 1: Liquid beta-
galactosidase assays are expressed in Miller units; 2: the expression of the HIS1 reporter 
is either strong, S (1 day it took for a strain to grow in the absence of histidine), weak, W 
(2 days it took for a strain to grow in the absence of histidine), or no growth, N. 
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Figure 3.2.4. Identification of CaGal4p Transcriptional Activation Domain. 
Structural and functional analysis of lexA-GAL4 derivatives. The structures of various 
lexA-GAL4 derived proteins are indicated by grey and black bars respectively, with the 
N- and C- terminal residues defined as in the wild type proteins. 1: Liquid beta-
galactosidase assays are expressed in Miller units; 2: the expression of the HISi reporter 
is either strong, S (1 day it took for a strain to grow in the absence of histidine), weak, W 
(2 days it took for a strain to grow in the absence of histidine), or no growth N. 
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Figure 3.2.5. The phylogenetic comparison of Gcn4p and Ga14p orthologs across the 
Ascomycota. The changes in the Gcn4p activation domain of C. albicans occurred 
relatively recently on the evolutionary scale. We used available genomic data of the 
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Ascomycota Schizosaccharomyces pombe, Neurospora crassa, Aspergillus niger, S. 
cerevisiae, S. paradoxus, S. mikatae, S. kudriavzevii, S. bayanus, C. glabrata, S. castellii, 
Kluyveromyces lactis, Ashbya gossypii, Debaryomyces hansenii, C. tropicalis, C. 
dubliniensis, and C. albicans to determine at what evolutionary stage the Gcn4p (A) and 
the Gal4p (B) have changed the sequence of their activation domains. The sequences of 
CaGcn4p, ScGcn4, CaGal4p and ScGal4p were blasted against the genomes of 
ascomycota using the standard blastp setting on http://seq.veastgenome.org/cgi-binlblast-
tùngal.pl, and confirmed usmg a standard paU-WIse blastp setting on 
http://www.ncbi.nlm.nih.gov/blast/bI2seq/wblast2.cgi. ScGcn4 activation domain II 
(ScGcn4 ADII) lies between amino acids 107-144, and ScGcn4 ADI is between amino 
acids 12-92. ScGal4 ADI is between amino acids 149-196, and ScGcn4 ADII is between 
amino acids 768-881. A. gossypii, C. glabrata, and S. kudriavzevii, are unable to 
metabolize galactose and lack Gal4p. S. pombe, N crassa, and A. niger do not posses 
close Gal4p homologue. The phylogenetic relationship between the fungi is shown as in 
(74). 
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Figure 3.2.6. The comparison of the transcriptional machinery between C. albicans and 
S. cerevisiae. 
The constituents of the transcriptional complexes were compared using a standard pair-
wise blastp setting on http://www.ncbi.nlm.nih.govlblastlbPseq/wblast2.cgi. The log 
values were averaged and shown by the associated color. 
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CHAPT ER 4: POSTGENOMIC STUDIES OF CANDIDA ALBICANS: 
RESULTS OF THE COMPARATIVE GENOMICS STUDIES OF C. 
ALBICANS INTERGENIC REGIONS. 
Section 4.1: Transcriptional rewiring in C. albicans. 
With the recent sequencing of many yeast genomes, the hemiascomycete lineage 
emerged as a central paradigm for studying the genetic basis of phenotypic diversity 
(238). Despite a strong conservation of gene content, yeast species exhibit major 
phenotypic differences. For example, almost two-thirds of C. albicans' ~6,000 open 
reading frames are orthologous to S. cerevisiae genes, yet their life styles are very 
different, probably due to the difference in gene expression. Differences in gene 
expression underlie many of the phenotypic variations between related organisms, yet 
approaches to characterize such differences on a genome-wide scale are not well 
developed. The availability of the genome sequences of both S. cerevisiae and C. 
albicans, which are related organisms that span a significant evolutionary distance, 
provides a useful framework to develop computational tools for comparative genomics. 
Phenotypic diversity can often be traced to the differential expression of specifie 
regulatory genes (1,45, 101,296, 310). Recently, microarray experiments revealed large-
scale differences in the genome-wide transcription response of related organisms to 
equivalent environmental conditions. For example, the transcription prograrn underlying 
insect metamorphosis differs considerably between related species of the Drosophila 
melanogaster subgroup (250). Similarly, both the meiotic and the mitotic cell cycle 
transcription program have diverged significantly between the budding and the fission 
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yeasts (257). The impact of such large-scale variations in gene expression on the 
phenotypes of the organisms is not yet understood. 
Transcriptional modules, i.e., groups of coregulated genes, play a central role in 
the organization and function of regulatory networks (137, 267, 283). Comparative 
studies have demonstrated that various transcriptional modules are highly conserved 
across a wide variety of organisms from Escherichia coli to humans (17, 214, 278). A 
common assumption is that conserved regulatory mechanisms underlie module 
conservation, because coregulation imposes tight constraints on the evolution of a 
module's promoters. Indeed, recent studies showed that orthologous transcriptional 
modules are often associated with conserved cis-elements (96). Divergence of cis-
elements in specific promoters has been documented, but it is difficult to explain the 
divergence in a regulatory program associated with coexpressed genes (194, 195). 
The use of comparative genomics to identify putative regulatory binding sites has 
attracted a lot of attention since the sequence of three non-cerevisiae Saccharomyces 
species was made public (153). It appears that for most known transcription factors the 
conservation of the DNA binding site amongst related species is a reliable detection 
strategy. C. albicans and its two closely related species C. dubliniensis and C. tropicalis 
(sequenced at the Sanger Centre and the Broad Institute respectively) form a comparative 
genomic system similar to the four Saccharomyces species. Although C. tropicalis is 
more distant to C. albicans than any of the Saccharomyces species, the gene conservation 
and the high level of synteny with C. albicans makes C. tropicalis an excellent organism 
for a comparative genomics study. 
The previously discussed genome assembly and the release of a genome 
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annotation of C albicans (33) also provide functional comparison of the two groups of 
yeasts. In this study, we show that the identification of cis-regulatory elements from three 
Candida species (C albicans, C dubliniensis, C tropicalis) and four Saccharomyces 
species (s. cerevisiae, S. paradoxus, S. mikatus, S. bayanus) shows reorganization of the 
transcriptional regulatory network between the se two groups of yeasts. 
For each group of yeast the contigs were first aligned and the intergenic 
sequences from syntenic regions extracted. A constrained sampling method was then 
used to find aIl the conserved mini-alignments from each intergenic region. To identify 
regulatory elements, the intersection between the set of genes that have a conserved mini-
motif and every Gene Ontology (GO) set was systematically tested and scored. 
Randomized gene sets were used to establish the false discovery threshold. Every motif-
GO pair found in one genus was further tested and scored in the other genus. Our analysis 
rediscovered most known Saccharomyces regulatory motifs as weIl as new motifs 
specific or common to Saccharomyces and Candida. The comparison of the detected 
motifs and their target genes reveals important rewiring events. 
Many conserved transcription factors in Saccharomyces and Candida have kept 
their preferred DNA binding motif but the sets of genes that they regulate show 
significant variability. For example Gal4p, In04p and Cbflp are involved in such 
rewiring events. The Gal4p binding site (CGG(NIJ)CC) is no longer found conserved 
upstream of galactolysis genes in Candida. Instead, it is enriched in glycolysis genes and 
a different motif is found to regulate galactolysis in Candida. The In04p motif 
(CATGTGAA), upstream of lipid biosynthesis genes in Saccharomyces is conserved 
upstream of multiple peroxisomal genes in Candida. The centromere binding factor 
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Cbflp (CACGTG), while maintaining its role in sulfur and methionine metabolism (24), 
is also found upstream of more than 25 ribosomal genes in Candida. These examples 
illustrate the adaptation of transcriptional regulation over the 100 million years of 
evolution that separate the Saccharomyces and Candida species and provide insight on 
fundamental aspects of their respective biology. 
The Ga14p mediated activation of the Leloir pathway (GALl, GAL 7, GALlO) 
genes of S. cerevisiae in response to galactose is among the most intensively studied and 
best understood of aIl metabolic regulatory pathways. Microarray analysis of C. albicans, 
grown on galactose as the sole carbon source shows transcriptional activation of the 
Candida homologs of the GALl, 2, 10, and 7 genes, while loss of CaGa14p does not 
modulate growth on galactose or the transcriptional activation of the Leloir pathway 
genes. CaGal4p instead acts as a transcriptional activator of the telomeric TLO gene 
family as weIl as genes who se products are involved in glycolysis and the TCA cycle. We 
identified cis-acting regions in the promoters of the C. albicans GAL genes, including a 
unique GAL-specifie palindrome. RimlOlp and Rrnd5p transactivate the expression of 
GALlO in the presence of dextrose and galactose respectively, while Cphl p acts as an 
activator in galactose through the GAL-specifie palindrome. Our studies show that C. 
albicans and S. cerevisiae can regulate the same process by different regulatory circuits. 
The full spectrum of evolutionary events we discovered, encompassing both 
conservation and divergence, provides a general framework for the study of the evolution 
of transcription regulation and highlights the flexibility and evolvability of cis-regulatory 
programs. The evolution of transcriptional modules is an important aspect in 
understanding regulatory networks. 
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Transcription rewiring within the galactose metabolism circuitry of Candida 
albicans. 
Mikhail Martchenko l, Anastasia Levitin2, Wiriya Chiranand3, Herve Hogues2, Andre 
Nantel2, Michael Gustin3, and Malcolm Whitewayl,2*. 
1 Department of Biology, McGill University, Montreal, Quebec, Canada H3A 1 BI; 
2Genetics Group, Biotechnology Research Institute, National Research Council, 
Montreal, Quebec, Canada H4P 2R2 
3Dept Biochemistry, Rice University, Houston, TX, USA 77251-1892 
4.1.1 Abstract 
The Leloir pathway genes encode the enzymatic machinery involved in the 
metabolism of galactose. In the distantly related fungi Saccharomyces cerevisiae and 
Candida albicans the genes encoding these enzymes are syntenically arranged but the 
upstream regulatory regions are highly divergent. In S. cerevisiae the Leloir pathway 
genes are positively regulated by Gal4p acting through the UASG sequence 
CGG(N Il)CCG. However, in C. albicans the Gal4p and UASG combination is found to 
regulate genes unrelated to galactose metabolism. We identified a palindromic sequence 
that acts to control GALlO expression in C. albicans in the presence of galactose. This 
palindrome is found upstream of other Leloir pathway genes in C. albicans, and in the 
absence of other regulatory sequences, activation of expression through this sequence in 
the presence of galactose requires Cph 1 p, the homolog of the Ste 12p transcription factor 
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of S. cerevisiae. Thus, although the cellular process of galactose induction of the Leloir 
pathway is conserved between the two organisms, the regulatory circuits achieving the 
cellular process are completely distinct. 
4.1.2 Introduction: 
The diploid fungal pathogen, Candida albicans, which causes the majority of 
human fungal infections, diverged from the bakers or brewers yeast S. cerevisiae 
approximately 250 million years ago (116). With the recent sequencing of many yeast 
genomes, the hemiascomycete lineage has emerged as an important model for studying 
the genetic basis of functional diversity (238), and despite a strong conservation of gene 
content, yeast species exhibit major phenotypic differences. For example, almost two-
thirds of C. albicans' ~6,000 open reading frames are orthologous to S. cerevisiae genes 
(33), yet the organism's life-styles are very different. This suggests that differential 
regulation of gene expression, and not simply differential gene content, plays an 
important role in phenotypic variation among related organisms. 
The evolution of gene regulation could occur either through modifications to the 
trans-acting regulatory prote in or by changes to the cis-acting DNA elements in 
promoters. Recent studies show that both processes function to direct transcriptional 
rewiring, which can drive regulatory divergence (121, 298). For example, a group of 
mating genes that is transcriptionally regulated by an activator in C. albicans is 
transcriptionally regulated by a repressor in S. cerevisiae, a modification that was 
achieved by changing both Gis and trans-acting elements (298). 
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Because many of the fundamental biological processes of C. albicans are similar 
to those of S. cerevisiae, budding yeast is an important guide for studying the pathogen. 
Yet, as these related organisms span a significant evolutionary distance there are also 
significant differences in cellular function. Unlike S. cerevisiae, C. albicans can form true 
hyphae, can escape mammalian immune cells, and can proliferate in mammalian hosts, 
and thus has the tools to be a pathogen. Despite a strong conservation of gene content, 
yeast species exhibit major phenotypic differences due to the different environmental 
selections imposed on them; the se pressures may in turn drive changes in gene regulation. 
For example, unlike S. cerevisiae Gcn2p, C. albicans Gcn2p does not control the 
translation of Gcn4p, the regulator of amino acid biosynthetic genes (290). The regulation 
of the ribosomal prote in genes in C. albicans is different from that in S. cerevisiae (282), 
and perhaps because of the different stress conditions imposed by the environment, the C. 
albicans homologues of the S. cerevisiae general stress response transcription factors 
Msn2p and Msn4p play no obvious role in stress response (228). 
We are interested in whether transcriptional rewiring occurs for conserved 
processes such as sugar and amino acid metabolism. Galactose is utilized by almost aIl 
organisms through its conversion to glucose-6-phosphate in a reaction catalyzed by the 
enzymes of the Leloir pathway (179). In S. cerevisiae these enzymes are encoded by 
GALl (galactokinase), GAL7 (galactose-l-phosphate uridyl transferase), GALlO (UDP-
glucose-4-epimerase), and GAL5 (phosphoglucomutase) (75, 77). Galactose enters S. 
cerevisiae cells through a specific permease, encoded by GAL2 (297). Because 
eukaryotic genes are not organized in operons, it is intriguing that the GALl, GAL7, and 
GALlO genes are c1ustered near the centromere of chromosome II (12). 
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The expression of these GAL genes is controlled by a network of activating and 
repressing activities, encoded by the specific regulatory genes GAL3, GAL4, and GAL80. 
In S. cerevisiae GAL4 serves as the transcriptional activator of galactose catabolism (172, 
192), while Gal80p is involved in the repression of GAL genes by binding the 
transcriptional activation domain of Gal4p (287). Ga13p functions by forming a complex 
with Gal80p to relieve inhibition of Gal4p; in the presence of galactose and ATP, Ga13p 
sequesters Gal80p in the cytoplasm, preventing inhibition of Gal4p and thus activating 
GAL gene expression (237,240). ScGal4p contains a DNA binding do main that interacts 
with a specific upstream activating sequence (UASG; CGG(Nll)CCG), located in the 
promoter regions of GALl, 2, 3, 7, 10, 80 (303); the GAL5 gene is unregulated, being 
expressed under aIl conditions, and lacks the UASG (21). 
This genetic regulatory circuit acting on the S. cerevisiae GAL genes is among the 
most highly studied and best understood of eukaryotic metabolic control pathways. As 
such it has acted as a paradigm for general principles ofmetabolic control (147, 192), and 
has served as weIl as a template for the application of a systems biology approach to 
metabolic circuitry (136). In this investigation we studied the regulation of galactose 
metabolism in the pathogenic fungus Candida albicans. This work helps define the 
network in C. albicans that regulates GAL genes and shows that C. albicans and S. 
cerevisiae control the same process through different regulatory circuits. 
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4.1.3 Materials and Methods 
C. albicans strains and plasmid constructions: The C. albicans strains used in this 
study are listed in Table 1. BWP17 (305) was used to generate GAL4/gaI4, gal4 and its 
wild type phototrophic equivalent BWPI7-HA. Strains CAI4 (88) and CAI8 (88) were 
used to map pGALIO regulatory motifs. Strains rmd5, rimlOI, riml3, DAY286 (71), and 
JKC 19 (188) were used to identify the transcriptional regulators of the GALlO promoter. 
Strains ga14 and its wild type equivalent, CMM1, were used to show that CaGal4p 
regulates the expression from the TLO and LATI promoters through the GaI4p-DNA 
binding site. JKC 19 (cphl) was used to show that Cph 1 P regulates expression from the 
GALlO promoter through a GAL-specifie palindrome. 
Plasmids and oligonucleotides are shown in Tables 2 and 3. The GAL4 deletion 
cassettes, pHISI-GAL4 and pARG4-GAL4, were created by cloning the 500 bp GAL4 
flanking regions into pF A-HISI and pF A-ARG4 (l00). The TL 0, LA Tl , and GALlO 
promoters as weIl as their shorter versions were cloned into the plac-poly backbone 
(Alistair Brown, unpublished), and the GAL palindromic sequence was cloned into 
pCR/aeZ (256). AlI of the constructs created in this study were integrated into the 
genome of C. albieans using digestion with StuI to target them to the RPSI locus (219). 
Microarray analysis. Transcription profiling and analysis were performed using long 
oligonucleotides microarrays as described (225). Total RNA was extracted by the hot 
phenol extraction method (44). GeneSpring software (Agilent Technologies) was used for 
normalization and for the identification of significantly regulated transcripts. We used a 
T -test P value cutoff of 0.05 to be statisticaIly significant. To analyze the transcriptional 
response under each experimental condition at least 8 individual biological replicates 
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were used. 
C. albicans strain ga14 and its wild type equivalent (CMM3 and CMMl) were 
inoculated overnight in media containing 1 % yeast extract, 2% peptone, with either 2% 
dextrose (YPD) or 2% galactose (YPGal) supplemented with uridine (25 !-tg/ml) for the 
growth of C. albicans Ura auxotrophic strains. These overnight cultures were diluted to 
an OD600 of 0.1 in their respective media and grown to an OD600 of 1.0 (~3 generations). 
The wild - type strain SC5314 (88) was either grown in YPD or in YPGal media. The 
overnight cultures were inoculated from a fresh colony and were grown in either YPD or 
in YPGal at 30°C. These overnight cultures were diluted to OD600 of 0.1 in their 
respective media: overnight YPD and YPGal- grown cells were diluted into a fresh YPD 
and YPGal media and grown to an OD600 of 1.0. 
f3-galactosidase and growth assays. (3-galactosidase assays were performed as described 
in (255). The growth of the ga14 strain was assayed as described (211). 
4.1.4 ResuUs 
Elements of the C. albicans GAL regulon: 
The sequencing of the C. albicans genome (148) provides a framework for the 
post-genomic studies of this important fungal pathogen. We have recently completed the 
assembly of the Candida albicans genome (Van het Hoog et al, submitted) and 
established a detailed annotation of its genes (33). Intriguingly, although overall the 
synteny between C. albicans and S. cerevisiae is very low, the genomic organization of 
the region involving the galactose metabolism cluster in S. cerevisiae is remarkably 
similar to that found in C. albicans. The galactokinase, galactose-1-phosphate uridyl 
144 
Chapter 4: C. albicans intergenic comparison 
transferase and UDP-glucose-4-epimerase genes show conservation of sequence (63%, 
79%, and 71 % similarity respectively), and these genes are clustered together on 
chromosome 1 of C. albicans in the same relative arrangement as was found in S. 
cerevisiae. In the fungal pathogen this cluster also includes GAL2 and two open reading 
frames between C. albicans GALlO and GAL7 that are conserved in C. dubliniensis, C. 
parapsilosis, Debaryomyces hansenii, and Schizosaccharomyces pombe (Figure lA). 
Although the galactose metabolism structural genes are weIl conserved between 
S. cerevisiae and C. albicans, the regulatory components show less similarity. We were 
not able to detect even weak candidates for Ga13p in the C. albicans genome. A candidate 
for Ga180p, encoded by ORF 19.6899, shares only 40 percent sequence similarity with 
ScGal80p. ORFl9.5338, annotated as CaGal4p, shares strong sequence similarity (86%) 
with its S. cerevisiae homologue only in the DNA binding domain (Figure lB), with the 
six cysteine residues, the linker region, and the dimerization region aIl weIl conserved. 
This C. albicans gene encodes a much smaIler prote in of 261 amino acids compared to its 
S. cerevisiae homo log of 881 amino acids. The activation domains of those two proteins 
share no similarity, and the negatively charged region that serves as the ScGal80p 
interaction domain is missing in CaGal4p (212). 
Galactose regulates expression of GALl, 2, 7, and 10: 
T 0 investigate whether galactose regulates expression of the GALl, 2, 7 and 10 
genes in C. albicans, we performed a transcriptional microarray analysis of ceIls grown 
on galactose as the sole carbon source, as compared to ceIls grown on glucose. Just as in 
S. cerevisiae, galactose strongly induced the transcription of genes for the Leloir pathway 
145 
Chapter 4: C. albicans intergenic comparison 
enzymes; the GALl, 2, 7 and lO genes were among the most highly expressed of all the 
induced genes. In addition, the expression of 78 genes involved in glycolysis, glycogen 
synthe sis, formation of the cell wall, transport, fatty acid metabolism, and a variety of 
unknown functions was higher in galactose grown cells compared to glucose grown cells 
(Figure 2A and Table 4.1.1), while the expression of a further 54 C. albicans genes, 
including genes for cell wall components, transporters, transcription factors, ribosome 
synthesis elements, as well as for unknown functions, was higher in glucose than in 
galactose (Figure 2B and Table 4.1.2). 
The C. albicans GALlO promoter has a conserved and functionally important 
element: 
In order to study the regulation of the galactose metabolizing genes, we cloned the 
promoter of GALlO upstream of a lacZ reporter (Brown Al, unpublished), and 
transformed this reporter construct into a wild type strain. Cells were grown in liquid 
medium with raffinose as the carbon source, and shifted to medium containing either 
dextrose or galactose. After 90 minutes growth the galactose treated cells expressed 5-
fold greater j3-galactosidase activity than the dextrose treated cells. The raffinose-grown 
cells showed intermediate levels of lacZ expression (not shown); therefore, as in S. 
cerevisiae, GALlOis apparently regulated by both activation and repression mechanisms. 
Since the presence of galactose coordinately upregulates the expression of the GAL 
genes, we searched for an upstream activating sequence (UASG). We compared the DNA 
sequences of the GALl, GAL7, and GALlO promoters, and found a common palindromic 
stretch 5'-TGTAACGTTACA-3' that occurs only four times in the intergenic regions of 
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the C. albieans genome, with aU occurrences in the promoters of the GALl, GAL 7, and 
GALlO genes. As weU, the promoter of GAL2 has the sequence GTTACGTT AC, which 
is a GTTAC repeat rather than GTT AC palindrome. The palindromic sequence is also 
conserved in the promoters of the Leloir pathway genes of C. dubliniensis, C. 
parapsilopsis, and Debaryomyees hansenii. 
To test the importance of this GAL-palindrome sequence in the regulation of 
GALlO expression in the presence of galactose, we deleted it from the GALlO promoter. 
When cells were grown overnight in either galactose or dextrose medium, the GAL-
palindrome appears critical for the galactose-mediated induction of GALlO expression. 
The palindrome-Iess full-Iength GALlO promoter showed a slight 1.3-fold reduction of 
expression in the presence of dextrose, and a strong 5-fold drop of expression in the 
presence of galactose, compared to the intact GALlO promoter (Table 4.1.5). A truncated 
version of the promoter was also assayed. In these constructs the laeZ reporter was 
linked to a minimal promo ter containing or lacking the palindromic sequence. After 
overnight growth the palindrome directed 10-fold higher expression in the presence of 
galactose compared to dextrose, which suggests that the GAL palindrome acts as a 
galactose-dextrose dependent regulator of the GALlO promoter under these growth 
conditions (Figure 5, Table 4.1.5). 
Definition of the C. albicans Gal4p regulon: 
In S. cerevisiae Gal4p activates the expression of GAL genes to metabolize the 
galactose present in the environment, and the deletion of ScGal4 leads to the inability of 
cells to grow on galactose (192). To investigate which C. albicans genes are regulated by 
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the Gal4p homologue, we created a C. albieans gal4 knock out strain. The C. albieans 
gal4 strain grew identically to the wild type strain when utilizing galactose, dextrose, 
ethanol, or glycerol as a sole carbon source (data not shown). Using microarrays we then 
compared the transcriptional behavior of the wild type and ga14 strains when both were 
grown on galactose-containing media (YPGal). The expression of GAL genes remained 
unchanged (Tables 3 and 4). In addition, deletion of the GAL4 gene had no effect on the 
regulation of GALl O-driven laeZ expression, suggesting that Gal4p does not transactivate 
the expression of GALlO (Table 4.1.5). 
Further transcriptional analysis of the gal4 strain compared to the control grown 
on galactose showed that loss of gal4 reduces the expression of 87 genes and increases 
the expression of 37 genes: the Gal4p-influenced gene set represents 2% of the genome 
and includes genes who se products are involved in a diverse range of cellular processes. 
The 87 genes that are reduced in the absence of Gal4p encode transporters, cell wall 
proteins, nucleic acid binding proteins, and hypothetical proteins (Figure 3A, Table 
4.1.3). Interestingly, one third of the se downregulated genes are members of a newly 
discovered subtelomeric gene family TLO (Van het Hoog et al., submitted), and 14 genes 
encode products involved in glycolysis (e.g. PGI12, LSe2, LA Tl). The expression of a 
further 37 genes, which encode transporter s, cell wall proteins, nucleic acid binding 
proteins, iron and copper uptake regulators, and hypothetical proteins, is elevated in the 
absence of CaGal4p (Figure 3B, Table 4.1.4). 
The strongest Gal4p-transactivated genes are members of the subtelomeric TLO 
gene family not found in S. cerevisiae. Almost aIl of the TLO genes share an identical 
promoter region, which contains the sequence CGG(N Il )CCG that represents the binding 
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site for ScGal4p. When cloned upstream of lacZ, a TLO promoter that includes the Gal4 
binding site was 5.5 times less active in a ga14 mutant strain, confirming that Gal4p is 
required for proper expression ofthis gene through the UASa site (Figure 4, Table 4.1.5). 
The absence of the Gal4 binding site alone leads to a 3-fold drop in reporter expression; 
the combined absence of both Gal4p and its binding site leads to a 5-fold drop of TLO-
driven reporter expression. This suggests that Gal4p transactivates the expression of TLO 
through a classical UASa. Because the absence of the Gal4p binding site in the wild type 
allows greater fj-galactosidase activity than does the absence of Gal4p, it is possible that 
there is additional Gal4p-dependent regulation of TLO expression. 
The promoters of a number of the Gal4p-upregulated glycolysis genes (e.g. LAT1, 
LSe2) contain a potential regulatory site CGG(N )))CCA that is conserved in the 
promoters of the same genes in C. dubliniensis and C. tropicalis, and which closely 
resembles a UASa site. The removal of this site from the LAT1 promoter, the loss of 
Gal4p, or the combined loss of both Gal4p and the regulatory site alliower expression by 
about 2.5 fold, suggesting Gal4p works through this site to regulate LAT1 expression 
(Figure 4, Table 4.1.5). This implies that the proper expression of TCA cycle genes is 
dependent on both the presence of a functional Gal4p and the Gal4p binding sites within 
their promoters. 
To test whether Gal4p is responsible for the differential expression of the genes 
whose transcription changes in response to a carbon source of either dextrose or galactose 
(Figure 2, Tables 4.1.1 and 4.1.2), we used microarrays to compare the transcriptional 
behavior of the ga14 strain to that of its wild type equivalent grown on dextrose-
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containing media (YPD). We observed that Gal4p is needed for the expression of the 
same genes in the presence of either dextrose or galactose. 
The regulators of the expression of GALlO: 
To identify the trans-acting regulator(s) of galactolysis, we transformed the 
promoter of GALlO fused to a laeZ reporter into a C. albieans mutant library (229). We 
observed that in the rmd5 background GALlO-driven laeZ yields two times less ~­
galactosidase when grown on galactose compared to growth on dextrose (data not 
shown). In addition, we found that in the riml 0 l strain GALlO-driven laeZ yields three 
times lower ~-galactosidase levels when grown on dextrose than when grown on 
galactose (data not shown). In C. albieans Rim13p activates RimlOlp by a proteolytic 
cleavage (184), and as expected, the rim13 strain shows the same pattern of GALlO-
driven laeZ expression as does the rimlOI strain (data not shown). 
Extended incubation of C. albieans with macrophage cells leads to a differential 
expression of GAL genes through a process that may involve the MAP kinase pathway 
acting through Cphl p (273). The half-palindrome sequence TGT AAC is similar to the 
Stel2p/Cphlp binding site TGAAAC, so we analyzed the expression of the GALlO 
promoter in a ephl knock out strain (188). In order to exclude the influence of the 
upstream GALlO promoter regulatory sequence on the actions of the palindrome, we 
examined the expression patterns of the minimal promoter containing the palindrome. 
The absence of the palindrome alone leads to 3-fold drop in the reporter expression; the 
combined absence ofboth Cphlp and palindrome leads to a 5-fold drop of GALlO-driven 
reporter expression, suggesting that Cph 1 P transactivates the expression of GALlO by 
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interacting with the palindrome. Because the absence of the palindrome in the wild type 
strain permits greater j3-galactosidase activity than does the absence of Cph1p, it is 
possible that there is additional Cph 1 p-dependent regulation of GALlO expression. The 
removal of the Cph 1 p had a very mild effect on GALlO expression in the absence of the 
palindrome. These results suggest that in the presence of galactose Cph1p acts as an 
activator of the GALlO expression through the palindrome sequence. 
4.1.5 Discussion: 
Evolution of gene regulation is an important component of phenotypic diversity. 
In this study we show the same biochemical process, the induction of the Leloir pathway 
genes by galactose, is regulated by different transcriptional circuits in S. cerevisiae and in 
C. albicans. This transcriptional rewiring has resulted in the C. albicans protein that is 
the closest homologue of the S. cerevisiae transcriptional regulator Gal4p not controlling 
the expression of GAL genes in the pathogen. Since the presumptive C. albicans GAL4 
has a different function from its S. cerevisiae homologue, we suggest the name CG FI, for 
Candida Gal Eour homo log, for this transcription regulator, to reduce the confusion of the 
functional implications of the name GAL4. 
Our observations show that the mechanism of regulation of transcription of GAL 
genes is fundamentally different in S. cerevisiae and C. albicans. A previous study 
showed that unlike the case in S. cerevisiae, C. albicans Mig1p does not repress GAL 
genes (312). In S. cerevisiae the promoters of GAL genes contain a UASG, which 
functions as a galactose - inducible enhancer. We observed that the regulation of the 
GALlO promoter in C. albicans is controlled by at least 2 regulatory sites: an enhancer 
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and a galactose - dextrose responsive element. Our study shows that the latter is regulated 
by Cphlp, a homologue of Ste12p of S. cerevisiae. The difference in the regulation of the 
Leloir pathway genes may be due to the fact that galactose plays important roles in 
adhesion and biofilm formation of C. albicans, processes that contribute to the virulence 
ofthis pathogen and are absent in S. cerevisiae (144). 
To investigate when the changes of the cis-regulatory element in the GAL 
promoters occurred during the evolution of the yeast species, we used available genomic 
data of the ascomycota that have GAL genes conserved in a cluster in their genome: 
Schizosaccharomyces pombe, S. cerevisiae, S. paradoxus, S. mikatae, S. bayanus, S. 
castellU, Kluyveromyces lactis, Debaryomyces hansenU, C. parapsilosis, C. dubliniensis, 
and C. albicans (Figure 4.1.6). Saccharomyces species contain classic tandem Gal4p 
binding sites and lack Cph 1 p-like binding motifs, while Candida species contain Cph 1 p-
like binding sites and lack any Gal4p-like binding motifs in their GAL promoters. 
Interestingly, the intermediate species, S. castellU and K lactis, contain both Gal4p-like 
and Cph 1 p-like motifs. S. pombe, which lies outside of the Hemiascomycetes lineage, 
lacks a strong Gal4p homolog and lacks Gal4p binding motifs, but contains Cphlp-like 
motifs upstream of its GAL genes, which suggests a Gal4p role in galactolysis may be 
specific to Saccharomyces species. Recent studies show that the evolution of the 
regulatory circuits that control ceIl type regulation coincide with a whole-genome 
duplication event in yeast (298). We observed that evolution of metabolic GAL regulation 
appears to have similar evolutionary pattern; the Saccharomyces lineage controls circuits 
differently from other fungi, with K lactis representing an intermediate having both 
regulatory motifs (Figure 4.1.6). 
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Since Gal4p is present only in fungi it would be interesting to know what regulates 
GAL genes in humans, where the absence of those enzymes results in galactosemia (26). 
It is interesting to note that the core of the MAPK controlled AP 1 binding site, 
tgACGTca (145), shares similarity to the GAL palindrome, tgtaACGTtaca, and human 
GAL genes contain potential AP 1 binding sites. 
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Table 4.1.1. Genes whose expression was up-regulated in response to galactose. 
Systematic Normalized Common Description 
orfl9.3668 0.129 GAL2 hexose transporter 
orfl9.6169 0.178 conserved hypothetical gene, DNA metabolism 
orfl9.3672 0.181 GALlO UDP glucose-4-epimerase 
orfl9.7094 0.196 HGTI2 glucose sensor or transporter prote in 
orfl9.2849 0.209 AQYI aquaporin 
orfl9.3670 0.239 GALl galactokinase 
orfl9.3675 0.242 GAL7 galactose-I-phosphate uridyl transferase 
orfl9.4384 0.266 HXT5 fructose symporter 
orfl9.7310 0.300 MSCI Meiotic Sister-Chromatid recombination 
orfl9.4527 0.301 HGTI hexose transporter 
orfl9.4591 0.305 CTN2 camitine acetyltransferase, amino acid metabolism 
orf19.3359 0.320 ARP8 actin-related prote in 
orfl9.5307 0.328 JEN2 carboxylic acid transporter 
orfl9.734 0.331 GLKI aldohexose specifie glucokinase 
orfl9.4555 0.348 ALS4 agglutinin-like prote in 4 
orfl9.1408 0.370 GLK2 glucokinase 
orfl9.4980 0.376 HSP70 heat shock prote in 70 
orfl9.2882 0.380 highly conserved hypothetical prote in, putative purine permease 
orfl9.2496 0.387 FUN34 transporter involved in nitrogen utilization 
orfl9.6491 0.389 hypothetical prote in 
orfl9.13 0.399 GLKI glucokinase, aldohexose specifie 
orfl9.111 0.408 CAN2 arginine permease 
orfl9.3160 0.415 HSPI2 heat shock protein;molecular chaperone 
orfl9.6116 0.416 GLK4 aldohexose specifie glucokinase 
orfl9.3637 0.417 hypothetical prote in 
orfl9.7021 0.435 GPHI glycogen phosphorylase 
orfl9.1097 0.455 ALS2 cell wall protein 
orfl9.4539 0.457 putative rho GDP dissociation inhibitor 
orfl9.1794 0.457 hypothetical protein 
orfl9.4735 0.461 putative omithine cyclodeaminase 
orfl9.7514 0.462 PCKI Phosphoenolpyruvate carboxykinase gluconeogenesis 
orfl9.2896 0.473 SOUI peroxisomal 2,4- dienoyl-CoA reductase, and sorbitol utilization 
orfl9.2515 0.479 hypothetical prote in 
orfl9.3131 0.479 OYE32 NADPH dehydrogenase 
orfl9.3684 0.481 SPS20 peroxisomal 2,4-dienoyl-CoA reductase 
orfl9.802 0.487 UGAI2 4-aminobutyrate aminotransferase (nitrogen) 
orfl9.4274 0.487 PUTI proline oxidase 
orfl9.1847 0.492 AROIO Prote in described as pyruvate decarboxylase, LEU catabolism 
orfl9.2121 0.496 ALS4 cell wall protein 
orfl9.4551 0.498 CTNI mitochondrial camitine acetyltransferase 
orfl9.744 0.498 GDBI glycogen debranching enzyme 
orfl9.3070.1 0.500 FOX3 hydratase-dehydrogenase- epimerase 
orfl9.4317 0.518 GRE3 aldose reductase 
orf19.1743 0.518 ACSI acetyl-coenzyme A synthetase 
orfl9.3548.1 0.521 WHII heat shock prote in induced during entry into stationnary phase 
orfl9.4682 0.524 HGTI7 quinate permease 
orfl9.5037 0.524 conserved hypothetical prote in 
orfl9.682 0.525 hypothetical protein 
orfl9.5525 0.525 conserved hypothetical prote in 
orfl9.1862 0.545 conserved hypothetical protein 
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orfl9.7566 0.550 GNPI high-affinity glutamine permease 
orfl9.338 0.561 conserved hypothetical prote in 
orfl9.272 0.574 FAA2-2 long-chain fatty acid CoA ligase 
orfl9.1974 0.578 TFSI carboxypeptidase Y inhibitor 
orfl9.7520 0.584 POT! peroxysomal 3-ketoacyl-CoA thiolase A 
orfl9.5604 0.587 MDRI benomyl/methotrexate resistance prote in 
orfl9.7531 0.590 YMR90 conserved hypothetical prote in 
orfl9.6083 0.594 hypothetical protein 
orf19.1152 0.600 hypothetical prote in 
orfl9.3278 0.600 GSYI glycogen(starch) synthase 
orfl9.1788 0.602 XKSI Xylulokinase 
orfl9.4477 0.604 CSHI aryl-alcohol dehydrogenase 
orfl9.532 0.608 RBR2 Cell wall prote in 
orfl9.5000 0.610 CYB2 cytochrome b2 precursor 
orfl9.7281 0.612 PDK2 pyruvate dehydrogenase kinase 
orfl9.1149 0.620 ETRI mitochondrial 2-enoyl thioester reductase, respiration 
orfl9.4287 0.623 alcohol dehydrogenase (glucose catabolism to butanediol) 
orfl9.3325 0.624 GLGI self-glucosylating initiator of glycogen synthesis 
orfl9.345 0.627 UGA2 succinate semialdehyde dehydrogenase 
orfl9.1180 0.627 conserved hypothetical prote in 
orf19.1809 0.629 FOX2 peroxisomal trifunctional hydratase-dehydrogenase-epimerase 
orfl9.2613 0.638 ECM4 involved in cell wall biogenesis and architecture 
orfl9.7676 0.640 SORI sorbitol dehydrogenase 
orf19.6443 0.641 ECll2 enoyl-CoA isomerase;delta3-cis-delta2-trans-enoyl- CoA isomerase 
orf19.6082 0.644 GSF2 ER localized promote secretion ofGAL2 
orfI9.5640 0.645 PEX5 peroxisomal protein receptor 
orf19.2737 0.646 Kinase 
orfl9.3029 0.651 EHD3 enpyl-CoA hydratase 
orfl9.6637 0.652 predicted glycosilase 
orfl9.1325 0.656 ECM38 gamma-glutamyltransferase, cell wall organization and biogenesis 
orfl9.854 0.660 UGAI 4-aminobutyrate aminotransferase (GABA transaminase) 
orf19.1652 0.662 POXI-3 fatty-acyl coenzyme A oxidase 
Table 4.1.2. Genes whose expression was up-regulated in response dextrose. 
Systernatic Normalized Cornrnon Description 
orf19.4737 4.88 TP03 membrane transporter of the MFS-MDR family 
orfl9.1354 3.77 YER67 conserved hypothetical prote in 
orfl9.6656 2.74 DUR3 urea transport protein 
orf19.4941 2.57 TYE7 basic helix-Ioop-helix transcription factor 
orfl9.3707 2.55 YHBI flavohemoglobin;dihydropteridine reductase 
orfl9.2659 2.52 conserved hypothetical prote in 
orf19.4716 2.40 GDH3 NADP-glutamate dehydrogenase 
orfl9.5288 2.26 IFE2 Zn-containing alcohol dehydrogenase 
orfl9.85 2.15 GPX2 glutathione peroxidase 
orfl9.5437 2.13 RHR2 DL-glycerol-3-phosphatase( glycewrol biosynthesis) 
orfJ 9.5626 2.07 conserved hypothetical prote in 
orfl9.978 2.03 BDFI transcription factor 
orfl9.889 1.96 THI20 thiamine biosynthesis;phosphomethylpyrimidine kinase 
orf19.3448 1.96 hypothetical protein 
orf19.1415 1.94 FREIO ferric reductase 
orfl9.6249 1.93 HAKI high affinity potassium transporter 
orf19.5193 1.93 FMAI benzil reductase 
orf19.670.2 1.88 hypothetical protein 
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orf19.909 1.77 STP4 TF 
orfl9.5305 1.75 RHD3 Putative GPI-anchored prote in 
orfl9.3712 1.73 hypothetical protein 
orf19.3441 1.73 FRP6 putative transporter 
orf19.2158 1.72 NAG3 related to MOR family transporters 
orfl9.6586 1. 71 conserved hypothetical protein 
orfl9.4779 1.71 multidrug-resistance transporter 
orfl9.740 1.71 HAP41 CCAA T-binding factor complex 
orfl9.23 1.70 RTA3 putative transporter upregulated during the acquisition of azole resistance 
orfl9.2475 1.69 PGA26 Putative GP1-anchored prote in 
orfl9.5759 1.65 SNQ2 ABC transporter 
orfl9.5025 1.65 MET3 A TP sulfurlyas 
orf19.5431 1.65 hypothetical prote in 
orf19.3676 1.61 ABPI40 hypothetical protein 
orf19.1855 1.60 SE02 putative permease 
orfl9.339 1.56 NOE1 mitochondria directed NAOH dehydrogenase 
orfl9.3088 1.56 TF 
orfl9.6770 1.56 ENT4 epsin N-terminal homology- containing protein 
orfl9.6766 1.56 NOPJ3 Nucleolar Protein \3 
orfl9.1264 1.55 CFL2 ferric reductase 
orfl9.183 1.55 HIS3 imidazoleglycerol-phosphate dehydratase 
orfl9.5992 1.55 ZCF33 zinc finger transcription factor 
orfl9.5305 1.55 RHD3 GPI-anchored prote in 
orfl9.3393 1.55 OBP9 dead-box protein 9 
orf19.449 1.55 possible phosphatidyl synthase 
orfl9.4033 1.54 PRP22 RNA-dependent A TPase 
orfl9.7657 1.53 POP3 RNase P and RNase MRP subunit 
orfl9.6902 1.53 OBP7 Oead-box protein;RNA helicase 
orfl9.2308 1.53 PFK26 6-phosphofructose-2-kinase 
orf19.6727 1.53 RIT! ribosyltransferase of initiator tRNA methionine 
orfl9.3040 1.53 EHT! alcohol acyl transferase, synthesis ofmitochondrial outer membrane 
orfl9.5010 1.52 DIMI dimethyladenosine transferase, rRNA 
orfl9.409 1.52 conserved hypothetical protein, membrane 
orf19.4459 1.51 YNL234W weakly simiular to to mammalian globins 
orf19.6014 1.50 RRSI regulator ofribosome synthesis 
orfl9.3406 1.50 highly conserved hypothetical protein 
Table 4.1.3. Genes whose expression was down-regulated in ga14 strain. 
Systematic Normalized Corn mon Description 
orfl9.6191 0.286 CTA2 hypothetical prote in 
orf19.3074 0.308 CTA2 hypothetical prote in 
orf19.3386 0.425 CTA2 transcription factor 
orfl9.5467 0.430 CTA2 transcription factor 
orfl9.710 0.453 LSC2 succinate-CoA ligase beta subunit (TCA) 
orfl9.4054 0.461 CTA24 transcriptional regulation 
orf19.5383 0.471 PMAI plasma membrane H+-A TPase (phosphate) 
orfl9.3182 0.475 GIS2 nucleic acid binding prote in 
orfl9.6112 0.481 CTA21 putative transcriptional activator 
orfl9.3145.4 0.507 PG1l2 glucose-6-phosphate isomerase (glycolysis) 
orfl9.2762 0.517 AHPI alkyl hydroperoxide reductase 
orfl9.362 0.526 CTA2 transcriptional activation 
orfl9.7544 0.553 CTA2 hypothetical prote in 
orfl9.4885 0.556 MIRI mitochondrial phosphate transport protein 
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orfl9.2777 0.566 TOS3 target ofSBF (glucose repression) 
orfl9.7680 0.581 CTA26 transcription al activation 
orfl9.5338 0.594 GAL4 potential fun gal Zn(2)-Cys(6) binuclear cluster domain sim to that ofGAL4 
orfl9.6561 0.596 LATl dihydrolipoamide acetyltransferase component (TCA) 
orfl9.7127 0.596 CTA2.5 hypothetical prote in 
orfl9.6435 0.600 conserved hypothetical prote in 
orfl9.655 0.606 PH0842 high-affinity inorganic phosphatelH+ symporter 
orfl9.6337 0.609 CTA28 transcriptional activator 
orfl9.4155.12 0.614 IDHI similar to protion of isocitrate dehydrogenase 1 alpha-4-beta-4 subunit (TCA) 
orfl9.7231 0.616 FTR2 plasma membrane iron permease 
orfl9.1860 0.616 LSC2 hypothetical protein 
orfl9.631 0.617 CTA2 transcription factor 
orfl9.6165 0.619 KGDI alpha-ketoglutarate dehydrogenase (TCA) 
orfl9.3642 0.625 SUN4 Putative cell wall prote in 
orfl9.5451 0.625 hypothetical prote in 
orfl9.2685 0.639 PGA54 GPI-anchored prote in 
orfl9.7635 0.641 DRSI A TP dependent RNA helicase 
orfl9.7276.1 0.642 CTA24 transcriptional activator, 3- prime end 
orfl9.1124.2 0.644 DPH52 diphthamide methyltransferase 
orfl9.7127.1 0.662 CTA2.3 hypothetical prote in 
orfl9.4211 0.663 FET3 multicopper ferro-02- oxidoreductase involved in high-affinity iron uptake 
orfl9.7424 0.664 NSA2 Killer toxin Resistant;ribosomal biogenesis 
orfl9.5193 0.668 benzil reductase 
orfl9.1105.2 0.669 PGA56 Regulator of sorbose utilization; putative GPI-anchor 
orfl9.1536 0.669 ZRCI zinc- and cadmium resistance protein 
orfl9.968 0.673 PGAI4 GPI-anchored prote in 
orfl9.7443 0.681 hypothetical prote in 
orf19.5305 0.683 PGA29 GPI-anchored prote in 
orfl9.6724 0.686 FUMI2 mitochondrial fumarate hydratase, 5-prime end (TCA) 
orfl9.1591 0.686 ERG 10 acetyl-CoA acetyltransferase;acetoacetyl CoA thiolase 
orfl9.903 0.689 GPMI phosphoglycerate mutase (glycolysis) 
orfl9.5892 0.691 HUL4 ubiquitin-protein ligase 
orfl9.3223 0.697 ATP3 proton-transporting A TP synthase, central stalk 
orfl9.6676 0.701 DPH5 diphthamide (modified histidine residue) biosynthesis methyltransferase 
orfl9.4309 0.701 GRP2 induced by osmotic stress 
orfl9.932 0.703 DNFI phopholipid transporting A TPase 
orfl9.4263 0.706 hypothetical prote in 
orfl9.3475 0.710 Gag-related protein; hyphal induced 
orfl9.7125 0.711 hypothetical prote in 
orfl9.10 0.713 ALK8 cytochrome p450 
orfl9.3713 0.715 hypothetical prote in 
orfl9.7673 0.715 SMD1 snRNA-associated prote in, snRNP 
orfl9.6189 0.715 conserved hypothetical prote in 
orfl9.339 0.722 NDE1 mitochondria directed NADH dehydrogenase (glycolysis) 
orfl9.3829 0.723 PHR1 pH regulated GPI-anchored membrane protein needed for morphogenesis 
orfl9.502l 0.723 PDXl pyruvate dehydrogenase complex protein X (TCA) 
orfl9.7534 0.723 MIS1 mitochondrial C 1- tetrahydrofolate synthase precursor 
orfl9.7219 0.727 FTR1 plasma membrane iron permease 
orfl9.717 0.727 HSP60 mitochondrial groEL-type heat shock prote in 
orfl9.5684 0.730 MRPL14 mitochondrial ribosomal protein L14 
orfl9.3097 0.731 PDA1 alpha subunit ofpyruvate dehydrogenase (TCA) 
orfl9.5052 0.733 conserved hypothetical protein 
orfl9.6948 0.734 CCCI transmembrane Ca2+ transporter 
orfl9.4051 0.735 HTSJ histidine tRNA synthetase 
157 
Chapter 4: C. albicans intergenic comparison 
orf19.30 1 0.735 hypothetical prote in, likely cell walliocalized and GPI-anchored 
orf19.6090 0.735 NSRI ribosomal small subunit assembly and maintenance 
orf19.2346 0.737 highly conserved hypothetical protein 
orfl9.962 0.738 hypothetical prote in 
orfl 9.6 105 0.739 MVO mevalonate pyrophosphate decarboxylase 
orf19.5112 0.740 TKLl transketolase 1 (pentose) 
orf19.327 0.742 HTA3 histone variant involved in chromatin and transcriptional control 
orfl9.252 0.742 conserved hypothetical prote in 
orf19.5943.1 0.743 STMI main tain telomere structure 
orfl9.929 0.747 hypothetical protein 
orf19.5989 0.748 HRPI nuc\ear polyadenylated-RNA- binding prote in 
orf19.930 0.751 PET9 ATP/AOP translocator 
orfl9.1329 0.752 hypothetical prote in 
orfl9.5444 0.753 TIM44 inner membrane translocase component 
orf19.6190 0.753 SRBI GOP-mannose pyrophosphorylase cell wall 
orf19.3038 0.756 TPS2 threalose-6-phosphate phosphatase 
orfl9.2200 0.756 VJP36 vesicular integral-membrane protein VIP36-like 
orfl9.2953 0.757 TOM20 mitoehondrial outer membrane translocase complex 
orfl9.4826 0.759 IDHI mitoehondrial isoeitrate dehydrogenase 1 (TCA) 
Table 4.1.4. Genes who se expression was up-regulated in ga14 strain. 
Systematic Normalized Common Description 
orf19.6139 2.42 FRE7 ferric reductase 
orfl9.3646 1.93 CTRI copper transport protein 
orfl9.2107.1 1.85 STF2 A TP synthase regulatory factor 
orfl9.7111.1 1.84 SOD3 superoxide dismutase 
orf19.1862 1.83 eonserved hypothetical prote in 
orfl9.2344 1.68 ASRI similar to heat shock prote in 
orfl9.2020 1.63 HGT6 hexose transporter 
orf19.638 1.62 FDHI formate dehydrogenase, glycine catabolism 
orfl9.4555 1.60 ALS4 agglutinin-like prote in 4 
orf19.3548.1 1.60 WH Il heat shock prote in potentially induced during entry into stationnary phase 
orf19.2048 1.58 hypothetical prote in 
orfl9.670.2 1.58 hypothetical prote in 
orf19.1996 1.57 CHAI catabol ie serine/threonine dehydratase 
orfl9.7077 1.53 FRE7 transmembrane subunit of ferric reductase 
orfl9.5626 1.51 conserved hypothetical prote in 
orfl9.2121 1.51 ALS4 cell wall prote in 
orfl9.73 10 1.49 MSCI Meiotic Sister-Chromatid reeombination 
orf19.1354 1.47 YER67 conserved hypothetieal prote in 
orfl9.4941 1.46 TYE7 basic helix-Ioop-helix transcription factor 
orf19.5288 1.45 YAL60 Zn-containing alcohol dehydrogenase 
orfl9.2849 1.42 AQYI Aquaporin 
orfl9.6816 1.42 aldehyde reductase 
orfl9.4682 1.42 HGTl7 quinate permease 
orfl9.5514 1.42 eonserved hypothetieal prote in 
orfl9.5876 1.39 hypothetical prote in 
orfl9.3682 1.38 CWH8 generation ofmannoprotein layer of the cell wall;putative phosphatase 
orfl9.3932 1.38 eonserved hypothetical prote in 
orfl9.1331 1.37 HSM3 MutS family (putative);mismateh repair 
orfl9.946 1.37 METl4 adenylylsulfate kinase 
orfl9.5000 1.37 CYB2 cytoehrome b2 precursor 
orfl9.2292 1.36 OPT4 oligopeptide transporter prote in 
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orfl9.2584 1.35 OPT9 oligopeptide transporter specifie for tetra- and pentapeptides;possible pseudogene 
orfl9.1974 1.35 TFSI carboxypeptidase Y inhibitor 
orfl9.2693 1.35 UREI nitrogen catabolite repression regulator and prion generator 
orfl9.7284 1.34 ASR2 conserved hypothetical protein 
orfl9.3749 1.34 IFe3 oligopeptide transporter protein 
orfl9.2173 1.33 MAFI nuclear-cytoplasmic transport;negative effector of Pol III synthesis 
Table 4.1.5: ~-galactosidase activities in Miller units of C. albicans promoters in C. 
albicans strains. 
WT WT cphl cphl ga14 ga14 
Construct Dextrose Galactose Dextrose Galactose Dextrose Galactose 
plac-poly O±O O±O O±O O±O O±O O±O 
pLA Tl-lacZ-270 379±34 IS0±10 
pLAT }-lacZ-2S3 146±ll IS2±11 
pCTA2-lacZ-126 430±33 76±6 
pCTA2-lacZ-114 138±9 81±6 
pGAU O-lacZ S03±37 SOS±36 
pGAU O-lacZ-840 SOI±30 499±31 S04±3S 489±31 
pGAU O-lacZ-840L'l 176-188 393±22 96±6 
pGAU O-lacZ-188 7±1 99±7 9±1 9±2 
pGAU O-lacZ-176 98±8 30±3 43±3 7±1 
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Figure 4.1.1. Candida albicans GAL regulon. 
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GALl 
~·li8 ! 65 
A. The structural members of the S. cerevisiae GAL regulon are aIl conserved in C. 
albicans and are also organized in a cluster. GAL2 is a part of the C. albicans GAL 
cluster. 
B. ScGal4p acts as the activator of the S. cerevisiae GAL regulon. The putative CaGal4p 
protein, encoded by C. albicans ORF19.5338, shares strong sequence similarity (86%) 
with S. cerevisiae Gal4p only within the DNA binding domain; the DNA binding domain 
has the six cysteine residues, the linker region, and the dimerization region aIl weIl 
conserved. 
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Galactolysis 
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Transporters and 
CcII wall 
21% 
Transcription Factors 
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Ribosome Synthesis 
13% 
Transporters and 
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Figure 4.1.2. Galactose leads to elevated expression of CaGAL genes. 
Galactose leads to higher expression of 82 genes including GALl, 2, 7, and 10 (A), while 
dextrose leads to higher expression of 54 genes in C. albicans (B). 
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Figure 4.1.3. The function of C. albicans Ga14p. 
The transcriptional gene targets of C. albicans Ga14p were analyzed by microarrays. Loss 
of C. albicans GAL4 led to reduced expression of 87 genes (A), and the increased 
expression of 37 genes (B). 
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Figure 4.1.4. Ga14 regulates expression through Ga14 DNA binding site. 
The promoter of TLO, a member of the C. albieans telomeric gene family, and of LA Tl, a 
member of the TCA cycle, were connected to drive the expression of the downstream 
laeZ reporter. The promoters either contained or lacked a potential Ga14p binding site 
(CGG(N 11)CCG/ A), and their resulting ~-galactosidase activities were analyzed in wild 
type and gal4 strains. 
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Figure 4.1.5. Cph 1 P regulates the expression of GALlO. 
The promo ter of GALlO, a member of the C. albicans Leloir pathway, was fused to a 
downstream lacZ reporter. The promoter either contained or lacked a potential GAL-
specifie palindrome (TGT AACGTT ACA). Their resulting f3-galactosidase activities were 
analyzed in wild type and cphl strains grown either in galactose or dextrose. 
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Figure 4.1.6. Analysis of cis-GAL regulation across Ascomycota. 
The primary sequences of GAL promoters were analyzed for the presence of UASG's in 
species only if those genes were arranged in a cluster. W stands for either T or A, and K 
stands for either G or T. The phylogenetic relationship between the fungi is shown as in 
(74). 
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CHAPT ER 5: FINAL CONCLUSION AND SUMMARY 
The genome comparison to S. cerevisiae revealed an increased number of C 
albicans superoxide dismutase genes. We analyzed the transcriptional regulation and the 
function of SOD5, who se role is to prote ct the pathogen against the extracellularly 
produced, neutrophil-generated superoxide radicals. The search for sequences similar to 
CuZnSOD in genomes of ascomycota revealed that aIl of these organisms have SODI 
homologs, but only filamentous fungi, such as N crassa and A. jumigatus, have 
additional sequences homologous to SOD5. It is possible that filamentous fungi have 
more sources of production of harmful radicals, which applies more pressure on these 
fungi to possess extra isoforms of the detoxifiers of such radicals. 
Comparative genomics showed that although many of the C albicans 
transcription factors, such as Gal4p and Gcn4p, have homologues in S. cerevisiae, the 
sequence similarities occur only in the DNA binding motifs of those proteins. Deletion 
analysis of the CaGcn4p prote in shows that the N terminus is needed for transactivation 
ability~ deletion analysis of CaGal4p identifies aC-terminal transactivation domain. 
These two transactivation regions show no sequence similarity to the respective domains 
in their S. cerevisiae homologues, and the two C albicans transactivating domains 
themselves show little similarity. The comparative analysis of the transcriptional 
machinery between C albicans and S. cerevisiae showed a poor homology of the 
mediator complex which bridges activation domains of transcription factors to the RNA 
polymerase II complex, which might explain the poor homology between S. cerevisiae 
and C albicans activation domains. As previously stated, one of the most important 
virulence factors of C albicans as a human pathogen is its ability to switch between 
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different cell shapes. We now know a number of transcription factors involved in this 
dimorphic switch, and the deletion of transcription factors that participate in the yeast to 
hyphal transitions leads to reduced virulence of this fungus (69, 190). The different 
structure of the mediator is of interest for a number of reasons: 1) the difference in 
transcriptional machinery elements, such as mediator, between fungi such as C. albicans 
and S. cerevisiae and metazoans presents a potential target for antifungal drugs; 2) 
different mediators and their interacting activation do mains are involved in different 
cellular biology processes such as transcriptional rewiring of signaling pathways and 
different posttranslational modifications of transcriptional activators; 3) the ability of the 
cell to change its mediator structure may suggest that the plasticity of the mediator plays 
a key role of the cell' s capacity to evolve in response to a changing environment. 
We also performed comparative genomics of intergenic DNA regions to identify 
the cis-regulatory elements from three Candida species and four Saccharomyces species 
to show the reorganization of the transcriptional regulatory network between these two 
groups of yeasts. We observed that C. albicans GAL genes lack Gal4p binding sites, and 
that Gal4p regulated the expression of telomeric genes and genes involved in glycolysis, 
aIl of which contain UASG. We observed that galactose activates the expression of the 
Candida homologs of the GALl, 2, 7, and IO genes. Our results show that the regulation 
of the C. albicans GALlO promoter is controlled by at least two regulatory sites: an 
enhancer and a galactose - dextrose responsive element. We show that the latter site is 
regulated by Cphlp, a homologue of Ste12p of S. cerevisiae. In the future we will assess 
the regions of the GALlO promoter, through which Riml0lp and Rmd5p regulate GALlO 
expreSSIOn. 
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S. cerevisiae responds to mating pheromone by activating a mitogen-activated 
prote in kinase (MAPK) signaling pathway (119). This MAPK pathway leads to the 
activation of Ste12p transcription factor that in turn binds, along with Mcmlp, the 
pheromone response elements (PREs) upstream of genes involved in mating, resulting in 
their expression (80). In addition, Ste12p regulates, in concert with Teclp, the genes 
involved in pseudohyphal growth by cooperatively binding filamentation response 
elements (FREs) upstream of genes involved in filamentous growth (189). The C. 
albicans Ste12p homologue, Cphlp, is also required for mating and hyphal growth (188, 
204), and in this work we show that Cphlp also regulates the expression of GAL genes. 
In future work it would be necessary to address the nature of the Cphlp-biniding partners 
in the presence of different carbon sources. 
In conclusion, sequencing the genome of any given organism proves to be a 
powerful tool in studying its biology. The comparison of the genome of any species to 
that of its close homologue to search for differences in both intergenic and intragenic 
DNA regions will reveal clues about its evolutionary path and will tell us a great deal 
about its environmental conditions. 
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APPENDIX A: Tables 
Table 1: Strains used in this study. 
Strain 
SC5314 
RMIOOO 
RMIOOO-HU 
HIO 
UHI6 
UH16-1 
UH16-2 
UH16-3 
HLC52 
DAY25 
DAYI85 
GK06 
BWPI7 
CMMI 
CMM2 
CMM3 
CMM4 
CMM5 
rmd5 
CMM6 
rimlOl 
CMM7 
rim!3 
CMM8 
gcn-l 
gen-l-ura3 
DAY286 
CMM9 
CAI8 
CRCI03 
CRCI06 
CMMIO 
CMMII 
CMMI2 
CMMI3 
CMM60 
CMMI4 
CMM62 
CMMI5 
CMMI6 
CMMI7 
CMMI8 
CMMI9 
CMM20 
CMM21 
CMM64 
CMM25 
CMM26 
CMM27 
CMM28 
CMM29 
CMM61 
Genotype 
Wild-type isolate 
ura3/J.:Àimm434!ura3/J :Àimm434 his! :hisG!hisl::hisG 
ura3/J::Àimm434!ura3/J :Àimm434 hi.<l :hisG/his!::hisG SOD5!SOD5 :[p37H]::[p37U] 
ura3/J:.Àimm434!ura3/J :Àimm434 hisl. 'hisG/hisl :h.sG sod5/J::HISJ/SOD5 
ura3/J::Àimm434!ura3/J :Àimm434 his!::hisG!his! ::hisG sod5/J::hisG-URA3-hisG!sod5/J :HlSl 
ura3/J : Àimm434/ura3/J :Àimm434 his!: :h.sG/h.sl: :hisG sod5/J: :hisG/sod5/J: :HISI 
ura3/J :Àimm434/ura3/J :Àimm434 hisl::hisG/hisl::hisGsod5/J.·:hisG/sod5/J::HISl :[p37U] 
ura3/J :Àimm434/ura3/J: Àimm434 hisl ::hisG/hisl: :hisG sod5/J::HlSl/sod5/J::hisG. '[pSOD5-IIO] 
ura3/J : Àimm434/ura3/J.·· Àimm434 efgl /J::h.sGlefgl /J: :hisG-URA3-hisG 
ura3/J :Àimm434'ura3/J :Àimm434 hisJ.·.·hisG hisl::h.sG arg4::hlsG/arg4::h.sG rimlOl:ARG4/rim!O!::URA3 
ura3/J :Àimm434ura3/J .·Àimm434 hisl :h.sG/hls! :hlsG ARG4::URA3::arg4:.·hlsG'(ug4::hisG 
ura3/J. 'Àimm-l3-1 ura3/J :Àimm434 hisl :hisGhis! :hlsG arg-l::hlsG'arg4::hlsG mds3:: Tn7-UAU!/mds3::Tn7-URA3 
ura3/J :Àimm434,ura3/J :Àimm434 hls!. ·hlSG·hls! :hl . o arg4::hisGiarg4: hlsG 
ura3/J:: Àimm434 ura3/J:: Àimm43-1 hls!: :hlsG'h.s! :hisG arg4: :hisG/arg4. 'hisG 
GAIA'GAL4::[pHls!-GAL4]::[pARG4-GAL4] 
ura3!J::Àimm-l3-1 ura3!J:.Àimm-l34 hls!::hisG his! :hisG arg.J::hlsGarg4::h.sG gal4/J :HlS!/GAL.f 
ura3/J::Àimm.J3.J ura3/J::Àimm.J3-1 hisl::h.sG h.s!::hlSG arg.J::hi . .o'arg4::hisG gal4/J :ARG4!ga/4/J :H!S! 
ura3/J:: Àimm43-1 ura3!J:: Àimm43-1 hisl. :hisGhi.<I: :hisG arg4: :hisG,arg4: :h.sG 
GAL.f/GAL4::[pHisl-GAL4]::[pARG.J-GAL4] RPS!/RPSI':[pGAL!O-/aeZ] 
ura3/J:: Àimm434/ura3/J.·· Àimm434 his l' :hisG/his 1: :hisG arg4: :hisG/arg4: :hisG gal4/J. 'ARG4/ga/4/J: : HIS 1 
RPS/ RPSJ.·:[pGALIO-/aeZ] 
ura3/J::Àimm43.J!ura3/J::Àimm434 his!::hisG/hisl :h.sG 
arg4:.·hisG/arg4::hlsG rmd5::Tn7-UAU!'rmd5 : Tn7-URA3 
ura3/J:: Àimm434/ura3/J:: Àimm434 his! ::h.sG/hisl: :hisG 
arg4::hisG/arg4::h.sG rmd5:: Tn7-UAUllrmd5:: Tn7-URA3 RPSI/RPSI :[pGALIO-lacZ-840-HlSI] 
ura3/J:: Àimm434/ura3/J:: Àimm434 hisl ::hisG/hisl: :hisG 
arg4::hisG!arg4::hisG rimlOl:.Tn7-UAUllrimlOl::Tn7-URA3 
ura3/J:: Àimm434!ura3!J:: Àimm434 hisl: :hisG!hisl: :hisG 
arg4::hisG!arg4::hisG rimIOl::Tn7-UAUlrimlOl::Tn7-URA3 RPSJ/RPSI :[pGALIO-lacZ-840-HlSI] 
ura3/J:: Àimm434!ura3/J:: Àimm434 hisl ::hisGlhisl ::hisG 
arg4: :hisGarg4: :hisG riml 3:' Tn7-UAUI !riml 3:: Tn7-URA3 
ura3/J:: Àimm43.J/ura3/J:: Àimm434 hisl: :hisGlhisl::hisG 
arg4::hisG/arg4: :hisG riml 3:: Tn7-UAUI mm 1 3:: Tn7-URA3 RPS!!RPSI :[pGALIO-lacZ-840-HlSl] 
ura3/J:: Àimm434/ura3/J:: Àimm.J3.J hisl::hisG/h.sl: .·hisG 
arg4: :h.sG/arg.J: :h.sG gcn.J:: Tn7-UA UI/gcn4:: Tn7-URA3 
ura3!J:: Àimm-l3-1 Ura3/J:: Àimm-l3-1 hi .. l: :hisG'hisl ::hisG 
arg4::hisG"arg-l::hisG gcn4:.Tn7-UAUIgcn4::Tn7 
ura3/J::Àimm-l34'ura3/J:: Àimm-l3.J arg4::URA3::arg4::h.sG/arg4::h.sG h.sl :hisGlhisl :hisG 
ura3/J:: Àimm.J34ura3/J:: Àimm434 arg4:: URA3::arg4::hisGiarg4::hisG h.s! :h.sGhisl :hisG 
RPS!. RPSJ..·[pGALIO-/acZ-750-H/SI] 
ura3/J:: Àimm.J34 'ura3!J:: Àimm434 ade2: :hisG'ade2: :hisG 
ura3/J :Àimm.J34··ura3/J :À, ade2: :hisG'ade2::hlSG: : [pCRlaeZ] 
ura3/J . . Àimm434 'ura3/J : À, ade2: : hisGlade2::hlsG: : [pOP/aeZ] 
ura3/J :Àimm434!ura3/J :À, ade2 :hisG/ade2.· hisG.··[pOPlacZ] RPSl/RPSl. '[Clp-lexA] 
ura3/J :Àimm434/ura3/J :À, ade2 :h.sGlade2 :hisG : [pOPlacZ] RPSIIRPSI :[Clp-/exA-GAL4] 
ura3/J :Àimm434/ura3/J'À, ade2 :hisG/ade2 :hisG :[pOPlacZ] RPSI/RPSI::[Clp-/exA-GAL4-GCN4AD] 
ura3/J :Àimm434/ura3/J :À, ade2::hisG!ade2 .hisG : [pOPlacZ] RPSIIRPSI::[Clp-/exA-GAL4/J188-261] 
ura3!J : Àimm434/ura3/J:: À, ade2::hisGlade2 :hisG:: [pOPlacZ] RPSIIRPSl:: [Clp-/exA-GAL4/JlO-187] 
ura3/J : Àimm434Iura3/J:: À, ade2::hisG!ade2 :hisG:' [pOPlacZ] RPSIIRPSl:: [Clp-lexA-GCN4] 
ura3/J' Àimm434/ura3/J:: À, ade2: hisG/ade2 :hisG: : [pOPlacZ] RPSl/RPSl: : [Clp-/exA-GCN4/J247-323] 
ura3/J :Àimm434Iura3/J::À, ade2: hisG/ade2 :hisG : [pOPlacZ] RPSl!RPSl::[Clp-/exA-GCN4/J161-323] 
ura3/J :Àimm434/ura3/J::À, ade2. 'hisGade2 :h.sG : [pOPlacZ] RPSI/RPS!::[Clp-lexA-GCN4/J123-323] 
ura3/J . Àimm434 'ura3/J:: À, ade2 :hisG'ade2. 'hisG : [pOPlacZ] RPSJlRPSI:: [Clp-/exA-GCN4/J82-323] 
ura3/J .Àimm43.Jura3/J :À, ade2 .hisG'ade2 :hisG : [pOPlacZ] RPSl/RPSl::[Clp-/exA-GCN4/J69-323] 
ura3/J :Àimm.J3.J'ura3/J .À, ade2 :hisG/ade2. 'hisG :[pOPlacZ] RPSl!RPSl::[Clp-/exA-GCN4!J56-323] 
ura3/J .·Àimm-l34 ura3/J : À, ade2 .N<G'ade2 :hisG :[pOPlacZ] RPSl/RPSl::[Clp-/exA-GCN4!J42-323] 
ura3.1 :Àimmn.J'ura3.1 :À, ade2 :hisG ade2 :hisG : [pOPlacZ] RPSI 'RPS/::[Clp-/exA-GCN4.1/-B/] 
ura3/J . Àimm.J3.J/ura3/J : À, ade2:'hisG ade2.· :h.sG:: [pOPlacZ] RPSI, RPSI:: [Clp-/exA-GCN4/J1-8/ /J2./7-323] 
ura3/J:: Àimm.J3-1 'ura3/J:: Àimm43-1 hisl::h.sG/his!: :hisG arg4 .. ·hisG,arg4: :hisG:: [p/exA-HlSl] 
ura3/J:: Àimm-l3.J/ura3/J:: Àimm434 his/ .. hisG/hisl ::hisG arg4::hi . .o/arg4: :hisG:: [p/exA-HlSI] 
RPSIRPSI .. [Clp-/exA] 
ura3/J.··Àimm434/ura3/J.:Àimm434 hisl :hisG/hisl :hisG arg4::hi..o/arg4 :hisG :[p/exA-HISI] 
RPSl/RPSl::[Clp-/exA-GAL4] 
ura3/J:: Àimm-l34/ura3/J:.· Àimm434 hisl: .·hisGhisl. 'hlSG arg4 :hisG/arg4. 'hisG :[p/exA-HISl] 
RPSl/RPSl·.·[Clp-/exA-GAL.f-GCN4AD] 
ura3/J::Àimm434/ura3/J::Àimm434 hisl::hisG/his/ :hisG arg4 :h.sG/arg4. 'hisG :[p/exA-HlSl] 
RPSl/RPS!::[Clp-/exA-GAL4/J188-261] 
ura3/J::Àimm434/ura3/J.:Àimm434 hlsl::hisG!hisl .·hisG arg4 :hi . .o/arg4::hisG :[p/exA-HISl] 
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Source 
(88) 
(226) 
This study 
This study 
This study 
This study 
This study 
This study 
(190) 
(69) 
(69) 
(71) 
(305) 
This study 
This study 
This study 
This study 
This study 
(229) 
This study 
(229) 
This study 
(71) 
This study 
(229) 
This sludy 
(71) 
This study 
(88) 
(256) 
(256) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This sludy 
This study 
This study 
This study 
This study 
This sludy 
This study 
CMM30 
CMM63 
CMM31 
CMM32 
CMM33 
CMM34 
CMM35 
CMM36 
CMM37 
CMM65 
CAI4 
CMM41 
CMM43 
CMM44 
CMM99 
CMMIOO 
CMMIOI 
JKCI9 
CMMI02 
CMMI03 
CMMI04 
CMMI05 
CMMI06 
CMM54 
CMM55 
CMM56 
CMM57 
CMM65 
CMM66 
CMM67 
CMM68 
CMM58 
CMM59 
CMM85 
CMM86 
CMM87 
CMM88 
CMM89 
RPS1IRPS!::[Clp-!exA-GAL4L110-187] 
ura3L1:: Àimm434Iura3L1:: Àimm43 4 his 1:: hisGlhl.' 1 : hisG arg4 : hlsGlarg4. 'hisG : [plexA-HlS 1] 
RPS1IRPS1:.[CIp-lexA-GCN4] 
ura3L1::Àimm434Iura3L1:.Àimm434 hisl::hisGlhisl :hisG arg4 :hisGlarg4 :hisG :[plexA-HIS1] 
RPS1IRPS1:: [CIp-lexA-GCN4L1247-323] 
ura3 LI:: Àimm434Iura3L1:: Àimm434 his 1:: hisGlhls 1:: hisG arg4:.· hisGlarg4. 'hisG : [plexA-HlSl] 
RP SI IRP SI:: [CIp-/exA-GCN4L11 6 1 -323] 
ura3L1:: Àimm434Iura3L1: :Àimm434 hisl::hisGlhisl::hisG arg4::hlsGlarg4 :hisG. '[p/exA-HlSl] 
RP S 1. 'RP SI:: [CIp-/exA-GCN4L11 2 3-3 2 3] 
ura3L1:: Àimm434 ·ura3L1.· : Àimm434 his 1:: hISG/lllS 1 . . hlsG arg4:: hlsG/arg4: :hisG:: [p/exA-HlS 1] 
RPSl/RPS/.·[CIp-/exA-GCN4L182-323] 
ura3 LI:. Àimm4341ura3L1:: Àimm434 his 1:: hisG/hls 1 : hisG arg4:: hisGlarg4 :hisG : [plexA-HlS 1] 
RPSI /RPSI ::[CIp-/exA-GCN4L169-323] 
ura3 LI:: Àimm434ura3L1:: Àimm434 hls 1:: hlsC;lhls 1 : hlsC; arg4:: hisG/arg4 :hisG . . [plexA-HlS 1] 
RPSl/RPS1"[Clp-lexA-GCN4L156-323] 
ura3L1::Àimm434ura3L1::Àimm434 hlsl::hisG/hlsl :hlsG arg4 :hisG/arg4: hisG :[p/exA-H1Sl] 
RPS1RPS/.:[Clp-/exA-GCN4L142-323] 
ura3L1:'Àimm434/ura3L1::Àimm434 hisl::hisGlhis! :hisG arg4 :hisGlarg4::hisG :[plexA-HlSl] 
RPS1.'RPS1·:[CIp-/exA-GCN4L11-8J] 
ura3L1::Àimm434 ura3L1::Àimm434 hisl::hisG/his/ :hisG arg4 :hi.lGlarg4::hlsG::[plexA-H1Sl] 
RPSI .RPS1 .. [Clp-/exA-GCN4L1! -8! Ll247-323] 
ura3L1:: Àimm434Iura3L1:: Àimm434 
ura3L1:: Àimm434/ura3L1:: Àimm434 RPS/RPS/:: [plac-poly] 
ura3L1: :Àimm434'ura3L1:: À/mm434 RPSl/RPS1:: [pGAU O-/aeZ] 
ura3L1:: Àimm4341ura3 LI:: Àimm43 4 RPSI IRPS1:: [pGAU O-/aeZ-840] 
ura3L1: :Àimm434Iura3L1:: Àimm434 RPSI IRPS1:: [pGALlO-IaeZ-188] 
ura3L1.·:Àimm434/ura3L1 .. Àimm434 RPS/·RPS/.· : [pGALlO-/aeZ-1 76] 
ura3L1:: Àimm434ura3L1.: Àimm434 RPS1·RPS/.· : [pGALl O-/aeZ-840li 176-188] 
ura3L1.·:Àimm434.ura3L1::Àimm434 ephl::hisG/ephl::hisG-URA3-hisG 
ura3L1:: Àimm434'uro3L1:.Àimm434 ephl: :hisG/cphl: :hisG 
ura3L1 :Àimm434/uro3L1 :Àimm434 cphl::hisG/ephl::hisG RPS1,RPS1::[pGALlO-IacZ-840] 
ura3L1 :Àimm434 ura3L1 :Àimm434 cphl::hisGlcphl::hisG RPSl/RPS1:: [pGAL10-/acZ-840lil 76-1 88] 
ura3L1. . Àimm434/uro3L1 : Àimm434 cphl: :hlsG/cphl. :hlsG RPS! IRPS! ::[pGAUO-/acZ-188] 
ura3L1 . Àimm434 ura3L1 :Àimm434 cphl::hlsG.cph!::hisG RPS1IRPS1:: [pGALlO-/acZ-1 76] 
ura3L1:: À/mm434 'ura3L1:: Àimm434 hlsl::hisG/hisl: :hisG arg4: :hisG/arg4: :hisG GAL4IGAL4 :[pH]: :[pA] 
RPSI RPSL'[pTLO-/acZ-126] 
ura3L1::À/mm434 'ura3L1::Àimm434 hisl :hisG/hisl :hlsG arg4 :hisGlarg4 :hisG ga/4L1::ARG4·ga/4L1::HISl 
RPSI RPS/.:[pTLO-IacZ-126] 
ura3L1::Àimm434 'ura3L1::Àimm434 hisl :hisG/hlsl .hlsG arg4 :hisG-arg4 :hisG GAL4/GAL4::[pH]::[pA] 
RPSI RPS1.:[pTLO-/acZ-114] 
ura3L1:: Àimm434/ura3L1::Àimm434 hisl :hisG/hisl::hi.1G arg4 :hl.lG/arg4 :hisG ga14L1::ARG4/ga/4L1::H1Sl 
RPS1IRPSl ::[pTLO-lacZ-114] 
ura3L1::Àimm434Iura3L1::Àimm434 hisl::hisG/hlsl :hisG arg4 :hisGlarg4 :hisG GAL4/GAL4::[pH]::[pA] 
RPS1IRPS1::[pLATl-lacZ-270] 
ura3L1:: À/mm434/ura3L1:: Àimm434 hisl :hisGhisl :hlsG arg4 :hisG/arg4 :hisG ga/4L1: :ARG4Iga/4L1:: H1Sl 
RPS 1 IRPS 1:: [pLA Tl-IacZ-270] 
ura3L1::Àimm434Iura3L1::Àimm434 hisl :hisGlhisl::hisG arg4 :hisGlarg4 :hisG GAL4IGAL4::[pH]::[pA] 
RPSI IRPS 1:: [pLA Tl -lacZ-253] 
ura3L1::Àimm434Iura3L1::Àimm434 hisl::hisGlhisl::hisG arg4 :hisG/arg4 :hisG ga14L1::ARG4/gaI4L1::HISl 
RPS!IRPS!.: [pLA Tl-IacZ-253] 
ura3L1:: Àimm434/ura3L1::Àimm434 hisl :hisGlhisl::hisG arg4: :hisGlarg4: :hisG ga14L1 :HISl/GAL4 
Clp-/exa-GAL4 
ura3L1:: Àimm434·ura3L1:. Àimm434 hisl :hisGlhisl: :hlsG arg4::hisG/arg4: :hisG gal4L1 :HlS1IGAL4 
Clp-/exa-GAU-GCN4AD 
ura3L1:'Àimm434 'ura3L1::Àimm434 arg4 .·hisGlarg4::hisG hisl :h/.,G/hlsl :hisG :[pOPlacZ-HlSl] 
gcn4::Tn7-UAUl gcn4::Tn7 
ura3L1::Àimm434 ura3L1: : Àimm434 arg4::hlsG'arg4::hisG hisl :hlsGhl.d. 'hisG :[pOPlacZ-H1Sl] 
gcn4 .. Tn7-UAUl gLn4::Tn7 RPSI Rl'Sl .. [Clp-/exA] 
ura3L1:' Àimm434 Ura3L1.: À/mm434 arg4.:hlsG!arg4: :hisG hls 1: :hisG/hisl. 'hlsG: :[pOPlacZ-H1Sl] 
gen4.··Tn7-UAU1/gcn4::Tn7 RPSI RPS/."[Clp-lexA-GCN4] 
ura3L1:: À/mm434'ura3L1: : Àimm434 arg4::hisG·arg4: :hlsG hisl: :hlsGlhisl :hisG :[pOPlacZ-HIS/] 
gcn4:: Tn7-UAU//gen4.·: Tn7 RPS/RPS/::[Clp-/exA-GCN4L11-8/] 
ura3L1:: Àimm434-ura3L1:: À/mm434 arg4::hlsG/arg4::hlsG hlsl: :hlsG/hlsl. :hlsC; :[pOPlacZ-HIS1] 
gen4 .. Tn7-UAUl gen4.·:Tn7 RPS1RPS1::[Clp-/exA-GCN4L11-81 Ll247-323] 
APPENDIXA 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
(88) 
This study 
This study 
This study 
This study 
This study 
This study 
(188) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Table 2: Plasmids used in this study. 
Plasmids 
pYEC 
p37 
p37H 
p37U 
pSOD5-110 
Description 
CaARS CaURA3 
CaARSupstream tlank Ikb CaSOD5 downstream tlank Ikb 
CaARSupstream tlank Ikb CaHISldownstream tlank Ikb 
CaARSupstream tlank IkbhisG-CaURA3-hisG downstream tlank Ikb 
CaARSCaURA3 upstream tlank Ikb CaSOD5 downstream tlank Ikb 
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Source 
(205) 
This study 
This study 
This study 
This studv 
p5921 
pRMIOO 
pFA-HISI 
pFA-ARG4 
pHISI-GAL4 
pARG4-GAL4 
pOPlaeZ 
pOPlaeZ-HISl 
pCRlaeZ 
plexA-HISI 
Clp-lexA 
hisG-CaURA3-hlsG 
CaARS CaH/SI 
pFA6a backbone, CaHISI 
pF A6a backbone, CaARG4 
pF A6a backbone, upstream flan 600bp CaHISI downstream flank 500bp 
pF A6a backbone, upstream flan 600bp CaARG4 downstream flank 500bp 
CaADE2, laeZ, lexA operon, CaADH / basal promoter 
CaADE2, laeZ, lexA operon, CaADHl basal promoter, CaH/S/ 
CaADE2, laeZ, CaADHI basal promoter 
pFA-ARG4 backbone, promoterless CaHISI, lexA operon, ADH2 TATA box 
CaURA3, CaRPS/, promoter ofCaACTI, lexA 
Clp-lexA-GCN4 
Clp-lexA-GAL-I 
Clp-lexA-GCN4"16I-323 
Clp-lexA-GCN4"247-323 
Clp-lexA-GCN4"123-323 
Clp-lexA-GCN4"82-323 
Clp-lexA-GCN4"69-323 
Clp-lexA-GCN4!J56-323 
Clp-lexA-GCN4M2-323 
Clp-lexA-GCN4"/-81 
Clp-lexA-GCN4"l-8/ &47-323 
Clp-lexA- GAL4"l88-261 
Clp-lexA- GAIA"lO-/87 
Clp-lexA- GAIA-GCN4AD 
plac-poly 
Cal/RA 3, CaRPS/, promoterofCaACTI, lexA, CaGCN4 
Ca URA 3, CaRN,/, promoter of CaACTl, lexA, CaGAU 
Cal/RA 3, CaRPSI, promoterofCaACTI, lexA, CaGCN4"161-323 
CaURA3, CaRPSI, promoterofCaACT/, lexA, CaGCN4"247-323 
Cal/RA3, CaRPSI, promoter of CaACTI, lexA, CaGCN4"123-323 
CalfRA3, CaRPSI, promoter of CaACTI, lexA, CaGCN4!J82-323 
CalfRA3, CaRPSI, promoter of CaACT/, lexA, CaGCN4!J69-323 
CaURA3, CaRPSI, promoter of CaACTI, lexA, CaGCN4!J56-323 
CaURA3, CaRPSI, promoter of CaACT/, lexA, CaGCN4M2-323 
CaURA3, CaRPSI, promoterofCaACTl, lexA, CaGCN4"1-81 
CaURA3, CaRPSI, promoter of CaACT/, lexA, CaGCN4"/-8/ &47-323 
CaURA3, CaRPSI, promoter of CaACT/, lexA, CaGAL4!J188-26l 
CaURA3, CaRPSI, promoter ofCaACTl, lexA, CaGAL4"IO-188 
CaURA3, CaRPS/, promoter ofCaACT/, lexA, CaGAL4-GCN4AD 
CaURA3, RPS/, laeZ 
p TLO-laeZ-126 
p TLO-laeZ-1 09 
pLAT/-laeZ-270 
pLA Tl-laeZ-253 
pGALI O-laeZ 
pGALI O-laeZ-840 
pGALI 0-laeZ-188 
pGALI O-laeZ-176 
CaURA3, RPSI, laeZ, 126 bp promoter ofCaCTA2 
CaURA3, RPSI, laeZ, 114 bp promoter ofCaCTA2 
CaURA3, RPSl, laeZ, 270 bp promoter of CaLA Tl 
CaURA3, RPSI, laeZ, 253 bp promoter of CaLA Tl 
CaURA3, RPSI, laeZ, fulliength promoter of CaGALIO 
CaURA3, RPSI, laeZ, 840 bp promoter of CaGALIO 
CaURA3, RPSI, laeZ, 180 bp promoter of CaGALIO 
CaURA3, RPSI, laeZ, 176 bp promoter ofCaGAL/O 
pGALI O-laeZ-840â 176-188 CaURA3, RPS/, laeZ, 840 bp â176-188 promoter ofCaGALIO 
Table 3: Oligos used in this study. 
Oligos 
ODH 1 57(EeoRl) 
ODH 1 58(EeoRl) 
OMM 1 (BamHI) 
OMM2(BamHI) 
OMM3(XbaI) 
OMM4(XbaI) 
CB20R(BamHI) 
OMM8 
OMM9 
OMMIO 
OMM Il 
OMM 1 4 
OMM 1 5 
OMMI6 
OMMI7 
OMMI8(BamHI) 
OMMI9(XbaI) 
UOI06 
UOI07 
OMM46(Sall) 
OMM47(SunJ) 
OMM50(SunJ) 
OMM51 (Sunl) 
OMM56(MluJ) 
OMM57(Pstl) 
OMM58(Pstl) 
OMM59(Pstl) 
OMM60(Pstl) 
OMM61 (Pstl) 
OMM62(Pstl) 
OMM63 (Pstl) 
OMM71(Pstl) 
OMM66(MluI) 
OMM67(Pstl) 
OMM 1 25(Aatll) 
OMM87(SunI) 
Sequence 
ggaattcAAACCTGGTCT ACCAGAAGTT 
ggaattccGGTT ATGTT AACGGTT AGAG 
cgggatccGA TGAA TGGT AAGTT AGA TTGA T AT 
cgggatccGAAAAA T AAAA T AGA TGAGCCA TTT 
gctctagaAAAGAAAAA T AAAA T AGA TGAGCC 
gctctagaGGT ACCTGGAGGA TGAGGAG 
cgggatccAA T A TTTA TGAGAAACTATCACTTC 
GGAGCAGTAGAAGCCATACTA 
ATGGGCGAGTCCTACAAAACT 
ACCAGTGAATCATTTGAAGTT 
AGAAGCACTAGTTGATGAACC 
TCCAGAAGATGATGAAAGACATG 
GTCTAGCACCAGCATGACCAG 
AACACAACTTGCTTTGAGTTGAAA 
ACAATCACTAGAGATTCCGTGGAT 
cgggatccCGGTTA TGTT AACGGTT AGAG 
gctctagaAAACCTGGTCT ACCAGAAGTT 
AAGCCGGTTTTGCCGGTG 
TGGTGAACAATGGATGGAC 
caggtcgacGAGAA TGCCT ATTGACTTT AAAGG 
cttcgtacgCGAACAAA T A TTCGA T A T ACAAGCACT ACACA T AA TGGA TTT A 
GTCAATCATTTACCAG 
gtacgA T ACGAACAAA T A TTCGCAAA T ACGAACAAA T A TTCGCAAcccgggc 
gtacgcccgggTTGCGAA TA TTTGTTCGT ATTTGCGAA TATTTGTTCGTA Tc 
GTAATTGGTTTGTACCGCGAAATG 
CACCGTACGGACTGCAGCTC 
aactgcagttaAGT A TCTTCTCTTGGAACAAGAGCA 
aactgcagttaAGCT A T AGCAACACCA TCA TCA TTG 
aactgcagttaA TCATTGACTCCA TCCAAA TTGGTG 
aactgcagttaACCAA TTTCGTTTTTGGT AGCAACA 
aactgcagttaT ACACTGGAA TGGA TTTGAAA TGGA 
aactgcagttaTGAAGCCTTTTGCA TTTCTGGT AAA 
ccacgcgtatgACCAA TTTGGA TGGAGTCAA TGAT A 
ccacgcgtA TGTCTGAAACT AA TGAAA TCAAA TTGG 
aactgcag TCAAACGTT AACAGTTTCA TCGACC 
ttgacgtctA TGCCTGCT ACT ACTCCT A TT A TTT A TGAAGA 
ttcgtacgTGTTGGATTACCAAGCACTTAAGCAT 
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(88) 
(239) 
(100) 
(100) 
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(256) 
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(256) 
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(256) 
(256) 
This study 
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This study 
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This study 
This study 
(Brown A, not published) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Vsed to create 
SOD5 + Ikb flank F 
SOD5 + Ikb flank R 
Diverge SOD5 F 
Diverge SOD5 R 
Diverge SOD5 R 
CaH/SI F 
CaH/SI R 
SOD5 R Northem 
SOD5 F Northem 
SOD4 F Northem 
SOD4 R Northem 
SODI F Northem 
SODI R Northem 
SOD6 F Northem 
SOD6 R Northem 
SOD5 + Ikb flank R 
SOD5 + 1 kb flank F 
ACTl probe F 
ACTI probe R 
plexa-HIS/ R 
plexa-HISl F 
p/exa-H/Sl R 
plexa-HISI F 
Clp-lexA-GCN4's F 
Clp-lexA-GCN4"1-8I R 
Clp-lexA-GCN4"161-323 R 
Clp-lexA-GCN4"/23-323 R 
Clp-lexA-GCN4"82-323 R 
Clp-lexA-GCN4M2-323 R 
Clp-lexA-GCN4"69-323 R 
Clp-lexA-GCN4"56-323 R 
Clp-lexA-GCN4"l-8l F 
Clp-lexA-GAL4 F 
Clp-lexA-GAL4 R 
Clp-lexA-GAL4-GCN4AD 
gal4 knock out 
OMM88(BamHl) 
OMM89(Pmel) 
OMM90(Sacl) 
OMM95 
OMM96 
OMM99(BamHl) 
OMMI00(BamHl) 
OMMI15(Psll) 
OMMI16(Psll) 
OMMI23(Pst/+BsrGl) 
OMMI24(Psl/ + Bsnll) 
OMMI31(Psl/+Bsnll) 
OMMI32(Psl/+ Bsnll) 
OMM 133(Psll) 
OMM202(Pst/ + BamHl) 
OMM203(Psl/ + BamHl) 
OMM204(Psl/+ BamHl) 
OMM205(Pst/+ BamHl) 
OMM239(Zral) 
OMM240(Zral) 
OMM241 (PSIl) 
OMM242(Psll) 
OMM243(BamHl) 
acggatccGGCTGTTGGTAGTTTGGCGAA 
ctgtttaaacTGAGTTTGTTTTTT ATCGTTT AG TT 
acgagctcAACT AACCCAAAAAAAAA TCGT 
CAGATCTTTATACCCATGGTTG 
AAACATACTATGGAAATAAATACCACC 
ggggatccGGT A T AACTCTTTCTT A T AAAAA TCGG 
ggggatccGTTT AAGTTTTT A TT A TT ATGAGTTGT AT ATG 
ggctgcagTTGGTTCCTCTTCGTCAA TAT 
ggctgcagCTGAAGAAAACACA T AA T AAACGG 
gAGTGTAACGTTACATTGGTTCCTCTTCGTCAATATCAGATCTTCCCTCAO 
gtacaGTGAGGGAAGA TCTGA T A TTGACGAAGAGGAACCAA TGT AACGTT ACACTctgca 
gctgcagTTGGTTCCTCTTCGTCAA T A TCAGA TCTTCCCTCACt 
gtacaGTGAGGGAAGA TCTGA TA TTGACGAAGAGGAACCAActgcagctgca 
ggctgcaGGGCCCGTCGACAAG 
gCGGAGGTCGTGTCTCCGTCTACACTCTGGGTGTAGATGTCCCTATATATCAAGGTGG 
TATTTCCCTGACACAAACGTCGCATAAACCAACAAGAATAATTTTATCACACCTTTAT 
TTCCCCCCACCg 
APPENDIXA 
ga/4 knock out 
ga/4 knock out 
ga/4 knock out 
ga/4 knock out 
ga/4 knock out 
pGALIO-/aeZ 
pGALIO-/aeZ 
pGALI 0-/aeZ-840t.l 76-188 
pGALIO-/aeZ-840t.176-188 
pGAL/0-/aeZ-188 
pGALI 0-/aeZ-188 
pGALI 0-/aeZ-176 
pGALIO-/aeZ-176 
pGALIO-lacZ's 
p TLO-lacZ-/26 
gatccGGTGGGGGGAAA T AAAGGTGTGA T AAAA TT A TTCTTGTTGGTTT A TGCGACGTT P TLO-lacZ-/26 
TGTGTCAGGGAAATACCACCTTGATATATAGGGACATCTACACCCAGAGTGTAGACG 
GAGACACGACCTCCGctgca 
gTCTACACTCTGGGTGTAGATGTCCCT AT A TATCAAGGTGGTA TTTCCCTGACACAAA pTLO-laeZ-/09 
CGTCGCATAAACCAACAAGAATAATTTTATCACACCTTTATTTCCCCCCACCg 
gatccGGTGGGGGGAAA T AAAGGTGTGA T AAAA TT A TTCTTGTTGGTTT ATGCGACGTT pTLO-lacZ-/09 
TGTGTCAGGGAAA T ACCACCTTGA T A T AT AGGGACA TCTACACCCAGAGTGTAGActgca 
ttgacgtcTCCAA TTTGATTTCA TT AGTTTCAGA Clp-lexA-GAL4AD F 
CA TTGACGTCTCCTTCA TCGTT A TT A Clp-lexA-GAL4AD R 
ggctgcagTGGAAAACACCTCCCCG pLSC2-lacZ-504 F 
ggctgcagCAGCCCGGAAACAACAGG pLSC2-lacZ-487 F 
ggggatccTGTTGAAAAA T A T A T AGA TTATGAA T ATGT AA TA TCAG pLSC2-lacZ R 
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APPLICATION FOR USE OF LIVE ANIMALS IN RESEARCH 
- ANIMAL USE PROTOCOL -
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Prolocoll.D.# 02-011 
Part 1. COVER PAGE Slart Avril 2002 
1a. TITLE OF PROJECT Please give a title that generally describes the project. 
Role of the TLR-2 receptor in the resistance to Candida albicans infection. 
End March 2003 
1 b. SUMMARY OF PROCEDURES Describe the procedures to which the animais will be subjected (Use key words. See 
example at annexe A. 
Injection (intravenous), peritoneal lavage, fungal infection, tissue collection, breeding, euthanasia 
2. PRINCIPAL INVESTIGATOR 
Name (degree/title) 
Anne-Marie Alarco (Ph.D.)/ 
Post-doctoral fellow 
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Health sector/BRI 
3. NRC GROUP/SECTION AFFILIATION OF PROJECT 
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Strain AgeNVeight Sex 
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Telephone 
(work & home) 
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Telephone 
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Acule (Non-survival) Chronic Maximum Duralion of Survival, Chronic Max. Invasiveness (A-E) 
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